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ABSTRACT 
 
Present research was carried out with the main objective to determine the effect of 
different sources and combinations of gonadotrophin for superovulation on ovarian 
responses and subsequent embryo transfer (ET) performance in goats. A total of 5 
experiments had been designed. In Experiment 1, effect of supplementation of human 
chorionic gonadotrophin (hCG) or gonadotrophin releasing hormone (GnRH) on 
ovulation and subsequent embryo production of equine chorionic gonadotrophin (eCG) 
superovulated does were evaluated. In Experiment 2, effect of supplementation of hCG 
or GnRH on ovulation and subsequent embryo production of follicle stimulating 
hormone (pFSH) superovulated does were evaluated. The suitable gonadotrophin was 
selected from Experiments 1 and 2 for further research. In Experiment 3, effect of pFSH 
dosage based on body weight (BW) (3, 5 and 8 mg pFSH per kg BW) on superovulation 
performance was evaluated. In Experiment 4, effects of donor age (2-4 yr and >4 yr) 
and body weight (BW) (15-25 kg and >25 kg) on superovulation were evaluated. In 
Experiment 5, effect of recipient physical condition (surgery cycle) on pregnancy rate 
and subsequent kidding were evaluated. Oestrus was synchronised with a controlled 
intravaginal drug release device (CIDR) for 14 days and an i.m. injection of 
prostaglandin F2α (PGF2α) was carried out on Day 11. Subsequently superovulation 
was performed by using the exogenous gonadotrophin (eCG or pFSH) and initially 
administered on Day 12. eCG was administered with1500 IU in a single injection and 
pFSH was administered with 6 decreasing dosages (0800 to 0900 hr and 1900 to 2000 
hr) for 3 consecutive days. After CIDR removal, oestrus was observed 3 times every 
day. Natural mating and artificial insemination (AI) were performed after showing the 
oestrus. Recipient does synchronisation for ET was carried out by inserting CIDR for 14 
days and an i.m. injection of 300 IU eCG on Day 12. Embryo flushing from donor does 
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were carried out during the laparotomy session on Day 7 after CIDR removal, and 
subsequently embryos were transferred to the recipient does. The findings of the present 
research were as follows: a) hCG supplementation was needed for eCG-superovulated 
donor does for better ovulation synchronisation and structures recovery; b) for pFSH-
superovulated donor does, no difference was observed among the treatment groups; c) 
pFSH dosage based on BW had a significant effect on embryo production performances 
and 5 mg pFSH per kg BW performed better for embryo production; d) the donor does 
of 2 to 4 years of age and more than 25 kg BW performed better on the ovulation and 
embryo production performances; e) intact recipient does produced significantly higher 
number of pregnancy after ET than the recipient does used for different surgeries 
earlier. In conclusion, it was suggested that the dosage based on per kg BW as well as 
age and BW of the donor does affected the performances in ovarian response and 
embryo production of superovulated donor does for ET programme. 
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 ABSTRAK  
 
Objektif utama adalah untuk menentukan kesan sumber dan kombinasi yang berlainan 
gonadotrofin untuk superovulasi terhadap respons ovari dan prestasi pemindahan 
embrio berikutnya dalam kambing. Sebanyak 5 eksperimen telah direkabentuk. Dalam 
Eksperimen 1, kesan suplementasi gonadotrofin korionik manusia (hCG) atau hormon 
pelepas gonadotrofin (GnRH ) terhadap ovulasi dan pengeluaran embrio seterusnya 
daripda kambing betina yang disuperovulasi dengan  gonadotrofin korionik kuda (eCG) 
telah dinilai. Dalam Eksperimen 2, kesan suplementasi hCG atau GnRH terhadap 
ovulasi dan pengeluaran embrio berikutnya pada bambing betina yang disuperovulasi 
dengan hormon perangsang folikel (pFSH)  telah dinilai. Gonadotrofin yang sesuai 
dipilih daripada Eksperimen 1 dan 2 untuk penyelidikan selanjutnya.  Dalam 
Eksperimen 3, kesan dos pFSH  brasaskan berat badan ke atas prestasi superovulasi 
telah dinilai. Dalam Eksperimen 4, kesan umur penderma dan berat badan ke atas  
prestasi superovulasi  telah dinilai. Dalam Eksperimen 5, kesan keadaan fizikal 
penerima (kitaran pembedahan) terhadap kadar kehamilan dan kadar kelahiran 
berikutnya telah dinilai. Estrus telah disinkroni dengan controlled intravaginal drug 
release dispenser (CIDR) selama 14 hari dan suntikan i.m. prostaglandin F2α (PGF2α) 
telah dijalankan pada Hari 11. Selepas itu, superovulasi telah dilakukan dengan 
menggunakan gonadotrofin eksogenus (eCG atau pFSH) dan mulanya disuntik pada 
pada Hari 12. eCG telah disuntik dalam suntikan tunggal dan pFSH telah disuntik 
dengan 6 dos menuruan (pagi dan petang) selama 3 hari berturut-turut. Selepas 
penyingkiran CIDR, estus diperhatikan sebanyak tiga kali setiap hari. Pengawanan tabii 
dan permanian beradas (AI) telah dijalankan selepas kambing betina menunjukkan 
estrus.  Pensinkronian penerima bagi pemindahan embrio telah dijalankan dengan 
memasukkan CIDR selama 14 hari dan suntikan i.m. eCG pada Hari 12. Pengepaman 
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keluar embrio daripada penderma telah dijalankan semasa sesi laparotomi pada Hari 7 
selepas penyingkiran CIDR, dan kemudiannya embrio dipindahkan kepada penerima. 
Hasil kajian ini adalah seperti berikut: a) suplementasi hCG diperlukan untuk kambing 
betina disuperovulasi dengan eCG untuk ovulasi yang lebih baik dan perolehan struktur 
tetapi pengeluaran embrio adalah setara bagi kedua-dua perlakuan; b) untuk kambing 
betina penderma disuperovulasi pFSH, tiada perbezaan diperhatikan antara kumpulan 
perlakuan; c) dos pFSH  berdasarkan berat badan mempunyai kesan yang ketara ke atas 
prestasi pengeluaran embrio; d) umur dan berat badan kambing betina penderma 
mempunyai kesan signifikan keatas prestasi ovulasi dan pengeluaran embrio; e) 
kambing betina penerima utuh yang menghasilkan secara sigifikan yang lebih tinggi 
dalam kehamilan  selepas pemindahan embrio jika dibandingkan dengan penerima yang 
digunakan dalam pembedahan sebelumnya. Kesimpulannya, adalah dicadangkan 
bahawa dos berdasarkan per kg berat badan dan umur kambing betina penderma akan 
mempengaruhi respons ovari dan penghasilan embrio daripada kambing betina yang 
disuperovulasi untuk program pemindahan embrio. 
 
 
 
 
 
 
 
 
 
 
 
 
 
vii 
 
ACKNOWLEDGEMENTS 
 
All praises are due to Almighty Allah Subhanota’la, the supreme Authority of this 
universe, who has enabled me to complete this PhD research. 
 Valuable guidance and assistance have been received from many persons during 
the progress of this research. Though it is not possible to mention here the name of all 
the persons, I acknowledge their contribution with gratitude. However, it will be an act 
of ungratefulness if valuable guidance and encouragement received from some persons 
are not mentioned here. 
My heartfelt gratitude and respect is addressed to both of my supervisor, 
Professor Dr. Ramli bin Abdullah and Professor Dr. Wan Khadijah Wan Embong for 
their sincere and scholastic guidance, patience, endless encouragement, sacrifice their 
precious and valuable time in supervising and performing embryo transfer surgeries 
throughout this 3 years of candidature. I also thankful to my supervisors for providing 
me research assistantship throughout my candidature.  
I am deeply grateful to Professor Dr. A N M Aminoor Rahman for his valuable 
suggestions, important directions and profound encouragement to make me continue in 
the arena of higher education. I would cordially like to thank all my colleagues of the 
School of Agriculture and Rural Development, Bangladesh Open University and all my 
friends for their good-hearted feelings. 
My sincere gratitude is expressed to all the ABEL members for helping me 
during the research, exchange of knowledge and motivation. Special appreciation 
should goes to Mr. Parani Baya, Dr. Md. Mijanur Rahman, Dr. Kwong Phek Jin, Mr. 
Mohd Nizam B. Abd. Rashid, Ms. Soh Hui Hui, Ms. Asdiana Amri, Mrs. Azieatul 
Ashikin Bt. Abdul Aziz, Mrs. Nor Farizah Abdul Hamid, Mr. Xiao Zhi Chao, Ms. Tan 
viii 
 
Wei Lun, Mrs. Goh Siew Ying, Mrs. Siti Khadijah Binti Idris, Ms. Nurin Farhanah 
Norzaiwin, Ms. Siti Haslinda Mohd Sharif and Mr. Razali Jonit for their patience and 
unfailing helpful attitude. Appreciation is also addressed to all the staff in ISB Mini 
Farm. 
I would like to acknowledge Bangladesh Open University for providing me 
study leave during my candidature and University of Malaya for awarding me research 
grant IPPP (PV115/2011A) for funding this project. 
With deep sense of affection, I would like to express my heartfelt gratitude to 
my honorable mother and father who inspired me and gives endless encouragement and 
support. Although being far away from home, they remain connected at all times and 
thus create a positive mental enforcement for me to overcome the difficult and 
challenging work. I would like to offer my deepest appreciation to all of my family 
members and relatives who encouraged me numerously at all stages of my study. 
Finally, I could never forget my wife and daughters Rayeesah, Jannah and Amirah who 
always inspired me and sacrificed their happiness for completion of this research. 
May Allah bless them and accept all the good deeds. 
 
Sincerely, 
Rokib 
  
ix 
 
TABLE OF CONTENTS 
 
Contents  Page 
  
DECLARATION ii  
ABSTRACT iii  
ABSTRAK v  
ACKNOWLEDGEMENTS  vii  
TABLE OF CONTENTS  ix  
LIST OF TABLES  xiii  
LIST OF FIGURES  xiv  
LIST OF SYMBOLS AND ABBREVIATIONS  xvi  
  
CHAPTERS  
Chapter 1  
1.0  INTRODUCTION  1-8  
1.1  BACKGROUND  1  
1.2  STATEMENT OF PROBLEMS  4  
1.3  JUSTIFICATION OF THE PRESENT RESEARCH 5  
1.4  OBJECTIVES OF THE PRESENT RESEARCH  8 
  
Chapter 2  
2.0  REVIEW OF LITERATURE  9-38  
2.1  TIMELINE OF SUPEROVULATION AND EMBRYO 
TRANSFER (ET) IN GOATS  
9  
2.2  REPRODUCTIVE CYCLE OF GOAT 15  
2.3 FACTORS AFFECTING SUPEROVULATION IN 
GOAT 
18 
    2.3.1  Progestagen 18  
    2.3.2  Source of Gonadotrophin  21  
    2.3.3  Protocol for Oestrus Synchronisation and 
Superovulation 
23  
 
    2.3.4 Follicular Waves 25 
x 
 
    2.3.5 Follicular Status 26 
    2.3.6 Breed 27 
    2.3.7 Age 27 
    2.3.8 Nutrition 28 
    2.3.9 Season of the Year 29 
    2.3.10 Movement of Donor, Recipient and Embryo 30 
    2.3.11 Embryo Transfer in Malaysia 30 
2.4 FACTORS AFFECTING SURVIVABILITY OF 
TRANSFERRED EMBRYO IN GOAT 
32 
    2.4.1 Synchrony of the Onset of Oestrus between the Donor 
and Recipient Does 
33 
    2.4.2 Ovulation Rate and Progesterone Level 33 
    2.4.3 Ovulation and Transfer Site 34 
    2.4.4 Quality of Transferred Embryo 35 
    2.4.5 Number of Transferred Embryo 36 
    2.4.6 Method of Embryo Transfer in Goats 36 
    2.4.7 Origin of the Embryos Transferred 37 
   
Chapter 3   
3.0 MATERIALS AND METHODS 39-65 
3.1 LOCATION OF STUDY 39 
3.2 MATERIALS 39 
    3.2.1 Experimental Goats and Their Management 39 
    3.2.2 Reagent and Media 40 
            3.2.2.1 Preparation and use of normal saline solution 40 
            3.2.2.2 Preparation of embryo flushing medium 40 
            3.2.2.3 Preparation of embryo holding medium 41 
    3.2.3 Equipment 43 
            3.2.3.1 Ultrasound scanner 44 
3.3 METHODS 45 
    3.3.1 Ultrasonography of Experimental Animal 45 
    3.3.2 Oestrus Synchronisation of Donor and Recipient Does 45 
    3.3.3 Oestrus Detection and Breeding 48 
    3.3.4 Surgical Procedure for Ovarian Responses Assessment 
and Embryo Flushing 
48 
xi 
 
    3.3.5 Embryo Transfer 52 
3.4 EXPERIMENTAL DESIGN 53 
    3.4.1 Effect of Supplementation of hCG or GnRH on 
Ovulation and Subsequent Embryo Production of eCG-
Superovulated Does (Experiment 1) 
53 
 
    3.4.2 Effect of Supplementation of hCG or GnRH on 
Ovulation and Subsequent Embryo Production of pFSH-
Superovulated Goats (Experiment 2) 
56 
    3.4.3 Effect of pFSH Dosage Based on BW on 
Superovulation Performance (Experiment 3) 
58 
    3.4.4 Effect of Donor Age and BW on Superovulation 
Performance (Experiment 4) 
59 
    3.4.5 Effect of Recipient Physical Condition on Pregnancy 
Rate and Subsequent Kidding (Experiment 5) 
60 
3.5 STATISTICAL ANALYSIS 62 
 
Chapter 4   
4.0 RESULTS 66-89 
4.1 EFFECT OF SUPPLEMENTATION OF hCG OR 
GnRH ON OVULATION AND SUBSEQUENT 
EMBRYO PRODUCTION OF eCG- 
SUPEROVULATED GOATS (EXPERIMENT 1) 
66 
4.2 EFFECT OF SUPPLEMENTATION OF hCG OR 
GnRH ON OVULATION AND SUBSEQUENT 
EMBRYO PRODUCTION OF pFSH- 
SUPEROVULATED GOATS (EXPERIMENT 2) 
71 
4.3 EFFECT OF pFSH DOSAGE BASED ON BW ON 
SUPEROVULATION PERFORMANCE 
(EXPERIMENT 3) 
75 
4.4 EFFECT OF DONOR AGE AND BW ON 
SUPEROVULATION PERFORMANCE 
(EXPERIMENT 4) 
82 
4.5 EFFECT OF RECIPIENT PHYSICAL CONDITION 
ON PREGNANCY RATE AND SUBSEQUENT 
KIDDING (EXPERIMENT 5) 
86 
 
xii 
 
Chapter 5   
5.0 DISCUSSION 90-123 
5.1 EFFECT OF SUPPLEMENTATION OF hCG OR 
GnRH ON OVULATION AND SUBSEQUENT 
EMBRYO PRODUCTION OF eCG-
SUPEROVULATED GOATS (EXPERIMENT 1) 
90 
5.2 EFFECT OF SUPPLEMENTATION OF hCG OR 
GnRH ON OVULATION AND SUBSEQUENT 
EMBRYO PRODUCTION OF pFSH-
SUPEROVULATED GOATS (EXPERIMENT 2) 
95 
5.3 EFFECT OF pFSH DOSAGE BASED ON BW ON 
SUPEROVULATION PERFORMANCE 
(EXPERIMENT 3) 
99 
5.4 EFFECT OF DONOR AGE AND BW ON 
SUPEROVULATION PERFORMANCE 
(EXPERIMENT 4) 
104 
5.5 EFFECT OF RECIPIENT PHYSICAL CONDITION 
ON PREGNANCY RATE AND SUBSEQUENT 
KIDDING (EXPERIMENT 5) 
108 
5.6 GENERAL DISCUSSION 112 
    5.6.1 Summary of Significant Findings and Strength of the 
Research 
118 
    5.6.2 Constraints of the Present Research 119 
    5.6.3 Future Directions 122 
 
Chapter 6   
6.0 CONCLUSIONS 123 
REFERENCES  125 
APPENDICES  147 
 APPENDIX 1: LIST OF MATERIALS 147 
 APPENDIX 2: STATISTICAL DATA 150 
 APPENDIX 3: LIST OF PUBLICATIONS 
APPENDIX 4: OESTRUS DISTRIBUTION 
 
 
171 
172 
xiii 
 
LIST OF TABLES 
 
Table  Page 
2.1 Timeline of selected milestones of superovulation and ET in goat 9 
2.2 Summary of the features of the main pharmacologic treatments 
available to control reproduction in small ruminants 
20 
3.1 Composition of normal saline solution 40 
3.2 Composition of flushing medium 41 
3.3 Composition of KSOMaa stock solution 42 
3.4 Composition of in vitro culture medium-KSOMaa A 43 
3.5 Composition of in vitro culture medium-KSOMaa B 43 
4.1 Ovarian stimulation upon hCG or GnRH on ovulation after eCG 
superovulation 
67 
4.2 Effect of hCG or GnRH supplementation on embryo production 
characteristics of eCG superovulated does 
70 
4.3 Ovarian stimulation upon hCG or GnRH on ovulation after pFSH 
superovulation 
72 
4.4 Effect of hCG and GnRH on embryo production characteristics after 
pFSH superovulation 
74 
4.5 Ovarian stimulation upon pFSH dosages based on BW 76 
4.6 Effect of pFSH dosages based on BW on embryo production 
characteristics 
78 
4.7 Correlation coefficient among the characteristics of ovarian stimulation 
and embryo production performances for different treatment groups   
81 
4.8 Ovarian stimulation based on donor age and BW 83 
4.9 Effect of donor does age and BW on embryo production characteristics 85 
4.10 Effect of recipient surgery cycle on pregnancy rate and kidding 87 
5.1 Research objectives achievement 119 
6.1 A summary of the proposed protocols for the superovulation and ET 125 
xiv 
 
LIST OF FIGURES 
Figure  Page 
2.1 Schematic representation of the different physiological events 
occurring during oestrous cycle in goat: pattern of follicle 
development, ovarian cycle and endocrine reglutions. *Ovulatory 
follicle(s) (Adapted from Fatet et al., 2011). 
17 
2.2 Schematic representation comparing the Day 0 Protocol vs. the 
traditional protocol for superovulation in goats. (Adapted from 
Menchaca et al., 2007). 
23 
2.3 Schematic representation of NCSynch-TAI protocol for goats. 
(Adapted from Bowdridge et al., 2013). 
25 
2.4 Follicular dynamics ( X  ± S.E.M.) in goats with 4-wave pattern of 
follicular growth (Adapted from Tenorio Filho et al., 2007). 
26 
2.5 Effect of plane of nutrition and diet type during oocyte maturation on 
ruminant embryo development following superovulation and/or in vitro 
embryo production (Adapted from Robinson et al., 2006). 
29 
3.1 Ultrasound machine ALOKA SSD500 equipped with 7.5 MHz   
transrectal probe. 
44 
3.2 Thermic printer Sony UP-860. 44 
3.3 Scanning procedure of goat. 45 
3.4 EAZI-BREED CIDR. 46 
3.5 CIDR applicator. 46 
3.6 CIDR insertion for oestrus synchronisation. 47 
3.7 CIDR withdrawal. 47 
3.8 i.v. injection of anaesthetic.  49 
3.9 Goat on surgery cradle. 49 
3.10 Surgical set arranged on surgery table. 50 
3.11 Assessment of ovarian responses. 51 
3.12 Superovulated ovary. 51 
3.13 Embryo flushing procedure. 51 
3.14 Embryo searching procedure. 52 
3.15 ET procedure for recipient does. 53 
3.16 Schematic representation of the superovulation protocol using eCG.  
a) Control, b) hCG and c) GnRH. 
55 
xv 
 
3.17 Schematic representation of the superovulation protocol for pFSH.  
a) Control, b) hCG and c) GnRH. 
57 
3.18 Schematic representation of the superovulation protocol using different 
dosages of pFSH based on BW (Expt 3). 
59 
3.19 Schematic representation of the superovulation protocol for evaluating 
donor age and BW using pFSH (Expt 4).  
60 
3.20 Schematic representation of the oestrus synchronisation protocol for 
recipient does. 
61 
3.21 Flow chart of experimental design. 63 
3.22 Flow chart of experimental activity. 65 
4.1 Superovulated ovary with CL. 68 
4.2 Superovulated ovary with anovulatory follicles. 68 
4.3 Recovered embryos during the embryo flushing. 79 
4.4 Recovered unfertilised oocytes during the embryo flushing. 79 
4.5 Typical ultrasound image of a recipient doe before ET. 88 
4.6 Typical ultrasound image of a pregnant recipient doe after 37 days of 
ET. 
88 
4.7 ET kids with recipient doe. 89 
4.8 Twins ET kids from Figure 4.6 just after delivery. 89 
5.1 Flow chart of steps involved in oestrus synchronisation, superovulation 
and ET. 
113 
   
   
   
   
xvi 
 
LIST OF SYMBOLS AND ABBREVIATIONS 
 
% Percentage 
β Beta 
MHz Megahertz 
μg Microgram 
ml Millilitre 
mm Millimetre 
cm Centimetre 
hr Hour 
g Gram 
w/v Weight/volume 
ABEL Animal Biotechnology-Embryo Laboratory 
AI Artificial insemination 
ANOVA Analysis of variance 
ARTs Advances reproductive technologies/ assisted 
reproductive technologies 
BW Body weight 
CIDR Controlled intravaginal drug release device 
CL Corpus luteum 
ET Embryo transfer 
eCG Equine chorionic gonadotrophin 
e.g. For example 
et al. et alii (and other) 
FSH Follicle stimulating hormone 
FGA Fluorogestoneacetate 
G Gauge 
g/d Gram per day 
g/h/d Gram per head per day 
GnRH Gonadotrophin releasing hormone 
hCG Human chorionic gonadotrophin 
hr Hour 
HAP Horse anterior pituitary 
IPPP Institute of Research Management and Monitoring 
IU International unit 
xvii 
 
IVC In vitro culture 
i.e. That is 
i.v. Intravenous 
i.m. Intramuscular 
KSOM Pottasium Simplex Optimisation Medium 
KSOMaa Pottasium Simplex Optimisation Medium with amino 
acid 
kg Kilogram 
Kg/h/d Kilogram per head per day 
LH Luteinising hormone 
LOPU Laparoscopic ovum pick-up 
NaCl Sodium chloride 
NaTuRe Nuclear Transfer and Reprogramming Laboratory 
MAP Melengestrolacetate 
mg Milligram 
ng/ml Nanogram per milliliter 
oFSH Ovine-derived FSH 
PBS Phosphate buffered saline 
PGF2α Prostaglandin F 2 alpha 
PMSG Pregnant mare’s serum gonadotrophin 
PVP Polyvinylpyrrolidone 
pFSH Porcine-derived FSH 
yr Year 
± Plus minus 
> Greater than 
< Smaller than 
 
1 
 
Chapter 1 
1.0 INTRODUCTION 
 
1.1 BACKGROUND 
Developing countries produced about 95% of world goat population and signifying its 
importance in alleviation of poverty in those nations (FAO Statistical Yearbook, 2012). 
It had some superior traits, such as ability to survive well under harsh climatic 
conditions, adaptability of the breeds and ability to produce high quality meat, milk, 
skin and hair. This specie was gaining popularity worldwide particularly for meat and 
milk production. Goat meat production had been increased by 1.8% in the world and 
8.3% in Malaysia from 2000 to 2010 (FAO Statistical Yearbook, 2012).  
In Malaysia, the goat population was still relatively low which approaches 
505,034 heads in the year 2012 (DVS, 2012). Number of goats slaughtered in the year 
2012 was 38,552 heads and produced 3,156 metric tonnes mutton (goat and sheep meats 
were commonly termed as mutton in Malaysia), which fulfilled only approximately 
13% of the countries demand of total 24,522 metric tonnes mutton (DVS, 2012). 
Therefore, Malaysia needed to import approximately 87% of the total mutton 
requirement to fulfil the country’s demand (DVS, 2012). Malaysian goat population 
comprised of the indigenous Katjang (small-framed animals), Jermasia, purebred and 
crossbred of other imported exotic breeds such as Jamnapari, Boer, Australian feral 
goat, Saanen, Toggenberg, Alpine and Anglo-Nubian. The Katjang goat was primarily a 
meat producer and was known for its heat and tick tolerance, prolificacy and ability to 
breed all the year round even with sub-optimal nutrition. Owing to low mature body 
weight (BW) (male:- 25 kg and female:- 20 kg) and low BW gain (55 g/d until 12 
months of age), it was very much difficult to fulfil country’s demand with this breed. As 
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a consequence, Malaysia imported purebred Boer goats for improving the goat 
production which regularly crossed with the local stock. These Boer crossbred goats 
were more adaptive to the local condition. However, these crossbred goats were rarely 
used in different scientific research related to assisted reproductive technologies (ARTs) 
for further development.  
ARTs such as artificial insemination (AI), oestrus synchronisation, 
superovulation and embryo transfer (ET) had been introduced to overcome reproductive 
inefficiencies in goats, and accelerate genetic gain (Bilton and Moore, 1976; Nicholas, 
1996). Using AI technology, benefit from male germplasm could be optimised via pure-
breeding and cross-breeding, however, the female potential remained untouched. 
Superovulation is traditionally considered to be the main approach to utilise the superior 
female genetic potential effectively in order to produce high number of quality embryos 
from each donor at a rapid rate. Technology such as superovulation and ET could 
improve the productivity of a breed by increasing the rate of genetic progress (Nicholas, 
1996) and the number of offspring by up to 10 folds (Bilton and Moore, 1976). 
Superovulation and ET techniques had the potential to increase the selection differential 
by shortening the generation interval (Baldassarre and Karatzas, 2004). From a health 
point of view, it had the potential to facilitate safe worldwide movement of germplasm, 
provides that management and handling of the animals and embryos in accordance to 
good animal husbandry practices (GAHP) (Thibier and Guerin, 2000). In a standard 
situation, superovulation and ET research requires donor and recipient does in excellent 
body condition with known genetic and reproductive performances.  
Superovulation and ET is a systematic programme consists of management of 
donor and recipient does, oestrus synchronisation of donor and recipient does, 
superovulation of donor does, natural mating or artificial insemination, embryo 
collection by flushing fallopian tubes, evaluation of collected embryos and subsequently 
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transfer of the embryos to the fallopian tube of recipient does. The first successful 
superovulation and ET was reported in rabbit by Walter Heape in 1891 (Betteridge, 
2003). In goat, the first superovulation and ET was reported by Warwick et al. in 1934 
(Rahman et al., 2008). Till now, three main methods of ET, namely, laparoscopic ET, 
surgical ET and transcervical ET had been reported in small ruminants (McKelvey et 
al., 1985) of which laparoscopic ET was more successful (Abdullah et al., 1995; Ishwar 
and Memon, 1996; Shin et al., 2008). However, the outcome of any superovulation and 
ET programme was inconsistent, which was the major drawback for the success of 
superovulation and ET technology (Cognie, 1999). Use of exogenous gonadotrophin, 
fertilisation failure, anovulatory follicles, breed, season, donor age and reproductive 
status at the onset of a superovulatory treatment, nutrition, management, stress were 
some factors responsible for superovulation variation (Baril and Vallet, 1990; Goel and 
Agrawal, 1990; Gonzalez-Bulnes et al., 2004a). At the same time different factors 
influenced the survivability of transferred embryos in recipient does such as types of 
embryos, quality of embryos, number of embryos and site of transfer, number of corpus 
luteum (CL) in recipient does (Armstrong et al., 1983a; Mani et al., 1994; Ishwar and 
Memon, 1996; Bari et al., 2003; Guignot et al., 2006; Siqueira et al., 2009). 
In Malaysia, most of the goats were produced from random mating or non-
systematic breeding plan which was low in number and quality as well as unknown 
genetic and reproductive backgrounds. Consequently, variable results were obtained 
when compared with the standard protocols as recommended by the researchers in 
different countries, particularly in temperate region, who were using optimised animals 
for research. In addition, little research had been conducted to determine the productive 
and reproductive traits of Boer crossbred goats in Malaysian local condition. Currently, 
there had some reports on Malaysian goat research such as on growth performance 
(Vadiveloo, 1988; Hirooka et al., 1997) and heterosis (Tsukahara et al., 2008) of 
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crossbred goats (e.g., German Fawn x Katjang) under Malaysian condition. In spite of 
this, there is a scarcity of published information on superovulation and ET efficiency in 
non-descriptive Boer crossbred goats.  
 
1.2 STATEMENT OF PROBLEMS 
In general, the number of research on goat superovulation and ET is comparatively low 
than cattle and sheep. Therefore, there are many areas of research that can be carried out 
to increase the superovulation and ET performance. Although there are some valuable 
improvements have been achieved, some major questions have yet to be answered: 
a) Can ovarian stimulation inconsistency in a superovulation programme be 
solved? 
b) Can anovulation problem in a superovulation programme be solved? 
c) Can unfertilisation problem in a superovulation programme be solved? 
d) What is the appropriate dosage of gonadotrophin based on BW for 
superovulation programme?  
e) What is the effect of luteinising hormone (LH) such as human chorionic 
gonadotrophin (hCG) or gonadotrophin releasing hormone (GnRH) 
supplementation in equine chorionic gonadotrophin (eCG) or porcine follicle 
stimulating hormone (pFSH) superovulated donor does? 
f) What is the suitable age of donor does for producing good quality and quantity 
embryo in a superovulation programme? 
g) What is the suitable BW for producing good quality and quantity embryos in a 
superovulation programme? 
h) What is the suitable combination for age and BW for better superovulation 
programme? 
i) When is the best time to do embryo flushing? 
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j) How many times can the superovulation technique be repeated in the same 
valuable donor does? 
k) Which method is better for embryo flushing; oviduct flushing or uterine horn 
flushing? 
l) How many embryos can be transferred into one recipient doe for maximising kid 
production? 
m) Which stages of embryos give better survival rate in recipient doe? 
n) What is the physical condition (used for surgery or not) of recipient does 
suitable for embryo survival?  
o) What is the suitable age of recipient doe for better pregnancy and kidding rates?  
p) What are the factors affecting early pregnancy loss in ET recipient does? 
q) How early can the pregnancy be diagnosed using ultrasound scanner in ET 
recipient does? 
 
1.3        JUSTIFICATION OF THE PRESENT RESEARCH 
Justification on the need and importance of this research was addressed by focusing on 
4 issues based on scientific discovery and possible application in goat industry. Firstly, 
why goat was chosen as the experimental animal for this research? Secondly, how 
superovulation and ET was beneficial to goat industry? Thirdly, why gonadotrophin 
(pFSH) dosage was so important for caprine superovulation? Fourthly, why the physical 
condition of donor and recipient does in ET was important?  
Goat was selected for this research due to some special characteristics such as 
ability to survive well under harsh climatic conditions, ability to produce high quality 
meat, milk, skin and hair. It had relatively short gestation period, multiple litter size and 
has potentiality to produce different bioactive protein in its milk through transgenesis. 
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Goat meat contained relatively less intramuscular fat than other red meat and steadily 
becoming a choice meat for health conscious society (Brzostowski et al., 2008). Goat 
milk fat globule size was very small compared to cow milk and easily digestible due to 
higher levels of medium chain fatty acids. Therefore, any age group of people could 
take goat milk without any major digestive complication (Attaie and Richter, 2000). It 
gained popularity worldwide particularly for meat and milk production. As a multiracial 
and multi-religious country, goat meat was more acceptable to all the citizen of 
Malaysia. Due to those good characteristics of goat meat and milk as well as high 
demand and low supply of goats in Malaysia, this project was undertaken to add 
knowledge on how to increase goat production in this country through superovulation 
and ET.    
ET was a powerful tool for multiplication of superior animals. In a successful 
goat superovulation and ET programme, an average of 6 to 8 transferable embryos per 
donor doe could be produced. However, this result might vary (range from 0 to 30 per 
donor) due to many factors including exogenous gonadotrophin, breed, age and 
nutrition. Superovulation and ET helped to increase the number of animals with high 
genetic merit at a rapid rate. For example, in natural breeding, a single female doe could 
produce annually 1 to 3 progenies but using superovulation and ET technologies, it was 
feasible to collect around 30 to 50 embryos from one female per year. Superovulation 
and ET also helped in the constant supply of different animal products (meat, milk and 
skin) in the market by breeding animal out of the breeding season which showed 
seasonality in breeding like goat (Leboeuf et al., 2000). Superovulation facilitated safe 
worldwide movement of germplasm of superior animal (Thibier and Guerin, 2000). 
Using this technology, goat could be a good model animal to transform from animal 
farming to animal pharming by producing different recombinant pharmaceutical 
proteins in its milk (Paramio and Izquierdo, 2014). To achieve this objective, ET was an 
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essential technique among the assisted reproductive technologies due to the requirement 
of all the desired manipulated embryos to be transferred to produce offspring. With the 
improvement of ET and related techniques, the target to produce superior goats for the 
industry could possibly be achieved. 
For goat superovulation research, a wide range of goat breed was used and 
mature body weight (BW) of goat was a breed dependent character which varies from 
20 to 70 kg. Superovulatory treatment of pFSH in goat mainly consisted of 200 mg 
pFSH without considering the size of the goat and also produced variable results 
(Menchaca et al., 2007; Lehloenya and Greyling, 2010a; Yuan et al., 2011; Xiao et al., 
2013). Thus, the dosage of gonadotrophin might be a cause of variation in 
superovulation response. Theoretically, it seemed that the goat with larger BW needed 
more pFSH than the smaller goat. For example, obese women required higher dosage of 
gonadotrophin and produced fewer follicles (Souter et al., 2011). Some researchers used 
different dosages of pFSH for superovulation without considering the BW of goat 
(Chang et al., 2006; Yuan et al., 2011; Abdullah et al., 2012) and cattle (Ali et al., 
2012). Thus, the dosage of pFSH according to BW was the matter of research interest 
for producing consistent and optimal result of the superovulation programme. 
Age and BW influenced the reproductive events of goat such as onset of 
puberty, kidding, litter size and birth weight. In farm animals, age and BW of does had 
positive correlation with the reproductive traits (Constantinou, 1989; Safari and 
Fogarty, 2003; Flores et al., 2008; Snyman, 2010). Therefore, for superovulation 
programme, age and BW factor should be considered for the donor doe since it had been 
shown to influence the production of subsequent embryos. Pregnancy and kidding were 
the last stages as an acid test of in vivo development in which the success of any goat 
superovulation and ET programme depended on. Generally, high number of does was 
needed for transferring embryos in any superovulation programme. A lot of does used 
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for different ARTs such as laparoscopic ovum pick up (LOPU), superovulation and ET 
research. Recycling as a recipient of that does which used for multiple surgeries could 
supply the abundant number of recipients in the ET programme. However, there was no 
data to substantiate whether any difference between intact recipient does and repeated 
surgery recipient does with regard to ET performance. 
 
1.4        OBJECTIVES OF THE PRESENT RESEARCH 
General objective of this research was to evaluate the reproductive performance of 
“non-descriptive” Boer crossbred goats under local condition in our effort to increase 
knowledge with an intention to improve goat production through reproductive 
technologies (specifically superovulation and ET approaches) in Malaysia. This study 
was conducted according to following specific objectives: 
a) To compare the effect of eCG or pFSH on superovulation responses and embryo 
production efficiency with or without supplementation of LH (hCG or GnRH). 
b) To evaluate the effect of gonadotrophin dosages based on BW on the 
superovulation responses and embryo production efficiency.  
c) To evaluate the effect of donor age on the superovulation responses and embryo 
production efficiency by using pFSH dosage based on BW.  
d) To evaluate the effect of donor BW on the superovulation responses and embryo 
production efficiency by using pFSH dosage based on BW. 
e) To evaluate the effect of recipient doe physical condition (surgery cycle) on 
pregnancy rate and subsequent kidding. 
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Chapter 2 
2.0 REVIEW OF LITERATURE 
 
2.1 TIMELINE OF SUPEROVULATION AND EMBRYO TRANSFER (ET) 
IN GOATS 
Table 2.1: Timeline of selected milestones of superovulation and ET in goat 
Year Author Significant event/ finding 
1949 Warwick et al. The first successful embryo transfer in goat with 
production of kids. 
1983 Armstrong et al. Ovarian responses varied in FSH- and eCG-
superovulated does due to the difference in the 
biological half-life of the gonadotrophin 
preparation. 
1989 Tsunoda and Sugie.  Development of the 2-cell, 4-cell, 8-cell, morula, 
blastocyst and zona-free blastocyst stage embryo 
were first observed 1.5, 2.5, 5.0 to 5.5, 6.0 and 6.5 
days after hCG administration, respectively. 
1990 Amoah and Gelaye Does could be superovulated and prepared for ET at 
anytime during the year. 
1992 Rosnina et al. Katjang goats were synchronised and superovulated 
with FSH or eCG in Malaysia. FSH performed 
better than eCG and 50% of does responded during 
the rainy season compared with less than 35% 
during the dry season. 
(continued) 
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(continued) 
Year Author Significant event/ finding 
1993 Wheaton et al. CIDR had been replaced successfully for 
intravaginal sponges for oestrus synchronisation, 
superovulation, AI and ET, and provided a 
convenient means for delivering exogenous 
progesterone. 
1995 Abdullah et al. Kids were produced through laparoscope assisted 
ET. 
1996 Keskintepe et al. The first report on in vitro goat embryos 
development to the blastocyst stage and obtained 
offspring following uterine transfer. 
1996 Mani et al. Short-term under nutrition appeared to decrease 
reproductive performance by interfering with 
gonadotrophin release. 
1997 Shamsul Azlin Two sets of twins kids were produced of through 
ET in Malaysia. 
1998 Saharrea et al. Premature luteal regression in goats superovulated 
with eCG could be prevented by administering hCG 
at 84 hr after the onset of oestrus.  
1999 Gonzalez-Bulnes et al. Donor and recipient does could be selected by 
assessing the multiple ovulations using transrectal 
ultrasonography. 
(continued) 
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(Continued) 
Year Author Significant event/ finding 
2001 Pierson et al. Season of the year shifted the time for onset of 
oestrus, LH surge and ovulation after sponge 
removal but the intervals between onset of oestrus 
and LH surge; LH surge and ovulation were not 
affected throughout the different seasons. 
2002 Menchaca et al. Presence of dominant follicle at the time of 
initiation of superstimulatory treatment was 
detrimental to ovulatory response. 
2003 Lima-Verde et al. Embryo recovery was carried out using 
transcervical technique. 
2003 Gonzalez-Bulnes et al. Variability in response to the superovulatory 
protocols were related with follicular status of the 
donor at the beginning of the treatment. The 
number of recovered and viable embryos were 
positively correlated with the total number of 
follicles with a diameter of 4 to 6 mm. 
2003 Medan et al. Inhibin antiserum treatment might be an alternative 
to the use of exogenous gonadotrophins for 
induction of superovulation in goats. 
2003 Pierson et al. GnRH treatment reduced the time duration between 
sponge removal to ovulation and improved 
ovulation synchronisation. Season affected the 
timing and the synchrony of estrus. 
(continued) 
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(continued) 
Year Author Significant event/ finding 
2003 Senthil Kumar et al. The presence of high levels of oestradiol at the time 
of implant insertion and onset of gonadotrophin 
treatment might have an unfavourable impact on the 
superovulatory response. Furthermore, the 
oestradiol producing capacity of anovulatory 
follicles had more negative impact on embryo 
recovery rate and embryo quality than their 
numbers. 
2005 Medan et al. Goat ovarian follicles developed in a wave-like 
pattern and follicular dominance was less apparent. 
Moreover, inhibin A might be regulated the 
follicular wave in goat by suppressing FSH 
secretion.  
2006 Lehloenya et al. Pre-treatment with GnRH was unfavourable for 
pFSH superovulation protocol during outside the 
natural breeding season. 
2007 Mohd Noor Hisham Effect of oestrus synchronisation and 
superovulation on progesterone and oestradiol 
levels in relation to oocyte recovery in goats. 
2007 Cervantes et al. Embryo recovery could be improved in 
superovulated dairy goats by inserting FGA after 
mating. 
(continued) 
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(continued) 
Year Author Significant event/ finding 
2007 Menchaca et al. Day 0 Protocol was effective in initiating 
superovulatory treatment in the absence of a large 
follicle and produced better superovulatory 
performance compared to the traditional protocol. 
2008 Souza et al. Supplementation of low doses of exogenous insulin 
was enhanced embryo quality in superovulated 
goats. 
2008 Lehloenya et al. Season had an effect on the time to onset and the 
duration of the induced oestrous period of pFSH 
superovulated goats but superovulation and embryo 
production performances were similar for the 
natural breeding season and the non-breeding 
season. 
2009 Wang et al. Active immunisation against inhibin might be an 
alternative to the use of exogenous gonadotrophin 
for superovulation protocols in goats. 
2010 Lehloenya and 
Greyling 
The mean number of transferable embryos was 
significantly higher in the adult than in the young 
Boer goats. 
2010 Lehloenya and 
Greyling 
Addition of a PGF2α had no effect on the 
superovulatory protocol following a long 
progestagen synchronisation treatment in Boer 
goats. 
(continued) 
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(continued) 
Year Author Significant event/ finding 
2010 Lehloenya and 
Greyling 
Embryo survival rate was less acceptable following 
the transfer of either fresh or cryopreserved 
embryos. 
2010 Heidari et al. GnRH antagonist treatment could improve the 
superovulatory response by 64% and embryo 
recovery rate by 90% in goats. 
2011 Souza et al. Autoclaved, previously used intravaginal 
progesterone releasing devices resulted in 
significant lesser plasma progesterone 
concentrations than new devices, but were similarly 
effective in inducing oestrus and ovulation in 
anestrus goats. 
2011 Vilarino et al. Intravaginal devices originally containing 0.3 g of 
progesterone was effective to synchronise oestrus 
and ovulation after first, second and third use in the 
short-term protocol. 
2012 Ayres et al. Does could be superovulated in the second 
follicular wave without using exogenous 
progesterone. 
2012 Abdullah et al. Multiple administration of high dosage (14.08 mg) 
of oFSH produced better results compared to 
multiple and single administration of low dosage 
(8.8 mg) of oFSH. 
(continued) 
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(continued) 
Year Author Significant event/ finding 
2013 Fonseca et al. Short-term superovulation protocol was adequate 
for Saanen donor does and embryos could be 
recovered using non-surgical technique. 
2013 Xiao et al. Superovulation using specific gonadotrophin 
protocol and localities were important 
considerations for superovulation and ET 
programme in goats. 
2013 Shariffah Nazari Effect of superovulation on ovarian response and 
subsequent embryo transfer in goats. 
2014 Paramio and Izquierdo Among the domestic animals, goat could be used as 
a main animal for biomedical research especially 
for producing the recombinant proteins in its milk. 
Poor animal health status, malnutrition and miss-
management were liable for the reduction of 
fertility in spite of the techniques used. 
 
 
2.2 REPRODUCTIVE CYCLE OF GOAT 
Oestrous cycle of a goat consisted of a series of physiological, morphological and 
endocrinological changes of ovaries and female reproductive tract for the production of 
new kids.  Oestrous cycle could be divided into two different phases, namely luteal 
phase and follicular phase.  The period of CL activity was called luteal phase, which last 
16 to 18 days. The follicular phase, from the regression of CL to ovulation, which was 
relatively short: 2 to 3 days. The luteal phase started from the time of ovulation. After 5 
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days of onset of oestrus, cells of the ovulating follicle turnned to luteal cells and form 
the CL. Progesterone secreted by CL increased concentration and remained at a high 
level (>1 ng/ml) during 16 days. During this luteal phase, gonadotrophin-dependant 
follicular growth continues in a wave-like manner but due to the presence of 
progesterone, ovulation was inhibited. 
At the end of the luteal phase, 16 to 18 days after oestrus, prostaglandin F2α 
(PGF2α) was secreted by the non-gravid uterus to induce the CL regression called 
luteolysis and decreased progesterone secretion. The decreased plasma progesterone 
concentration removed the inhibition of gonadotrophin secretion gradually and a new 
follicular phase was commenced (Baril et al., 1993). The luteal phase was also called 
the post-oestrus period; which could be divided in metoestrus, when peripheral 
concentration of progesterone began to rise; and dioestrus, when peripheral 
concentrations of progesterone were high up to the start of luteolysis. 
 During the follicular phase, pituitary gland secreted FSH for stimulating 
follicular growth. A cohort of gonadotrophin-dependant antral follicles of 2 to 3 mm in 
diameter was recruited and follicles enter into their terminal growth. Only 2 to 3 of 
follicles reached at 4 mm in diameter and were selected to enter the dominance phase. 
Under the influence of LH, they reached the pre-ovulatory stage (6-9 mm), while 
subordinate follicles were degenerated (follicular atresia). The increased peripheral 
concentration of oestradiol 17 β, secreted by bigger follicles, induced oestrus behaviour 
and acted as a positive feedback on the gonadotrophic axis. The consequence of 
increased GnRH secretion was induced the pre-ovulatory LH surge which induced 
ovulation at 20 to 26 hours after LH surge.  
  The interval between two successive expressions of oestrus is the length of 
oestrous cycle. The normal length of goat oestrous cycle varies from 18 to 22 days and 
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the average length is of 21days (Figure 2.1). Several factors affected the duration of 
oestrous cycle in goat such as day length or photoperiod, breed and environmental stress 
like nutrition (Hafez and Hafez, 2000). Follicular development during oestrous cycle in 
goats was characterised by wave-like patterns and follicular dominance was less 
apparent (Medan et al., 2003; 2005). A follicular wave was characterised by the 
sequence of three gonadotrophin dependent events in follicular growth: recruitment, 
selection and dominance (Driancourt, 2001). In goat, average ovulation rate was 
reported as 1.7 in Boer goat (Greyling, 2000), 1.5 in local Maure goat (Lassoued and 
Rekik, 2005) and much higher in Chinese Matou goat, which have an average litter size 
of 2.1 (Moaeen-ud- Din et al., 2008). 
 
 
Figure 2.1: Schematic representation of the different physiological events occurring 
during oestrous cycle in goat: pattern of follicle development, ovarian 
cycle and endocrine reglutions. *Ovulatory follicle(s) (adapted from Fatet 
et al., 2011). 
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2.3 FACTORS AFFECTING SUPEROVULATION IN GOAT 
The result of any superovulation programme was inconsistent and could be fluctuated 
from complete failure to total success without any change in the standard operating 
procedure (Baldassarre and Karatzas, 2004). This variation in ovarian responses occured 
not only between treatments but also within treatment. This might be attributed by many 
extrinsic and intrinsic factors including progestagen treatment, source of gonadotrophin, 
treatment protocols, season, breed, donor does age, nutrition and follicular status of 
donor does (Gonzalez-Bulnes et al., 2004a).  
 
2.3.1 Progestagen 
Oestrus synchronisation was developed in the early sixties of the last century; and there 
were many different practical methods used for oestrus synchronisation in goats 
(Chemineau et al., 1991; Gordon, 1997; Abecia et al., 2011). Control of oestrus and 
ovulation in goats consists of artificial replacement of a CL by prolonging the luteal 
phase with exogenous progestagen (Robinson 1964; Chemineau et al., 1991) or by 
regressing the CL with injecting PGF2α (Nandy et al., 1990; Romano, 1998). Squires 
(2003) noted that method for oestrus synchronisation must be produced a high 
proportion of females in heat or oestrus at predetermined time, maintained high rate of 
fertility and had no undesirable side effect. Many methods of oestrus synchronisation 
have been developed in goat (Gordon, 1997; Holtz et al., 2008; Abecia et al., 2011, 
Bowdridge et al., 2013), but most successful one was based on suppression of the 
oestruos cycle with synthetic progestagens (Chemineau et al., 1991; Carnevali et al., 
1997; Gordon, 1997; Squires, 2003; Whitley and Jackson, 2004).   
Several types of progestagens were available such as intravaginal sponges 
containing 45 mg fluorogestone acetate (FGA) or 60 mg medroxyprogesterone acetate 
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(MAP) or controlled internal drug release devices (CIDR) containing 0.30 g 
progesterone (Motlomelo et al, 2002; Espinosa-Marquez et al, 2004; Lehloenya et al, 
2005). Exogenous progestagen treatment was applied for a period of 5 to 20 days (Ritar 
et al., 1989, 1994; Waldron et al., 1999; Romano, 2004; Menchaca et al., 2007; 
Vilarino et al., 2011). Anisworth and Downey (1986) reported that, during progestagen 
treatment, plasma progesterone level increased rapidly within 2 hours after insertion of 
the device (5.5 ng/ml) and reached the highest concentration at 3 days after insertion. 
Progesterone levels remained relatively stable between Day 1 and Day 13 (1.9 ng/ml) 
(Hamra et al., 1986) and then decreased gradually (Gordon, 1997).  
Progesterone hormone released from the device was suppressed the LH secretion 
and helped to regress natural CL but other ovarian activities like oocyte maturation, 
ovulation and occurrence of oestrus symptom were stunted until removal of the 
exogenous progestagen device (Noel et al., 1994; Gonzalez-Bulnes et al., 2004b). 
Sometimes, dose or type of progestagen caused inadequate level of circulating 
progesterone at the last part of synchronisation treatment, which was inadequate to 
block the LH pulse secretion. At the same time, low progesterone at the beginning of 
superovulation lead to a reduction in embryo quality (Scudamore et al., 1992; Wallace, 
1992). Progesterone level throughout the synchronisation treatment could be increased 
by using two CIDR in the superovulation programme (first CIDR replaced on Day 9 by 
a new CIDR then removed on Day 12), which increased the superovulation response 
(Thompson et al., 1990). On the contrary, reuse of CIDR (first, second and third) 
appeared effective to synchronise oestrus and ovulation in the short-term protocol for 5 
to 7 days with acceptable pregnancy rate (Vilarino et al., 2011). On removal of CIDR, 
the level of the progesterone in the blood stream declined which stimulated to a 
observable heat or oestrus behaviour consequently. Table 2.2 presents the summary of 
pharmaceutical product used for controlling reproductive status of goat and sheep.  
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Table 2.2: Summary of the features of the main pharmacologic treatments available to control reproduction in small ruminants (adapted and 
modified from Abecia et al., 2011) 
Hormone Pharmaceutical 
form 
Route of 
administration 
Time for introduction of male 
animals into the females 
Comment 
Progesterone CIDR Intravaginal,  
12 to 14 days 
36 to 48 hr after removal  
of devices 
Can be used in combination 
with eCG 
Progestagen Sponge Intravaginal,  
12 to 14 days 
36 to 48 hr after  removal  
of sponges 
Can be used in combination 
with eCG 
 Melengestrolacetate In feed, 8 to 14 days 26 to 48 hr after removal  
of feed 
eCG needed to inject 8 hr after 
last feeding 
Prostaglandin  Injectable 
solution 
Intramuscular/ 
Subcutaneous 
48 hr after  
administration 
Two injections needed with a 10 
days interval 
Melatonin Implant  Subcutaneous 40 days after  
administration 
Males need to separate from 
females for 45 days before 
introduction 
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2.3.2 Source of Gonadotrophin 
Type and preparation of gonadotrophin were the most affecting factors on 
superovulation (Nowshari et al., 1995; Pintado et al., 1998; Holtz, 2005). There are 
several sources of gonadotrophin such as- a) eCG from equine, b) horse anterior 
pituitary (HAP) from equine and c) FSH from porcine (Folltropin-V) and from ovine 
(Ovagen). Among them, eCG was the first gonadotrophin used for superovulation in 
goats. It had some advantages like single administration compared to 6 to 8 injections 
for FSH, low cost and easily available (Armstrong et al., 1983a,b; Pendleton et al., 
1992). On the contrary, due to long biological half-life eCG persisted long time in the 
peripheral blood circulation (approximately 5 hr for FSH and 20 hr for eCG) (Amoah 
and Gelaye, 1990; Cognie, 1999) and gave continuous follicular stimulation which lead 
to heterogeneous follicular growth, large number of unovulated follicles (Boland et al., 
1978; Armstrong et al., 1983b; Saumande et al., 1984), early regression of CL 
(Pendleton et al., 1992; Pintado et al.,1998), reduced fertilisation and embryo quality 
(Evans and Armstrong, 1984; Johnson et al., 1996). Which impaired embryo production 
made it limited to use in caprine superovulation research. To overcome these problems 
several studies were conducted to identify a suitable gonadotrophin for superovulation.  
Moore (1974) used HAP in goats with satisfactory fertilisation and embryo 
recovery rates. Although HAP was not successful to decrease the quantity of large 
unovulatory follicles, it resulted higher embryo recovery and fertilisation rates than eCG 
(Moore and Eppleston, 1979). The most frequently used gonadotrophin was pure FSH 
prepared from whether ovine (oFSH) or porcine sources (pFSH) (Baril and Vallet, 
1990; Cognie, 1999). Owing to short half-life of FSH compared to eCG (Demoustier et 
al., 1988), it was usually injected twice a day in goat, over a period of 3 to 4 days 
(Pendleton et al., 1992; Gordon, 1997; Holtz, 2005; Menchaca et al., 2007). Satisfactory 
ovulation rates were found in goat superovulated with FSH but it varied from 2.0 to 29 
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(Senn and Richardson, 1992; Ishwar and Memon, 1996; Greyling et al., 2002). The 
effect of gonadotrophin sources (FSH and eCG) on superovulation of goats has been 
evaluated by different researchers. Using FSH in a superovulation program resulted in 
higher ovarian responses (ovulation and embryo recovery rates), than eCG (Goel and 
Agrawal, 1990, 2005; Selgrath et al., 1990; Mahmood et al., 1991, Pendelton et al., 
1992; Nowshari et al., 1992, 1995; Pintado et al., 1998) but it gave more stress to 
animal by too much handling during multiple administration over a period of 3 to 4 
days, twice a day and subsequently increased the labour cost.  
To minimise this trouble several attempts had been made over time like a single 
administration of a combination of FSH and eCG, or substitution of the last dose of 
FSH with eCG at the time of progestagen device withdrawal. A sinlge combined dose of 
FSH and eCG resulted with lower ovulation rate than the multiple FSH regime (Holtz, 
2005). On the other hand, Baldassarre et al. (2002) reported no difference between a 
multiple FSH regime and a combination of FSH and eCG in superovulation response. 
LH (hCG or GnRH) administration at the onset of oestrus improved embryo quality and 
recovery of FSH superovulated does which was not similar for eCG (Ishwar and 
Memon, 1996; Holtz, 2005). However, in a goat superovulation and ET programme, 
eCG was not preferred as a superovulating agent owing to less qualitative and 
quantitative embryo production compared to FSH counterpart. According to the 
findings of different researcher FSH produces more embryos than eCG, for example, 
8.80 and 3.00 in Jamunapari (Goel and Agrawal, 1990); 16.55 and 11.70 in Pashmina 
goats (Mahmood et al., 1991); 17.60 and 10.10 in feral goats (Armstrong et al., 1983a); 
15.00 and 6.00 in dairy goats (Kiessling et al., 1986); 9.20 and 3.10 in Boer goats 
(Nowshari et al., 1992, 1995), respectively. Repeated use FSH prepared from porcine in 
goat superovulation programme resulted in decline the superovulatory response due to 
the production of antibody (Beckers et al., 1990; Remy et al., 1991; Baril et al., 1993). 
23 
 
2.3.3 Protocol for Oestrus Synchronisation and Superovulation  
In goats, the superovulation and ET programme usually entailed the stimulation of the 
ovaries by administration of gonadotrophin during the last days of progesterone 
priming. Superovulatory response largely fluctuated by the ovarian status when the 
gonadotrophin treatment was started (Gonzalez-Bulnes et al., 2003). That was the 
reason of research to establish different protocols for superovulation.  
 
 
 
Figure 2.2: Schematic representation comparing the Day 0 Protocol vs. the traditional 
protocol for superovulation in goats (adapted from Menchaca et al., 2007). 
  
 Figure 2.2 showed the schematic diagram of Day 0 protocol, which was 
established to initiate superovulatory treatment in an ovarian status at which more 
number of gonadotrophic responsive follicles in a homologous condition. Menchaca et 
al. (2007) proposed Day 0 protocol which consisted of insertion of CIDR for 5 days, an 
injection of PGF2α (160 mg) at CIDR insertion and 200 IU of eCG at CIDR 
withdrawal. One dose of a GnRH (8.4 mg) was given 36 hr after CIDR withdrawal. As 
a superovulation treatment, FSH was administered 84 hr after CIDR removal and was 
given in six decreasing dosages, twice daily (2.5, 2.5, 1.5, 1.5, 1.0, and 1.0 ml). Two 
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half-doses of PGF2α (80 mg of delprostenate) were given concurrently with the fifth 
and sixth FSH treatments. To synchronise the LH peak and ovulation, GnRH (8.4 mg) 
was given 24 hour after the first PGF2α treatment. Whereas, the traditional protocol 
consisted of 11 days of progesterone treatment, with FSH started 2 days before 
progesterone withdrawal. Lehloenya and Greyling (2010a) reported that Day 0 protocol 
showed a lower superovulation response than traditional long progesterone protocol in 
Boer goats. 
Oestrus detection was a difficult and laborious job in goat breeding. To 
overcome that, ovsynch protocol was established for fixed-time AI. Fixed-time AI was 
helpful to reduce the burden of oestrus detection and synchronise ovulation. In ovsynch 
protocol, the does were administered with GnRH (0.004 mg) on Day 0, after 7 days 
another injection of PGF2α (3.75 mg) was done. On Day 9, a second injection of GnRH 
(0.004 mg) was done. AI was done 16 hour after the second GnRH injection (Holtz et 
al., 2008).  
Recently, NCSynch, a simple and effective progestagen-free protocol for 
ovulation synchronisation and timed AI was established by Bowdridge et al. (2013). In 
NCSynch protocol, PGF2α (15 mg) was administered i.m. on Day 1 as a 
presynchronisation treatment. On Day 8, does were administered with GnRH (50 µg 
i.m.) to ovulate or luteinise any dominant follicles present. Seven days later, on Day 15, 
a second PGF2α injection was administered to induce luteolysis. AI was done 72 hour 
after the second PGF2α injection, at the same time a second injection of GnRH (50 µg 
i.m.) was administered to induce the LH surge and ovulation (Figure 2.3). 
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Figure 2.3: Schematic representation of NCSynch-TAI protocol for goats (adapted 
from Bowdridge et al., 2013). 
 
2.3.4 Follicular Waves 
Goat follicular development during oestrous cycle was first reported by Ginther and Kot 
(1994) by using transrectal ultrasonography. In goats, follicular growth was 
characterised by wave-like patterns such as recruitment, selection, dominance and 
atresia (Evans, 2003; Medan et al., 2003, 2005). In goats, normally 4 follicular waves 
were found during the oestrous cycle and follicular dominance occurred in the first and 
last waves (Ginther and Kot, 1994; de Castro et al., 1998, 1999; Gonzalez de Bulnes et 
al., 1999; Padilla and Holtz, 2000; Schwarz and Wierzchos, 2000; Menchaca and 
Rubianes, 2002).  
 In goats with 4 follicular waves as 1, 2, 3, and 4 was occurred around day 0-1, 4-
7, 9-12, and 13-17, respectively (Figure 2.4) (Ginther and Kot, 1994; de Casto et al., 
1999; Rubianes and Menchaca, 2003; Medan et al., 2005; Simoes et al., 2006; Tenorio 
Filho et al., 2007). However, a great variability in the number of follicular waves within 
goats and among goats between ovaries was found (cited by Driancourt, 2001) and it 
ranges from 2 to 6. 
 
 
26 
 
 
Figure 2.4: Follicular dynamics ( X  ± S.E.M.) in goats with 4-wave pattern of  
follicular growth (adapted from Tenorio Filho et al., 2007). 
 
2.3.5 Follicular Status 
Follicular status in ovary at the initiation of superovulatory treatment affected the 
production of transferable embryos and it varied a lot between different individual does 
(Cognie et al., 2003; Gonzalez-Bulnes et al., 2003, 2004a; Holtz, 2005). After 
gonadotrophin administration, small follicles (2-6 mm in diameter) started to develop 
and reached to preovulatory stage. In goats, the number of CL, viable embryos and 
transferable embryos were positively correlated with the number of gonadotrophin 
responsive ovarian follicles present at the onset of the superovulatory regime but was 
negatively influenced by the presence of a dominant follicle (Rubianes et al., 1995, 
1997; Lopez-Sebastian et al., 1999; Menchaca et al., 2002; Cognie et al., 2003; 
Gonzalez-Bulnes et al., 2004a; Holtz, 2005). The dominant follicle suppressed or 
inhibited the growth of small gonadotrophin responsive small follicles. On the contrary, 
the presence of a CL enhanced the growth of ovarian follicles (Gonzalez-Bulnes et al., 
2002, 2004a, 2005; Veiga-Lopez et al., 2005). Therefore, it can be suggested that if 
superovulatory treatment started in the absence of a dominant follicle, presence of large 
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number of gonadotrophin responsive follicles; and at the same time, presence of a CL 
will increase the ovulation rate and yield of transferable embryos. 
 
2.3.6 Breed 
Breed or genotype had been identified as a major factor that affected superovulation and 
ET program (Holness et al., 1980; Donaldson, 1984; Bindon et al., 1986; Nuti et al., 
1987; Baril et al., 1989; Dufour et al., 2000; Lee et al., 2000). All the breeds did not 
respond same way to the superovulation treatment. Different breeds showed different 
timing of oestrus; for example, 87% of the Nubian goats came into oestrus after 36 hour 
of sponge removal while only 50% of the Alpine goats came into oestrus on that time 
(Nuti et al., 1987), Jakharana goat showed oestrus within 12 to 60 hour after 2nd 
injection of PGF2α (Goel and Agrawal, 2005). In goats, a higher number of embryos 
(average of 10.1) were recovered in Alpine does compared to Angora does (average of 
7.5) (Baril et al., 1989). Breed effect had been associated with the prolificacy of breed 
where a high prolific breed had been reported to respond better to exogenous 
gonadotrophins (Bindon et al., 1986). 
 
2.3.7 Age 
Several studies had been conducted to evaluate the effect of age on the ovarian response 
to superovulation. Results from many studies showed that fertility in the goat increased 
up to about six years of age and after this age the conception rates was decreased 
gradually (Mohd Noor Hisham, 2007). General agreement was juveniles could be 
superovulated and the follicles were sensitive to gonadotrophin stimulation (Donaldson, 
1984; Driancourt et al., 1990; Rangel-Santos et al., 1991; Hasler, 1992; Kuhholzer and 
Brem, 1999) but ovarian response to superovulation (in terms of ovulation and 
fertilisation rates), embryo recovery and survival rates were not as good as compared to 
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multiparous or adult females (Quirke and Hanrahan, 1977; Mahmood et al., 1991; 
Rangel-Santos et al., 1991; Driancourt and Avdi, 1993). On the contrary, Koemann et 
al. (2003) reported a significant greater number of oocytes production in 3 to 7 months 
old prepubertal goats than in adult 2 to 4 years old goat. However, the use of older 
multiparous does as embryo donor does in a superovulation and ET program was 
favorable (Lehloenya and Greyling, 2010b). 
 
2.3.8 Nutrition 
A proper and well-balanced diet with high plane of nutrition is necessary for efficient 
reproductive performance in most species. Nutrition had been known to play a 
fundamental role in controlling several reproductive events including, hormone 
production, gametogenesis, fertilisation and early embryonic development in farm 
animals (Ashworth, 1995; Cox, 1997; Butler, 2000; Boland et al., 2001; Lucy, 2003; 
Peura et al., 2003; Paula et al., 2005). In goat, a low level of nutrition reduced oocyte 
development and ovulation rate (Smith, 1991; Mani et al., 1992; Downing et al., 1995). 
Dietary energy had been indicated to alter the follicular dynamics in superovulated 
ruminant (Gong, 2002). Negative energy balance inhibited GnRH secretion by the 
hypothalamus, absence of LH pulses, low FSH concentrations which inhibited 
folliculogenesis (Downing and Scaramuzzi, 1991; Gong, 2002; Wade and Jones, 2005; 
Scaramuzzi et al., 2006). On the other hand, high energy level above maintenance 
increased blood glucose, insulin and leptin, leading to increase folliculogenesis and 
ovulation rates (Figure 2.5) (Abecia et al., 2006; Scaramuzzi et al., 2006). McEvoy et 
al. (1997) showed that diets with a high urea concentration increased the embryo 
mortality and reduced the pregnancy rates following ET in sheep.  
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Figure 2.5: Effect of plane of nutrition and diet type during oocyte maturation on 
ruminant embryo development following superovulation and/or in vitro 
embryo production (adapted from Robinson et al., 2006). 
 
2.3.9 Season of the Year 
Seasonality of goat breeding depends on the location of the animals. The goat of the 
temperate zone showed seasonality in breeding that breed spontaneously during autumn 
to winter and in spring (short day length) and tropical zone showed year round breeding. 
Ovarian responses related to CL formation and function, LH peak and progesterone 
concentration, as well as the number and quality of embryos recovered varied during 
different seasons. At the beginning of the breeding season, goat showed best 
reproductive performance than the end of the season (Pendleton et al., 1986; Walker et 
al., 1989; Sebastian-Lopez et al., 1990; Mitchell et al., 2002). During the seasonal 
anoestrus period, the superovulated goat was failed to ovulate a large number of follicle 
which increased the number of unovulated follicles (Baril et al., 1989; Senn and 
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Richardson, 1992; Gonzalez-Bulnes et al., 2003). However, a large number of follicles 
could not ovulate due to the presence of dominant follicle during the superovulation 
treatment which was more frequent in the breeding season (Gonzalez-Bulnes et al., 
2003). Heat stress could compromise the reproductive events required for embryo 
production by decreasing expression of oestrus behavior, altering follicular 
development, compromising oocyte competence, and inhibiting embryonic development 
(Hansen et al., 2001). 
 
2.3.10 Movement of Donor, Recipient and Embryo 
ET between-farms could be acted as an effective means of spreading of quality genetic 
materials. However, the problem was transporting donor or recipient does or their 
embryos. Consequences of transporting donor does within 4 hour before embryo 
collection and embryo at 36.5 to 38.0ºC within 2 hr before ET had no significant effect 
on embryo recovery number, embryo survival rate and subsequent pregnancy in 
recipient doe. In contrast, transportation of recipient doe and embryo at 20ºC resulted in 
a significant lower survival rate and pregnancy rate (Quan et al., 2010). 
Cryopreservation of embryos simplified the transportation for a long distance but it 
might be caused chemical and physical injury to embryo which reduced embryo 
viability and pregnancy rate of recipient doe (Kasai, 1994; Hasler, 2001; Papadopoulos 
et al., 2002). Transportation stress increased plasma levels of cortisol and reduced 
ovulation rate as determined by CL formation in superovulated heifers (Edwards et al., 
1987). 
 
2.3.11 Embryo Transfer in Malaysia 
In Malaysia, the goats population was still relatively low which approaches 505,034 
heads in the year 2012 (DVS, 2012) and goat meat production increased by 8.3% from 
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2000 to 2010 (FAO Statistical Yearbook, 2012). The demand for goat meat in Malaysia 
was high and was continually increasing due to the improvement in standard of living, 
health consciousness as well as acceptability of goat meat to diverse ethnic groups of 
Malaysian citizen. As a consequence, Malaysia imports approximately 87% of total 
requirement of goat meat every year to fulfill the country’s demand (DVS, 2012). Some 
attempt had made to conduct research and development in reproductive biotechnology 
in goat to improve the goat production in Malaysia. Most of the research in goat 
reproduction has been conducted at the University of Malaya (UM). Other institutions 
involved are the Malaysian Agriculture Research and Development Institute (MARDI), 
the University Putra Malaysia (UPM) and Department of Veterinary Services (Abdullah 
and Wan Khadijah, 2009). 
  In Malaysia, goat superovulation was initiated in 1989 by using indigenous 
goat, Katjang and their crosses (Rosnina et al., 1992). Rosnina et al. (1992) did oestrus 
synchronisation by inserting progesterone impregnated intravaginal sponges (60 mg 
medroxyprogesterone acetate) for 17 days and superovulation by using pFSH and eCG. 
For better understanding of the physiology of oestrous cycle, time of ovulation and 
proper time of insemination, progesterone and oestradiol hormonal profiles in different 
breeds of mature does were investigated (Massita et al., 1999). Anna et al. (2013) used 
CIDR for 10, 14, 17 and 21 days but did not find any significant difference for the 
number of oocyte collection through LOPU. Oocyte retrieval cycle had no influence on 
the number of oocyte collection (Anna et al., 2013) but for embryo flushing, embryo 
production gradually decreased with the increasing number of flushing cycle 
(unpublished data from our research). In Malaysia, the goat did not show strong 
seasonality in breeding, but responded more during the rainy months compared to the 
dry months (Rosnina et al., 1992). In our laboratory at University of Malaya, different 
gonadotrophin such as eCG alone (Shamsul Azlin, 1997) or in combination with hCG 
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(Mohd Noor Hisham, 2007), pFSH (Xiao, 2013) and oFSH (Abdullah et al., 2012) were 
used to superovulate does during LOPU and ET programme. Among them pFSH 
produced more embryos (4.38) (Xiao, 2013), followed by oFSH (2.40) (Abdullah et al., 
2012) and eCG (0.63) (Xiao, 2013). However, due to higher variability of stimulation 
and lower embryo recovery rate, a combination of recombinant oFSH or pFSH and hCG 
as single dosages was introduced in our laboratory (Phua, 2003; Amir, 2007; Mohd 
Noor Hisham, 2007; Abdullah et al., 2012; Xiao, 2013). In 1997, two sets of twin kids 
were produced in Malaysia after ET (Shamsul Azlin, 1997). Superovulation and ET 
research encountered problems associated with the inconsistent results were poor 
response to the gonadotrophin, high number of unovulated follicles, fertilisation failure. 
However, goat superovulation and ET is still improving to overcome the technical 
constraints in order to make ET technology a practical tool to ensure profitability and 
sustainability of goat production for commercialisation. 
 
2.4 FACTORS AFFECTING SURVIVABILITY OF TRANSFERRED 
EMBRYO IN GOAT 
Embryo transfer was the final stage of a superovulation and ET programme. Fresh or 
frozen thawed embryos were transferred to the recipient does which showed sign of 
oestrus synchronously with the donor does or in accordance with the developmental 
stage of in vivo or in vitro derived embryos (Moore, 1974; Bessoudo et al., 1988; 
Wallace, 1992). Uterine environment was very much important for the transferred 
embryos to be developed inside the recipient does. Embryo survivability in an ET 
programme could be influenced by several factors such as synchrony of oestrus between 
donor and recipient, ovulation rate and progesterone level, ovulation and transfer site, 
nutrition and breed of the recipient does, quality of embryos (developmental stage and 
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grade), number of embryos transferred and origin of embryos. (Armstrong et al., 1983a; 
Mani et al., 1994; Ishwar and Memon, 1996; Bari et al., 2003; Guignot et al., 2006). 
 
2.4.1 Synchrony of the Onset of Oestrus between the Donor and Recipient Does 
Synchronisation of the donor and the recipient does oestrus period was very much 
important for achieving a favourable environment inside the recipient does reproductive 
tract. For evaluating the effect of oestrus synchronisation in donor and recipient does, 
embryos were recovered on Day 4 after oestrus from donor ewe and subsequently 
transferred to the recipient ewe on Day 7 of the oestrous cycle (72 hr asynchrony) and 
the embryos were failed to survive (Wilmut and Sales, 1981; Wallace, 1992). Best 
embryo survival rate was attained with the onset of oestrus of donor and recipient does 
within 24 hour of each other. However, asynchrony of donor and recipient onset of 
oestrus for 12 to 48 hour could produce satisfactory embryo survival rate (Moore, 1974; 
Moore and Eppleston, 1979; Ishwar and Memon, 1996; Oppenheim et al., 2000; Holtz, 
2005).  
 
2.4.2 Ovulation Rate and Progesterone Level 
In an ET programme, embryos were transferred to the CL-presented recipient does. The 
main function of the CL was to secrete progesterone for maintaining pregnancy. In 
1983, Armstrong et al. reported a significant relationship between the numbers of CL 
and embryo survivability in recipient does. It meant that embryo survival rate in a 
recipient doe with 1 CL was lower than the recipient doe with more than 1 CL. 
Conversely, there was no difference for embryo survival rate between recipients with 2 
or 3 CL which might be due to level of blood serum progesterone. Blood progesterone 
level was depended on not only on the number of CL but also the morphological and 
echogenic characteristics of a CL (Gonzalez-Bulnes et al., 2000).  For maintaining 
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pregnancy full term in goat, progesterone levels needed to be maintained between 4.3 to 
11.0 ng/ml during the entire gestation period (Khanum et al., 2008). Positive correlation 
between higher concentration of progesterone on Day 7 and embryo survivality was 
reported in sheep (Lynch et al., 2010), beef heifer (Diskin et al., 2002) and dairy cow 
(Stronge et al., 2005). On the contrary, White et al. (1981) and Bari et al. (2003) did not 
observe any effect of CL number on embryo survival rate in ewe. Therefore, in order to 
enhance ovulation in synchronised recipient does, eCG was administered at the end part 
of progestagen treatment (Moore, 1974; Armstrong et al., 1983a; Melican and Gavin, 
2008; Lehloenya and Greyling, 2010a). In normal circumstances, 1 CL was sufficient to 
secrete progesterone in order to maintain pregnancy in a doe. Therefore, the issue of 
number of CL affecting pregnancy still cannot be resolved. 
 
2.4.3 Ovulation and Transfer Site 
ET to recipient does was carried out by surgical, laparoscopic and transcervical methods 
but the surgical method was less strenuous compared to embryo flushing. Transfer site 
of any embryo was determined by the age or stage of development. Early stage embryos 
(8 - 16 cell stage) were transferred to the oviduct whereas advanced stage embryos 
(morula and blastocyst stage) were deposited in the uterine horn (Wang et al., 2003; 
Holtz, 2005). However, low embryo survival rate was obtained by transferring early 
stage embryo into the uterine horn indicated that the uterine environment was 
unfavourable for the development and survival of the embryo (Moore and Shelton, 
1964; Armstrong et al., 1983a; Ishwar and Memon, 1996). In goat superovulation and 
ET programme, embryos were normally transferred into the uterine horn of recipient 
does, at day 6 to 7 following oestrus. Goat embryos were transferred into the oviduct or 
uterine horn ipsilateral to the ovary with normal CL (Moore and Eppleston, 1979; 
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Bessoudo et al., 1988; Stefani et al., 1990; Besenfelder et al., 1994; El-Gayer and Holtz, 
2001; Holtz, 2005; Guignot et al., 2006).  
 
2.4.4 Quality of Transferred Embryo 
Embryo quality and developmental stage had a significant effect on the pregnancy of 
recipient does and subsequent embryo survival rate. Embryo quality was evaluated 
based on the morphological appearance and the stage of development. However, a 
higher embryo survival rate was obtained by transferring good quality embryo to the 
recipient does.  In goat superovulation programme, embryo flushing was carried out for 
morula and blastocyst stage embryos on Day 7 to 8 after oestrus. For goat ET 
programme, morula or blastocyst stage embryo was considered as transferrable embryo 
on Day 6 after oestrus (Bessoudo et al., 1988; Guignot et al., 2006; Lehloenya and 
Greyling, 2010a) and produced higher embryo survival rate than early stage embryo in 
ruminants (Traldi et al., 1999; El-gayer and Holtz, 2001; Baril et al., 2001; Guignot et 
al., 2006). However, some earlier researchers found higher survival rates for blastocyst 
compared to morula in cow (Armstrong and Evans, 1983; Donaldson, 1985; Hasler et 
al., 1987; Block et al., 2009) and in doe (Li et al., 1990). On the contrary, some other 
earlier researchers reported that there was no effect of embryo developmental stage on 
pregnancy and kidding rates in doe (Gibbons et al., 2011), ewe (Bari et al., 2003) and 
cow (Breuel et al., 1991). However, advanced blastocysts collected on Day 5 were 
produced higher survival rate compared to retarded morula embryos collected on Day 6. 
For this reason, embryos with retarded growth should be reduced in an ET programme 
to get better embryo survival rate (Donaldson, 1985; Breuel et al., 1991; Wallace, 1992; 
Bari et al., 2003). 
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2.4.5 Number of Transferred Embryo  
Number of transferred embryo might be a source of variations on pregnancy rate. Some 
researchers reported that transferring more than 2 embryos per recipient caused the 
lower survival rate of the transferred embryos (Armstrong et al., 1983a; Li et al., 1990; 
Ishwar and Memon, 1996; El-Gayar and Holtz, 2005). In addition, higher embryo 
survival rate was obtained in dairy goat by transferring 2 embryos per recipient (Moore 
and Eppleston, 1979; Armstrong and Evans, 1983; Tervit et al., 1983). Tervit et al. 
(1986) reported that maximum pregnancy and kidding rates could be achieved by 
transferring 2 blastocysts in each recipient which might be due to the ability of doe to 
produce multiple kids per pregnancy. On the contrary, Melican and Gavin (2008) had 
transferred 1, 2 or 3 embryos per recipient during traditional and non-traditional 
breeding season, and concluded that there was no effect of transferred embryo number 
on the pregnancy and kidding rates. They also mentioned that both pregnancy and 
kidding rates were increased by transferring single embryo to the recipient (Melican and 
Gavin, 2008). 
 
2.4.6 Method of Embryo Transfer in Goats 
ET in goats could be carried out by surgical, laparoscopic and transcervical methods and 
obtained pregnancy rate ranged from 27 to 86% (Bessoudo et al., 1988; Li et al., 1990; 
Lehloenya and Greyling, 2010a). In goat, ET was mostly carried out surgically into the 
oviduct or uterine horn (Bessoudo et al., 1988; Flores-Foxworth et al., 1992; 
Besenfelder et al., 1994). The reproductive tract was exteriorised via a mid-ventral 
laparotomy, which allowed for the inspection of the ovaries for presence of CL (Moore, 
1974; Armstrong et al., 1983; Kiessling et al., 1986; Bessoudo et al., 1988; Li et al., 
1990; Selgrath et al., 1990; Yuswiati and Holtz, 1990; Wallace, 1992; Holtz, 2005; 
Guignot et al., 2006). However, due to safe, easy and quick to perform, laparoscopic 
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method of ET had gained popularity in small ruminants. In laparoscopic ET a small 
incision was made as opposed to surgical transfer which involved the exterioration of 
the tip of the uterine horn in which ET was made (Kraemer, 1989; Stefani et al., 1990; 
Brebion et al., 1992; Flores-Foxworth et al., 1992; Besenfelder et al., 1994; Ishwar and 
Memon, 1996; Cognie, 1999). Transcervical ET in goats had been carried out with 
success. However, the transcervical ET method was not popular due to the low embryo 
survival rates generally obtained which might be due to the fact that this method did not 
allow for the confirmation of the presence of CL. Moreover, trancervical transfer had 
been reported to induce contractions of the cervix and the uterus, which resulted in the 
rejection of the transferred embryos. In cattle, embryos were found in the vagina a few 
hours following transfer (Rowson, 1971; Flores-Foxworth et al., 1992; Wallace, 1992; 
Cognie, 1999). 
 
2.4.7 Origin of the Embryos Transferred 
The availability of embryos for transfer in a superovulation and ET programme could be 
increased through the utilisation of not only in vivo produced embryos, but also in vitro 
produced embryos. Due to the fluctuation in superovulation response, in vitro 
production of goat embryos could be an alternative to superovulation as a source of 
embryos for transfer in an ET programme. For the production of in vitro embryos, 
oocytes might be collected from the ovary of slaughtered does or from live does by 
using (LOPU) technique (Baldassarre et al., 1994; Pawshe et al., 1994; Graff et al., 
1999; Crozet et al., 2000; Han et al., 2001; Reggio et al., 2001; Baldassarre et al., 2003; 
Baldassarre and Karatzas, 2004). The embryo survival rate following fresh in vitro 
produced embryos had been reported to range between 25 and 61% (Keskintepe et al., 
1994; Amoah and Gelaye, 1997; Cognie, 1999; Cognie et al., 2003). The survival rate 
of in vitro developed embryos were however been reported to be lower following 
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transfer, when compared to in vivo produced embryos (Greve et al., 1993; Cognie, 
1999). In goats, in vitro produced embryo survival rates of 47% have been recorded 
compared to 86% for in vivo produced embryos (Lehloenya and Greyling, 2010a). 
Several factors were indicated to contribute to the low survivability of in vitro produced 
embryos, when compared to the in vivo derived embryos such as differences in the gene 
expression, lower cell number, lower inner cell mass (ICM), less compactness, more 
fragile zonapellucida (Iwasaki et al., 1990; Greve et al., 1993; Pollard and Leibo, 1994; 
Thompson, 1997; Lonergan et al., 2001; Papadopoulos et al., 2002; Cognie et al., 
2003). The size of the follicles used for the production of in vitro embryo might be 
influenced the survival rate following ET. This was indicated by the low blastocyst 
development rate observed in oocytes from small follicles, compared to large follicles. 
Blastocysts from small and medium sized goat oocytes possessed a smaller number of 
cells, as well as ICM - which demonstrated a poor developmental capacity. It was thus, 
important to utilise selected oocytes from large follicles for in vitro production embryos. 
In goats, the survival rate of in vitro developed blastocyst stage embryos from larger (>5 
mm) follicles was higher than the embryos from smaller follicles (2-3 mm) (Crozet et 
al., 1995; Cognie, 1999). 
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Chapter 3 
3.0 MATERIALS AND METHODS 
 
3.1 LOCATION OF STUDY 
Oestrus synchronisation and superovulation of donor and recipient does were carried 
out at Institute of Biological Sciences (ISB) Mini Farm, University of Malaya, Kuala 
Lumpur, while embryo flushing from donor does and ET to the recipient does were 
conducted at the Nuclear Transfer and Reprogramming Laboratory (NaTuRe), Institute 
of Research Management and Monitoring (IPPP), University of Malaya, Kuala Lumpur. 
This location was situated at latitude of 2 º 30΄ N and 112 º 30΄ E. The altitude of the 
location was 60 metres above the sea level and annual rainfall was 2600 mm. All 
animals used in this experiment were in accordance with the guidelines of the 
University of Malaya. This project was carried out from April 2011 to February 2014. 
 
3.2 MATERIALS 
 
3.2.1 Experimental Goats and Their Management 
A total of 113 Boer crossbred (Boer × Katjang) does of 16.5 to 44.5 kg BW and 2 to 7 
years of age were used for this study. Out of those 85 and 28 does were used as donor 
and recipient, respectively. The experimental does were reared under intensive 
management system and received concentrate once in the morning, while the Napier 
grass (Pennisetum purpureum) was offered in the morning and afternoon. The average 
amount of grass supplied to the does was approximately 2 to 4 kg/h/d. According to the 
availability of concentrate, pellet or soya waste which was offered at a rate of 400 g/h/d 
or 1 kg/h/d, respectively. The pellet fed contained 15% crude protein, 15% crude fibre, 
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0.5% phosphorus and 0.8 to 1.5% calcium. The soya waste used in this experiment 
contained 27.9% crude protein, 30.5% neutral detergent fibre and 5.3% ash. All animals 
had free access to water and salt lick. 
 
3.2.2 Reagent and Media 
3.2.2.1  Preparation and use of normal saline solution 
Normal saline solution is 0.9% (w/v) NaCl in water and it is also known as a 
physiological solution. It was prepared by dissolving 9 g of NaCl in 1 litre of autoclaved 
Milli-Q water (Table 3.1). Milli-Q water was autoclaved at 121°C temperature for 20 
minutes. Normal saline was poured into peritoneal cavity before exteriorisation of the 
ovaries and fallopian tube and again after embryo flushing. The isotonic property of 
normal saline was suitable for preventing dehydration and adhesion of live tissues of the 
internal organs.  
Table 3.1: Composition of normal saline solution 
Component Quantity 
NaCl (S5886) 9.0 g 
Milli-Q water 1000 ml 
 
3.2.2.2 Preparation of embryo flushing medium 
The flushing medium was prepared by dissolving PBS (Phosphate-Buffered Saline; 
Oxid, UK) in autoclaved Milli-Q and supplemented with PVP360 
(Polyvinylpyrrolidone-360), Penicillin (Penicillin G Sodium Salt) and Streptomycin 
(Streptomycin Sulphate Salt). It was prepared according to the composition as shown in 
Table 3.2.   
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Table 3.2: Composition of flushing medium (1000 ml) 
Chemical components(catalogue number) Quantity/1000 ml 
PBS tablet (P4417) 10 tablets 
PVP (PVP360) 1 g 
Streptomycin (S9137) 0.6 g 
Penicillin (P3032) 0.5 g 
Milli-Q water 1000 ml 
 
3.2.2.3 Preparation of embryo holding medium 
Embryo holding medium potassium simplex optimisation medium with amino acid 
(KSOMaa B) which was prepared according to the description of Kwong et al. (2012) 
was used this study.  KSOM was invented by Lawits and Biggers (1993) and was 
further modified as KSOMaa by supplementing amino acids (Biggers et al., 2000). 
Finally, Kwong et al. (2012) supplemented glucose with KSOMaa to prepare KSOMaa 
B. It was prepared according to the composition as shown in Tables 3.3, 3.4 and 3.5.   
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Table 3.3: Composition of KSOMaa stock solution 
Chemical component 
(catalogue number) 
Final concentration  Quantity/100 ml 
NaCl (S5886) 95.0 mM 0.5553 g 
KCl (P5405)  2.50 mM 0.0186 g 
KH2PO4 (S5655) 0.35 mM 0.0048 g 
MgSO4 (M7506) 0.20 mM 0.0024 g 
Na Lactate, 60% syrup (L7900) 10.0 mM 0.1860 ml 
Pyruvic acid (P4562) 0.20 mM 0.0022 g 
D-Glucose (G6152) 0.20 mM 0.0036 g 
NaHCO3 (S5761) 25.0 mM 0.2101 g  
CaCl2 (C5670) 1.71 mM 0.0190 g 
L-Glutamine (G3126) 1.0   mM 0.0146 g 
EDTA (E9884) 0.01 mM 0.0004 g 
Milli-Q water - 99.814 ml 
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Table 3.4: Composition of in vitro culture medium-KSOMaa A 
Chemical component 
(catalogue number) 
Final concentration Quantity/ 20 ml 
KSOMaa stock solution  1x 20 ml 
BSA-V (A6003) 0.4 % 0.08 g 
MEM non-essential amino acids 
solution [100x] (M7145) 
- 100 µl 
BME amino acids solution [50x] 
(B6766) 
- 200 µl 
 
Table 3.5: Composition of in vitro culture medium-KSOMaa B 
Chemical component 
(catalogue number) 
Final concentration Quantity/ 10 ml 
KSOMaa A solution 1x 10 ml 
D-Glucose (G6152) 2.78 mM 0.0046 g 
 
3.2.3 Equipment 
The commonly used equipment included ultrasound scanner, autoclave, digital balance, 
laminar flow cabinet, CO2 incubator, laparoscopic system, micropipette, oven, stage 
warmer, stereomicroscope, inverted microscope, surgical set, surgical table, ultrapure 
purification water system and water bath. A list of equipment used in this project with 
model number, manufacturer’s and supplier’s name is presented in Appendix Table 1.1. 
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3.2.3.1 Ultrasound scanner 
B-mode ultrasound scanner, ALOKA SSD500 (Figure 3.1) equipped with a convex 5.0 
MHz transabdominal scanner (4.0 cm length) and linear array 7.5 MHz transrectal 
scanner (shaft length: 35 cm, shaft diameter: 1.4 cm) was used for scanning. Desired 
images were printed by using thermic printer Sony UP-860 (Figure 3.2) to obtain hard 
copies of the picture.  
 
Figure 3.1: Ultrasound machine ALOKA SSD500 equipped with 7.5 MHz   
                          transrectal probe. 
 
 
Figure 3.2: Thermic printer Sony UP-860. 
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3.3 METHODS 
3.3.1 Ultrasonography of Experimental Animal 
All the donor and recipient does were scanned to identify the ovarian status before 
starting the experiment by using ultrasound machine (ALOKA SSD 500) equipped with 
7.5 MHz transrectal probe. The tip of the probe was lubricated with 
carboxyethylcellulose contact gel and was gently inserted rectally until the urinary 
bladder was identifiable. The probe was moved gently forward and backward and 
rotated at 90° clockwise and 180° counter-clockwise to identify both ovaries (Figure 
3.3). Only non-pregnant does were used for this research. 
 
 
Figure 3.3: Scanning procedure of goat. 
 
3.3.2 Oestrus Synchronisation of Donor and Recipient Does 
Oestrus was synchronised by inserting controlled internal drug release device (CIDR, 
0.33 g natural hormone progesterone; EAZI-BREED CIDR, Pharmacia & Upjohn 
Limited, NZ) (Figure 3.4) with the help of a CIDR applicator (Figure 3.5) for 14 days 
and 125 µg of PGF2α (0.5 ml Estrumate®; Intervet International B.V.) was injected 
intramuscularly (i.m.) on Day 11 (Figures 3.6 and 3.7). 
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Figure 3.4: EAZI-BREED CIDR. 
 
 
Figure 3.5: CIDR applicator. 
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Figure 3.6: CIDR insertion for oestrus synchronisation. 
 
Figure 3.7: CIDR withdrawal. 
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3.3.3 Oestrus Detection and Breeding 
After CIDR withdrawal, oestrus was checked 3 times a day (morning at 800-900 hr, 
afternoon at 1300-1400 hr and evening at 1900-2000 hr) until exhibition of overt oestrus 
by placing a buck of proven libido. After showing the signs of oestrus, the doe was 
placed in a pen with a mature fertile buck for natural mating and AI was carried out at 
48 hour after CIDR removal. 
3.3.4 Surgical Procedure for Ovarian Responses Assessment and Embryo 
Flushing 
On Day 7 after CIDR removal, ovarian responses were evaluated and embryos were 
collected during laparotomy session. The donor goats were fasted for 18 to 20 hour 
before surgery. For anaesthesia, xylazine hydrochloride was mixed with ketamine 
hydrochloride at a ratio of 1:50 and administered through intravenous (i.v.) (0.5 ml per 
20 kg BW first time only, then 0.5 ml consecutively as necessary through i.m. injection) 
or consecutive i.m. injection (11 mg/kg BW) (Figure 3.8). After anaesthesia, animal was 
transferred to the surgery cradle and four legs were tied with the surgery cradle hook. 
The abdominal region of the does was saved and sterilised drapes were put on the doe 
with the help of clips. Then the reproductive tract was exteriorised through a mid-
ventral incision and the superovulatory responses were assessed by counting the CL and 
anovulatory follicles of both ovaries (Figures 3.9, 3.10, 3.11 and 3.12). Both the 
fallopian tubes were flushed by using a flushing medium. A two-way Foley catheter 
(Imex®) was used for embryo flushing (Figure 3.13). The recovered structures (embryos 
plus unfertilised oocytes) in the flushing medium were evaluated and classified 
accordingly under a stereomicroscope (SZH10; Olympus Optical Co. Ltd, Japan) 
(Figure 3.14).   
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Figure 3.8: i.v. injection of anaesthetic. 
 
 
 
Figure 3.9: Goat on surgery cradle. 
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Figure 3.10: Surgical set arranged on surgery table. The items included (1,2) sterile 
gauze, (3,16) different types of surgical scissors, (4) scalpel with surgical 
blade, (5-10) different types of forceps, (11-15) different types of 
haemostatic forceps, (17-20) clips to put the drapes, (21) collecting 
tubes, (22) sterile gloves, (23) sterile hand towel, (24) Foley catheter, 
(25) paper clip for ET, (26) Teflon i.v. catheter, (27) needle, (28,29) 
trocar and cannula, (30) light probe for endoscope, (31,32) atraumatic 
grasper, (33) drape for animal and (34) suture. 
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Figure 3.11: Assessment of ovarian responses. 
 
Figure 3.12: Superovulated ovary. 
 
Figure 3.13: Embryo flushing procedure. 
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Figure 3.14: Embryo searching procedure. 
3.3.5 Embryo Transfer 
All the recipient does were off-fed and off-water for 18 to 20 hour before surgery. On 
the day of surgery, for anaesthesia of recipient does, xylazine hydrochloride mixed with 
ketamine hydrochloride was administered through i.v. (0.5 ml per 20 kg BW first time 
only, then 0.5 ml consecutively as necessary through i.m. injection) or consecutive i.m. 
injection (11 mg/kg BW). After anaesthesia, recipient does were checked for the 
presence of functional CL through laparoscopic procedure similar to the LOPU 
procedure. After that, a 2 cm slit was made with a surgical blade at the cannulation point 
and the anterior part of the uterine horn was exteriorised over the surface of abdomen 
with the help of a grasping forceps. Fresh embryos (1-3) were loaded in a BD Unopette 
attached to a syringe (1 ml) along with a small amount of flushing medium (0.1-0.2 ml) 
and were transferred into the lumen of the anterior part of the uterine horn through a 
guided hole prior-punctured using a sterile paper clip (Figure 3.15). The procedure for 
the transfer of the embryos was repeated after exteriorising the opposite uterine horn. 
Once completed, the uterine horn was placed back into the abdominal cavity and the 
incision was sutured. Pregnancy diagnosis was performed arround 30 to 35 days after 
ET by using a real-time ultrasound scanner. 
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Figure 3.15: ET procedure for recipient does. 
 
3.4 EXPERIMENTAL DESIGN 
A total of 5 experiments have been designed to achieve the objectives of the present 
research. In Experiment 1, effect of supplementation of hCG or GnRH on ovulation and 
subsequent embryo production of eCG-superovulated does were evaluated. In 
Experiment 2, effect of supplementation of hCG or GnRH on ovulation and subsequent 
embryo production of pFSH-superovulated does were evaluated. The most suitable 
gonadotrophin combination was selected from Experiments 1 and 2 for further research. 
In Experiment 3, effect of pFSH dosage based on BW on superovulation performance 
was evaluated. In Experiment 4, effect of donor age and BW on superovulation was 
evaluated. In Experiment 5, effect of recipient physical condition (surgery cycle i.e. 
earlier used in any surgery or not) on pregnancy rate and subsequent kidding was 
evaluated.  
 
3.4.1 Effect of Supplementation of hCG or GnRH on Ovulation and Subsequent 
Embryo Production of eCG-Superovulated Does (Experiment 1) 
A total of 30 Boer crossbred donor does were used for evaluating the effect of 
supplementation of hCG or GnRH on ovulation and subsequent embryo production of 
54 
 
eCG-superovulated does. Oestrus was synchronised with the help of a CIDR for 14 days 
and an i.m. injection of 125 µg PGF2α (Estrumate; Intervet International B.V. Boxmeer, 
The Netherlands) on Day 11. Superovulation treatment was carried out by administering 
1500 IU eCG (Folligon®; Intervet International B.V., EU) at 2 days before the CIDR 
removal. Further, all the donor does were randomly and equally divided into 3 treatment 
groups; and animals received with or without hCG (Ovidrel®; PreFilled Syringe, 
Industria Farmaceutica Serono, S.P.A., Bari, Italy) or GnRH (Receptal®; Intervet 
International B.V., EU) after CIDR removal. The 3 treatment groups were administered 
with 2 dosages of hCG 500 IU each on Days 15 and 16 or a single dosage of 20 µg 
GnRH on Day 15 or without hCG or GnRH (Figure 3.16). After CIDR removal, oestrus 
was observed 3 times a day (morning at 0800-0900 hr, afternoon at 1300-1400 hr and 
evening 1900-2000 hr) until exhibition of overt oestrus by placing a buck of proven 
libido.  Subsequently, natural mating and AI were performed simultaneously when does 
showed oestrus signs. AI was performed approximately 2 days (40-48 hr) after CIDR 
removal. On Day 7 after CIDR removal, ovarian responses were evaluated and embryos 
were collected during laparotomy session (Figure 3.16). For ovarian response during 
superovulation, number of CL, number of anovulated follicles, transferrable embryos, 
number of degenerated embryos and number of unfertilised oocytes were counted for 
both the ovaries. Ovulation percentage was calculated as: 
Ovulation percentage = No. of CL ×100 Total no. of stimulation 
 
and recovery rate was calculated as: 
Recovery rate = No. of embryo + unfertilised oocytes ×100 Total no. of CL 
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Figure 3.16: Schematic representation of the superovulation protocol using eCG.  
a) Control, b) hCG and c) GnRH. 
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3.4.2 Effect of Supplementation of hCG or GnRH on Ovulation and Subsequent 
Embryo Production of pFSH-Superovulated Goats (Experiment 2) 
 
A total of 18 Boer crossbred does were used for the evaluation of the effect of 
supplementation of hCG or GnRH on ovulation and subsequent embryo production of 
pFSH-superovulated does. Oestrus was synchronised with the help of a CIDR for 14 
days and an i.m. injection of PGF2α on Day 11. For normal goat superovulation, 
treatment was performed by administering 200 mg or 10 ml pFSH (Folltropin®-V; 
Bioniche Animal Health, Canada). pFSH treatment was divided in six decreasing doses 
(2.5, 2.5, 1.5, 1.5, 1.0 and 1.0 ml) given twice daily at morning (0800-0900 hr) and 
evening (1800-1900 hr). pFSH treatment was initiated 2 days before CIDR removal. 
Finally, all the donor does were divided randomly into 3 treatment groups. Each 
treatment group was administered with 2 dosages of hCG 500 IU each on Days 15 and 
16 or a single dosage of 20 µg GnRH on Day 15 or without hCG or GnRH (Figure 
3.17). After CIDR withdrawal, oestrus was observed 3 times in a day (morning at 0800-
0900 hr, afternoon at 1300-1400 hr and evening 1900-2000 hr) until exhibition of overt 
oestrus by placing a buck of proven libido. Subsequently, natural mating and AI was 
carried out when the does showed oestrus sign. On Day 7 after CIDR removal, ovarian 
responses were evaluated and embryos were collected during laparotomy session 
(Figure 3.17). For ovarian response during superovulation, number of CL, number of 
anovulated follicles, transferrable embryos, number of degenerated embryos and 
number of unfertilised oocytes were counted for both the ovaries. Ovulation percentage 
and recovery rate were calculated. 
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a)  
 
b)  
 
c)  
 
Figure 3.17: Schematic representation of the superovulation protocol for pFSH.  
a) Control, b) hCG and c) GnRH. 
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3.4.3 Effect of pFSH Dosage Based on BW on Superovulation Performance 
(Experiment 3) 
 
A total of 39 Boer crossbred does were used to evaluate the effect of dosage of pFSH 
based on BW on the superovulation performance. Oestrus was synchronised with the 
help of a CIDR for 14 days and an i.m. injection of PGF2α on Day 11. After oestrus 
synchronisation, all the donor does were weighed and divided randomly into 3 groups, 
namely Groups 1, 2 and 3. The respective groups were administered with 3, 5 and 8 mg 
of pFSH (Folltropin®-V; Bioniche Animal Health, Canada) based on per kg BW 
through multiple i.m. injections. Total amount of pFSH for each donor was divided into 
6 decreasing (25, 25, 15, 15, 10, and 10%) dosages and given twice daily (0800-0900 hr 
and 1800-1900 hr) for a period of three successive days. Based on these percentages, the 
absolute amount of pFSH per kg BW was 0.75, 0.75, 0.45, 0.45, 0.30 and 0.30 mg for 
Group 1; 1.25, 1.25, 0.75, 0.75, 0.50 and 0.50 mg for Group 2; and 2.00, 2.00, 1.20, 
1.20, 0.80 and 0.80 mg for Groups 3, respectively. In other word, the average total 
amount for 3, 5 and 8 mg dosages were 89, 144 and 200 mg, respectively. The pFSH 
treatments were initiated at 2 days before the CIDR removal (Figure 3.18). After CIDR 
removal, oestrus was observed 3 times a day (morning at 0800-0900 hr, afternoon at 
1300-1400 hr and evening 1900-2000 hr) until exhibition of overt oestrus by placing a 
buck of proven libido.  Subsequently, natural mating and AI were carried out 
simultaneously when the does showed oestrus sign. AI was performed approximately 2 
days (40-48 hr) after CIDR removal. On Day 7 after CIDR removal, ovarian responses 
were evaluated and embryos were collected during laparotomy session (Figure 3.18). 
For ovarian response during superovulation, number of CL, number of anovulated 
follicles, transferrable embryos, number of degenerated embryos and number of 
unfertilised oocytes were counted for both the ovaries. Ovulation percentage and 
recovery rate were calculated. 
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Figure 3.18: Schematic representation of the superovulation protocol for different 
dosages of pFSH based on BW (Expt 3). 
 
3.4.4 Effect of Donor Age and BW on Superovulation Performance  
(Experiment 4) 
 
A total of 40 crossbred goats were used to evaluate the effect of donor age and BW on 
superovulation performance. Oestrus was synchronised with the help of a CIDR for 14 
days and an i.m. injection of PGF2α on Day 11. A 2×2 factorial experiment was 
designed including: a) two age group, namely 2 to 4 years of age and more than 4 years 
of age; b) two BW groups, namely 15 to 25 kg and more than 25 kg. After oestrus 
synchronisation, all the donor does were weighed and divided randomly into 4 groups: 
Group 1 (2-4 yr of age and 15-25 kg BW), Group 2 (2-4 yr of age and >25 kg BW), 
Group 3 (>4 yr of age and 15-25 kg BW) and Group 4 (>4 yr of age and >25 kg BW). 
The superovulatory amount of pFSH was calculated according to 5 mg pFSH per kg 
BW. Total amount of pFSH for each donor was divided into six decreasing (25, 25, 15, 
15, 10, and 10%) dosages and given twice daily (0800-0900 hr and 1800-1900 hr) for a 
period of three successive days. The absolute amount of pFSH per kg BW was 1.25, 
1.25, 0.75, 0.75, 0.50 and 0.50 mg. The pFSH treatments were initiated at 2 days before 
the CIDR removal (Figure 3.19). After CIDR removal, oestrus was observed 3 times a 
day (morning at 0800-0900 hr, afternoon at 1300-1400 hr and evening 1900-2000 hr) 
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until exhibition of overt oestrus by placing a buck of proven libido.  Subsequently, 
natural mating and AI were carried out simultaneously when the does showed oestrus 
sign. AI was performed approximately 2 days (40-48 hr) after CIDR removal. On Day 7 
after CIDR removal, ovarian responses were evaluated and embryos were collected 
during laparotomy session (Figure 3.19). For ovarian response during superovulation, 
number of CL, number of unovulated follicles, transferrable embryos, number of 
degenerated embryos and number of unfertilised oocytes were counted for both the 
ovaries. Ovulation percentage and recovery rate were calculated. 
 
 
Figure 3.19: Schematic representation of the superovulation protocol for evaluating 
donor age and BW using pFSH (Expt 4). Note: Similar basic protocols 
described in Expt 3. 
 
3.4.5 Effect of Recipient Physical Condition on Pregnancy Rate and Subsequent 
Kidding (Experiment 5) 
 
A total of 99 Boer crossbred recipient does from 2 physiological groups, such as intact 
recipient does (36 does) and recipient used for repeated surgeries (LOPU, ET) (63 
does), respectively, were synchronised to evaluate the effect of recipient does physical 
condition on pregnancy rate and subsequent kidding. All recipient does were 
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synchronised by inserting CIDR for 14 days and an i.m. injection of 300 IU eCG (as 
normally recommended to activate folliculogenesis) was carried out on Day 12 (Figure 
3.20). After CIDR removal, oestrus was observed 3 times in a day (morning at 0800-
0900 hr, afternoon at 1300-1400 hr and evening 1900-2000 hr) by placing a buck of 
proven libido.  On Day 7 after CIDR removal, ovaries were checked for CL and 
recipient does with functional CL were only used as recipients. After flushing, 
recovered embryos were examined under a stereomicroscope and only transferrable 
embryos (morula and blastocyst) were transferred. Uterine horn was exteriorised over 
the surface of abdomen with the help of a grasping forceps and a surgical blade. One to 
3 fresh embryos along with a small amount of flushing medium (0.1-0.2 ml) were 
loaded in a BD unopette attached to a 1 ml syringe and were transferred into the lumen 
of the anterior part of the uterine horn. The procedure for the transfer of the embryos 
were repeated after exteriorising the opposite uterine horn. Once completed, the uterine 
horn was placed back into the abdominal cavity and the incision was sutured. Pregnancy 
diagnosis was performed at around 30 to 35 days after ET by using a real-time 
ultrasound scanner. Pregnancy rate, kidding and gestation period were calculated. 
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Figure 3.20: Schematic representation of the oestrus synchronisation protocol for 
recipient does. 
 
 
62 
 
3.5 STATISTICAL ANALYSIS 
The effects of different treatments (gonadotrophin source, pFSH dosage, donor age and 
BW) on parameters (number of CL, total embryo, transferrable embryo, degenerated 
embryo, anovulated follicle and unfertilised oocytes) were statistically evaluated by 
one-way analysis of variance (ANOVA) using SPSS software (version 16.0, Statistical 
Package for the Social Sciences software, Chicago, IL, USA). Effect of recipient 
surgery cycle on pregnancy rate was analysed using χ2 test. Correlation analysis was 
carried out using SPSS software to determine the relationship among the parameters and 
expressed as a Pearson correlation coefficient (r). Results were expressed as the 
mean±SEM (standard error of means). Mean values were compared using Duncan's 
multiple range test (DMRT), and differences and correlations were considered as 
significant when (P<0.05.).  
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Effect of eCG or pFSH on Superovulation Performance 
Factors: 
a) Source of LH (hCG vs. GnRH) 
Parameters: 
• No. of ovulation 
• No. of embryo production 
• No. of transferrable embryo 
• No. of anovulated follicle 
• No. of unfertilised oocyte 
Effect of pFSH Dosage Based on BW on Superovulation Performance 
Factors: 
a) Dosage of pFSH based on BW (3, 5 and 8 mg pFSH per kg BW) 
Parameters: 
• No. of ovulation 
• No. of embryo production 
• No. of transferrable embryo 
• No. of anovulated follicle 
• No. of unfertilised oocyte 
Effect of Age and BW on Superovulation Performance 
Factors: 
a) Age (2-4 yr vs. >4 yr) 
b) BW (15-25 kg vs. >25 kg) 
Parameters: 
• No. of ovulation 
• No. of embryo production  
• No. of transferrable embryo 
• No. of anovulated follicle 
• No. of unfertilised oocyte 
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Figure 3.21: Flow chart of experimental design. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Effect of Recipient Physical Condition on Pregnancy Rate and Subsequent 
Kidding  
Factors: 
a) Surgery cycle (intact goat vs. used goat for repeated surgeries such as 
embryo flushing, ET and LOPU) 
Parameters:  
• Rate of pregnancies 
• Duration of gestation 
• No of kidding 
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Figure 3.22: Flow chart of experimental activity. 
Oestrus synchronisation 
 
Superovulation 
Oestrus checking and breeding 
 
Embryo flushing 
Embryo searching and grading 
 
Embryo transfer 
Pregnancy detection 
Kidding 
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Chapter 4 
4.0 RESULTS 
 
4.1 EFFECT OF SUPPLEMENTATION OF hCG OR GnRH ON 
OVULATION AND SUBSEQUENT EMBRYO PRODUCTION OF eCG- 
SUPEROVULATED GOATS (EXPERIMENT 1) 
Ovarian response of eCG-superovulated Boer crossbred does as affected by hCG or 
GnRH is presented in Table 4.1. All the donor does (100%) of 3 treatment groups 
showed signs of standing oestrus within 30 to 42 hour upon CIDR removal, 78 to 90 
hourr upon eCG injection and 12 to 24 hour upon hCG/GnRH injection.  Among the 
treatments, the higher number of donor does in Group 1 (10; 100%) had CL (Figure 4.1) 
followed by Group 2 (5; 50%) and Group 3 (4; 40%). Does in Group 1 showed 
significantly (P<0.05) higher average number of CL (10.90±1.73) per doe than Group 2 
(1.90±0.91) and Group 3 (0.90±0.50). Similarly, ovulation percentage (number of CL 
was divided by number of follicular stimulation and multiplied by 100) also followed 
same significant trend, with the values of 61.77±10.13% for Group 1; 11.40±5.69% for 
Group 2 and 10.24±7.05% for Group 3. Average numbers of ovarian stimulation 
(number of CL plus number of anovulatory follicles) per doe were relatively similar for 
all treatments groups. The values were as follows: 20.70±4.42 (Group 1), 16.10±4.19 
(Group 2) and 14.70±3.41 (Group 3). Average numbers of anovulatory follicles (Figure 
4.2) per doe were relatively similar for all groups (P>0.05) even though apparently 
Group 2 (14.20±4.18) and Group 3 (13.80±3.50) were slightly higher than Group 1 
(9.80±4.10).  
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Table 4.1: Ovarian stimulation upon hCG or GnRH supplementation on ovulation after eCG superovulation 
Parameters Group 1 
(eCG + hCG) 
(Mean±SEM) 
Group 2 
(eCG + GnRH) 
(Mean±SEM) 
Group 3 
(eCG; Control) 
(Mean±SEM) 
Number of doe 10 10 10 
Number of doe showed oestrus 10 10 10 
Average number of CL/doe  10.90±1.73b 1.90±0.91a 0.90±0.50a 
Average number of anovulatory follicle (AF)/doe  9.80±4.10a 14.20±4.18a 13.80±3.50a 
Average number of ovarian stimulation 
(CL+AF)/doe 
20.70±4.42a 16.10±4.19a 14.70±3.41a 
Ovulation percentage*(%)  61.77±10.13b 11.40±5.69a 10.24±7.05a 
a,b
 Mean values with different superscripts within a row were significantly (P<0.05) different.  
SEM= standard error of means. 
*Ovulation percentage was calculated for each donor doe and from that the average was calculated. 
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Figure 4.1: Superovulated ovary with CL. 
 
 
 
 
Figure 4.2: Superovulated ovary with anovulatory follicles. 
 
 
 
 
 
 
 
 
 
 
 
 
69 
 
Extending from the above findings, subsequent embryo production of eCG- 
superovulated does followed with hCG or GnRH co-treatment is presented in Table 4.2. 
Average number of structures (number of embryos plus unfertilised oocytes) recovered 
was significantly (P<0.05) higher in Group 1 (3.10) than Group 2 (0.70) and Group 3 
(0). Recovery rate {(number of structured recovered/number of CL) × 100} was not 
shown to have any significant difference between Group 1 (25.89%) and Group 2 
(21.11%). No structure (embryo plus unfertilised oocyte) was recovered from Group 3. 
Although there was no significant difference for average number of embryo production, 
Group 1 (0.90) produced numerically higher number of embryos than Group 2 (0.50). 
There was no significant difference in transferrable and degenerated embryos between 
the two treatment groups. Although, the number of structures recovered was higher in 
Group 1 than Group 2, it was negated by the production of significantly higher number 
of unfertilised oocytes in Group 1 (2.20) than Group 2 (0.20). 
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Table 4.2: Effect of hCG or GnRH supplementation on embryo production characteristics of eCG superrovulated does 
Parameters Group 1 
(eCG + hCG) 
(Mean±SEM) 
Group 2 
(eCG + GnRH) 
(Mean±SEM) 
Group 3 
(eCG; Control) 
(Mean±SEM) 
Number of doe with CL 10 5 4 
Average number of structures recovered/doe 3.10±1.02b 0.70±0.42a 0 
Average number of embryos/doe 0.90±0.35a 0.50±0.40a 0 
Average number of transferable embryos/doe 0.40±0.22a 0.30±0.21a 0 
Average number of degenerated embryos/doe 0.50±0.27 0.20 0 
Recovery rate (%) 25.89±7.57a 21.11±11.53a 0 
Average number of unfertilised oocytes/doe 2.20±0.81b 0.20±0.13a 0 
a,bMean values with different superscripts within a row were significantly (P<0.05) different.  
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4.2 EFFECT OF SUPPLEMENTATION OF hCG OR GnRH ON OVULATION 
AND SUBSEQUENT EMBRYO PRODUCTION OF pFSH- 
SUPEROVULATED GOATS (EXPERIMENT 2) 
Ovarian responses of pFSH superovulated Boer crossbred does as affected by hCG or 
GnRH supplementation are presented in Table 4.3. The number of donor does showed 
signs of standing oestrus were 5 (83%), 4 (67%) and 6 (100%) for Group 1, Group 2 
and Group 3, respectively. The time duration of onset of standing oestrus was within 72 
to 78 hour upon first pFSH injection, 24 to 30 hour upon CIDR removal and within 12 
hour upon hCG/GnRH injection.  The higher percentage of donor does in Group 1 
(67%) and Group 3 (67%) had CL than Group 2 (17%) but no significant differences 
were observed. The average number of CL produced per doe in Group 3 (4.83±2.56) 
and Group 1 (4.33±1.65) were numerically higher than Group 2 (0.83) but due to high 
variation it failed to show significant difference. Similarly, ovulation percentage was 
higher in Group 3 (45.96±19.88%) followed by Group 1 (19.31±6.64%) and Group 2 
(9.26%), but no significant differences were observed. Average number of ovarian 
stimulation (number of CL plus number of anovulatory follicles) per doe was higher in 
Group 1 followed by Group 3 and Group 2 but did not differ significantly. The values 
were as follows: 17.83±3.94 (Group 1), 10.33±3.63 (Group 2) and 11.66±1.91 (Group 
3). Average numbers of anovulatory follicles per doe were relatively similar for all 
groups (P>0.05) even though apparently Group 1 (13.50±3.00) and Group 2 (9.50±3.79) 
were higher than Group 3 (6.83±2.74). 
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Table 4.3: Ovarian stimulation upon hCG or GnRH on ovulation after pFSH superovulation 
Parameters Group 1 
(pFSH + hCG) 
(Mean±SEM) 
Group 2 
(pFSH + GnRH) 
(Mean±SEM) 
Group 3 
(pFSH; Control) 
(Mean±SEM) 
Number of doe 6 6 6 
Number of doe showed oestrus 5 4 6 
Average number of CL/doe  4.33±1.65a 0.83 4.83±2.56a 
Average number of anovulatory follicle (AF)/doe  13.50±3.00a 9.50±3.79a 6.83±2.74a 
Average number of ovarian stimulation (CL+AF)/doe 17.83±3.94a 10.33±3.63a 11.66±1.91a 
Ovulation percentage (%)*  19.31±6.64a 9.26 45.96±19.88a 
a
 Mean values with same superscript within a row were not significantly (P<0.05) different.  
SEM= standard error of means. 
*Ovulation percentage was calculated for each donor doe and from that the average was calculated. 
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Extending from the above findings, subsequent embryo production of pFSH 
superovulated donor does followed with hCG or GnRH co-treatment is presented in 
Table 4.4. Average number of structures (number of embryos plus unfertilised oocytes) 
recovered were higher in Group 3 (3.17±2.20) followed by Group 1 (2.33±1.38) and 
Group 2 (0.33) but the differences were not statistically significant. Recovery rate was 
higher in Group 1 (32.78±16.34%) followed by Group 3 (26.04±16.48%) and Group 2 
(6.67%) but did not show any significant differences among the treatment groups. 
Although there was no significant difference for average number of embryo production, 
Group 1 (1.50±1.12) produced numerically higher number of embryos than Group 3 
(1.00) followed by Group 2 (0.33). There was no significant difference in transferable 
and degenerated embryos between 3 treatment groups. Average number of unfertilised 
oocytes per doe was higher in Group 3 (2.17) than Group 1 (0.83±0.65).  
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Table 4.4: Effect of hCG and GnRH on embryo production characteristics after pFSH superovulation 
Parameters Group 1 
(pFSH + hCG) 
(Mean±SEM) 
Group 2 
(pFSH + GnRH) 
(Mean±SEM) 
Group 3 
(pFSH; Control) 
(Mean±SEM) 
Number of doe with CL 4 1 4 
Average number of structures recovered/doe 2.33±1.38a 0.33 3.17±2.20a 
Average number of embryos/doe 1.50±1.12 0.33 1.00 
Average number of transferable embryos/doe 1.33±1.15 0.33 0.83 
Average number of degenerated embryos/doe 0.17 0 0.17 
Recovery rate (%) 32.78±16.34a 6.67 26.04±16.48a 
Average number of unfertilised oocytes/doe 0.83±0.65a 0 2.17 
aMean values within a row were not significantly (P>0.05) different. 
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4.3 EFFECT OF pFSH DOSAGE BASED ON BW ON SUPEROVULATION 
PERFORMANCE (EXPERIMENT 3) 
 
Ovarian stimulation of Boer crossbred does as affected by different pFSH dosages 
based on BW is presented in Table 4.5. The time duration of onset of standing oestrus 
was within 72 to 78 hour upon first pFSH injection and 24 to 30 hour upon CIDR 
removal. All the donor does (100%) of Group 2 and Group 3 showed signs of standing 
oestrus, however, only 62% of the donor does of Group 1 showed signs of standing 
oestrus.  Average numbers of CL for Group 1, Group 2 and Group 3 were 5.23±1.68, 
7.69±2.35 and 5.08±1.49, respectively, and no significant (P>0.05) differences were 
observed among the treatment groups. Numbers of anovulated follicles were 
significantly (P<0.05) higher in Group 3 (6.20±2.05) than in Group 1 (0.20) and Group 
2 (3.50±1.83). Ovulation percentage {(number of CL/number of total stimulation) × 
100} was numerically higher in Group 2 (68.91±13.26%) than Group 3 (51.96±12.19%) 
and Group 1 (49.05±13.25%) but did not show any significant difference. Total ovarian 
stimulation was similar in Group 2 (11.00±1.93) and Group 3 (10.77±2.14) but higher 
than Group 1 (7.46±2.29) and did not show any significant difference. Out of 13 donor 
does, 5 donor does of Group 1 and 4 donor does of both Group 2 and Group 3 had no 
CL.   
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Table 4.5: Ovarian stimulation upon pFSH dosages based on BW 
Parameters Dosages of pFSH per kg BW 
Group 1 
(3 mg) 
(Mean±SEM*) 
Group 2 
(5 mg) 
(Mean±SEM) 
Group 3 
(8 mg) 
(Mean±SEM) 
Number of does 13 13 13 
Number of does showing oestrus 8 13 13 
Average number of CL/doe 5.23±1.68a 7.69±2.35a 5.08±1.49a 
Average number of anovulatory follicle (AF)/doe  2.23±1.46a 3.31±1.46a 5.69±1.69b 
Average number of ovarian stimulation (CL + AF)/doe 7.46±2.29a 11.00±1.93a 10.77±2.15a 
Ovulation percentage 49.05±13.25a 68.91±13.27a 51.96±12.19a 
a,b
 Mean values with different superscripts within a row were significantly (P<0.05) different.  
*SEM= Standard error of mean. 
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Extending from the above findings, subsequent embryo production of pFSH 
superovulated does affected by pFSH dosage based on per kg BW is presented in Table 
4.6. Average number of structures (embryos plus unfertilised oocytes) recovered per 
donor doe was higher in Group 2 (4.15±1.36) followed by Group 3 (2.62±0.99) and 
Group 1 (2.46±0.78), respectively. Recovery rate was not shown to have any significant 
difference between Group 1 (35.00±9.65%), Group 2 (37.54±9.77%) and Group 3 
(37.38±10.40%). Although the average number of CL per goat for the 3 treatment 
groups were similar, the total number of recovered embryos (Figure 4.3) were 
significantly (P<0.05) higher in Group 2 (4.08±1.37) than Group 1 (1.38±0.59) and 
Group 3 (1.23±0.52). Group 2 (3.77±1.42) produced significantly higher number of 
transferable embryos per doe than Group 3 (0.92±0.47) but the difference was not 
significant between Group 2 vs. Group 1 (1.23±0.53) and Group 1 vs. Group 3. There 
was no significant difference in degenerated embryos between the 3 treatment groups. 
The number of unfertilised oocytes (Figure 4.4) per donor doe was lower in Group 2 
(0.08) followed by Group 1 (1.08±0.65) and Group 3 (1.38±1.00), but no differences 
(P>0.05) were observed among treatment groups.  
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Table 4.6: Effect of pFSH dosages based on BW on embryo production characteristics 
Parameters Dosages of pFSH per kg BW 
Group 1 
(Mean±SEM) 
Group 2 
(Mean±SEM) 
Group 3 
(Mean±SEM) 
Number of does with CL 8 9 9 
Average number of embryos/doe 1.38±0.59a 4.08±1.37b 1.23±0.52a 
Average number of transferable embryos/doe 1.23±0.53ab 3.77±1.42b 0.92±0.47a 
Average number of degenerated embryos/doe 0.15±0.10a 0.08 0.31±0.13a 
Average number of structures recovered/doe 2.46±0.78a 4.15±1.36a 2.62±0.99a 
Recovery rate (%) 35.00±9.65a 37.54±9.77a 37.38±10.40a 
Average number of unfertilised oocytes/doe 1.08±0.65a 0.08 1.38±1.00a 
a,bMean values with different superscripts within a row were significantly (P<0.05) different.  
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Figure 4.3: Recovered embryos during the embryo flushing at 200x 
magnification. 
 
 
Figure 4.4: Recovered unfertilised oocytes during the embryo flushing at 200x 
magnification. 
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Correlations among the ovarian stimulation characteristics and embryo 
production performances for different treatment groups are presented in Table 4.7. For 
Group 1, positive correlations were shown between total stimulation and the number of 
CL (r=0.752, P<0.01); total stimulation and the number of anovulatory follicle 
(r=0.670, P<0.05); number of unfertilised oocytes and the number of anovulatory 
follicle (r=0.590, P<0.05); total stimulation and the number of unfertilised oocytes 
(r=0.736, P<0.01); the number of embryos and transferable embryos (r=0.989, P<0.01). 
In Group 2, positive correlations were shown between total stimulation and the number 
of CL (r=0.715, P<0.01); the number of CL and number of embryos (r=0.832, P<0.01); 
the number of CL and transferable embryos (r=0.778, P<0.01); total stimulation and the 
number of anovulatory follicle (r=0.669, P<0.05); the number of embryos and 
transferable embryos (r=0.986, P<0.01). In Group 3, a positive correlation was shown 
between total stimulation and the number of anovulatory follicles (r=0.725, P<0.05); 
total stimulation and the number of unfertilised oocytes (r=0.842, P<0.01); the number 
of CL and the number of unfertilised oocytes (r=0.823, P<0.01); the number of embryos 
and transferable embryos (r=0.969, P<0.01) and total stimulation and the number of CL 
(r=0.622, P<0.05). 
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Table 4.7: Correlation coefficient among the characteristics of ovarian stimulation and embryo production performances for different treatment groups   
 
Treatment 
groups 
No. of CL No. of anovulatory 
follicles 
Total 
stimulation 
No. of 
embryos 
No. of unfertilised 
oocytes 
Total stimulation  Group 1 0.752** 0.670*    
Group 2 0.715** 0.669*    
Group 3 0.622* 0.725*    
No. of embryos Group 1 NS NS NS   
Group 2 0.832** NS NS   
Group 3 NS NS NS   
No. of unfertilised 
oocytes 
Group 1 NS 0.590* 0.736** NS  
Group 2 NS NS NS NS  
Group 3 0.823** NS 0.842** NS  
Transferable embryos Group 1 NS NS NS 0.989** NS 
Group 2 0.778** NS NS 0.986** NS 
Group 3 NS NS NS 0.969** NS 
*Correlation is significant at the 0.05 level (2-tailed). ** Correlation is significant at the 0.01 level (2-tailed).  
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4.4  EFFECT OF DONOR AGE AND BW ON SUPEROVULATION 
PERFORMANCE (EXPERIMENT 4) 
Ovarian response of pFSH superovulated crossbred does as affected by donor age and BW 
is presented in Table 4.8. All the donor does (100%) of Group 2 showed signs of 
standing oestrus, however, 70, 70 and 80% of the donor does of Group 1, Group 3 and 
Group 4 showed signs of standing oestrus, respectively. The time duration of onset of 
standing oestrus was within 72 to 78 hour upon first pFSH injection and 24 to 30 hour upon 
CIDR removal. Among the treatments, the higher number of donor does in Group 2 (9; 90%) 
had CL followed by Group 1 (5; 50%), Group 3 (4; 40%) and Group 4 (3; 30%). Average 
numbers of CL for Group 1, Group 2, Group 3 and Group 4 were 3.30±1.27, 11.70±2.75, 
3.30±1.84, and 1.40±0.91, respectively.  Donor does in Group 2 produced significantly higher 
number of CL than the other groups but Group 1, Group 3 and Group 4 had failed to show 
significant (P>0.05) differences among them. Similarly, ovulation percentage also followed 
same significant trend, with the values of 43.33±15.75% for Group 1; 78.64±11.30% for Group 
2; 29.13±13.54% for Group 3 and 29.00±14.79% for Group 4. Total ovarian stimulation was 
significantly higher in Group 2 (16.90±4.17) than Group 1 (6.60±1.91), Group 3 
(6.20±2.00) and Group 4 (6.50±1.61) but other groups were failed to show the 
difference among them. All the donor does of Group 2 (100%) were stimulated 
whereas, 30, 30 and 20% donor does of Group 1, Group 3 and Group 4 were not 
stimulated, respectively. Average numbers of anovulatory follicles per donor doe were 
similar in Group 2 (5.2±2.74) and Group 4 (5.10±1.78) but higher than Group 1 
(3.30±1.67) and Group 3 (2.90±1.00) and did not show any significant difference.   
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Table 4.8: Ovarian stimulation based on donor age and BW 
Parameters Group 1 
2-4 yr, 15-25 kg 
(Mean±SEM) 
Group 2 
2-4 yr, >25 kg  
(Mean±SEM) 
Group 3 
>4 yr, 15-25 
(Mean±SEM) 
Group 4 
>4 yr, >25 kg 
(Mean±SEM) 
Number of does 10 10 10 10 
Number of does showing oestrus 7 10 7 8 
Average number of CL/doe 3.30±1.27a 11.70±2.75b 3.30±1.84a 1.40±0.91a 
Average number of anovulatory 
follicle (AF)/doe 
3.30±1.67a 5.20±2.74a 2.90±1.00a 5.10±1.78a 
Average number of ovarian 
stimulation (CL + AF)/doe 
6.60±1.91a 16.90±4.17b 6.20±2.00a 6.50±1.61a 
Ovulation percentage 43.33±15.75ab 78.64±11.30b 29.13±13.54a 29.00±14.79a 
a,b
 Mean values with different superscripts within a row were significantly (P<0.05) different.  
SEM= Standard error of mean. 
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Extending from the above findings, subsequent embryo production of pFSH 
superovulated Boer crossbred does affected by age and BW of donor does is presented 
in Table 4.9. Average number of structures (number of embryos plus unfertilised 
oocytes) recovered were significantly (P<0.05) higher in Group 2 (5.20±1.62) than 
Group 1 (1.10±0.55), Group 4 (0.80±0.70) and Group 3 (0.50±0.40). Recovery rate was 
significantly higher in Group 2 (50.50±12.05%) than Group 1 (16.30±7.05%), Group 4 
(12.80±8.78%) and Group 3 (7.50±5.34%). Average number of embryo production was 
significantly higher in Group 2 (5.10±1.64) than Group 1 (1.10±0.55), Group 4 
(0.80±0.70) and Group 3 (0.20±0.13). Transferable embryo production was significantly 
higher in Group 2 (4.90±1.70) than Group 4 (0.70) and Group 1 (0.60±0.50). Group 3 
did not produce any transferable embryos. There was no significant difference in 
degenerated embryos produced by two different treatment groups. The numbers of 
recovered unfertilised oocytes were not differed significantly among the treatment 
groups. 
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Table 4.9: Effect of donor does age and BW on embryo production characteristics 
Parameters Group 1 
2-4 yr, 15-25 kg 
(Mean±SEM) 
Group 2 
2-4 yr, >25 kg  
(Mean±SEM) 
Group 3 
>4 yr, 15-25 
(Mean±SEM) 
Group 4 
>4 yr, >25 kg 
(Mean±SEM) 
Number of does with CL 5 9 4 3 
Average number of structures recovered/doe 1.10±0.55a 5.20±1.62b 0.50±0.40a 0.80±0.70a 
Average number of embryos/doe 1.10±0.55a 5.10±1.64b 0.20±0.13a 0.80±0.70a 
Average number of transferable embryos/doe 0.60±0.50a 4.90±1.70b 0 0.70 
Average number of degenerated embryos/doe 0.20±0.13a 0.20±0.13a 0.10 0.10 
Recovery rate (%) 16.30±7.25a 50.50±12.05b 7.50±5.34a 12.80±8.78a 
Average number of unfertilised oocytes/doe 0 0.10 0.30 0 
a,b
 Mean values with different superscripts within a row were significantly (P<0.05) different.  
SEM= Standard error of mean. 
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4.5 EFFECT OF RECIPIENT PHYSICAL CONDITION ON PREGNANCY 
RATE AND SUBSEQUENT KIDDING (EXPERIMENT 5) 
Pregnancy rate and subsequent kidding as affected by the physical condition of does i.e. 
intact does (have not used for any surgery before) and used does (have repeated used for 
different surgeries- LOPU, embryo flushing or ET) are presented in Table 4.10. A total 
of 99 does were synchronised, out of that, 36 were intact does and 63 were used does. 
Total 39 and 41 embryos were transferred to 15 intact recipient does and 16 used 
recipient does, respectively. The average numbers of embryos transferred per recipient 
doe were 2.60 and 2.56 for intact and used groups, respectively. The percentage of 
pregnancy was 26.67% for intact group. No pregnancy was recorded in used group. In 
this experiment, only 4 recipient does of intact group were pregnant, and out of that 2 
does were delivered and another 2 does died before the delivery. One day before ET, 
the recipient does were scanned by using ultrasound scanner to confirm non-pregnant 
by the absence of pregnancy related structures such as placentomes and amniotic fluid 
(Figure 4.5). Pregnancy was confirmed by transabdominal ultrasound scanning at 37 
day after ET (Figure 4.6). The kidding was confirmed by the live born of 3 kids 
(Figures 4.7 and 4.8). Average number of embryo survival rate was calculated based on 
the number of kids born, which was 7.69. Average gestation length was 148.00±4.00 
days. The results showed that the intact does had a higher pregnancy rates compared to 
the used does. 
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Table 4.10: Effect of recipient surgery cycle on pregnancy rate and kidding 
Parameters Surgery cycle of recipient doe 
Intact goats   Non-intact goats 
Number of doe synchronised as recipient 36 63 
Number of synchronised recipient doe used 
for ET 
15 16 
Total number of transferred embryo  39 41 
Average embryo transferred/recipient  2.60 2.56 
Number of recipient doe pregnant  4 0 
Percent of recipient doe pregnant (%) 26.67a 0b 
Number of recipient doe kidded 2 0 
Viable young kid (No.) 3 0 
Embryo survival rate (%) 7.69 0 
Average gestation length (d) 148.00±4.00 0 
a,bSuperscripts within rows with different letters differ significantly (P<0.05). 
Non-intact goats: animals have been used in surgery (LOPU, embryo flushing or 
embryo transfer). 
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Figure 4.5: Typical ultrasound image of a recipient doe before ET. 
 
Figure 4.6: Typical ultrasound image of a pregnant recipient doe after 37 days of ET. 
 
Ovary 
Foetus 
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Figure 4.7: ET kids with recipient doe. 
 
Figure 4.8: Twins ET kids from Figure 4.6 just after delivery. 
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Chapter 5 
5.0 DISCUSSION 
 
5.1 EFFECT OF SUPPLEMENTATION OF hCG OR GnRH ON 
OVULATION AND SUBSEQUENT EMBRYO PRODUCTION OF eCG-
SUPEROVULATED GOATS (EXPERIMENT 1) 
Oestrus sign in does is a very important physiological reproductive behaviour typical in 
mammalian species particularly signifying ovulation during the oestrous cycle to 
facilitate successful natural mating. Understanding the basic endocrinology during the 
oestrus period will lead to its application in numerous reproductive techniques such as 
superovulation, AI and ET. In goats, efforts have been made to increase the efficiency 
of ovulatory cycle and embryo production performance by using various sources and 
combinations of gonadotrophins.  
In the present experiment, regardless the hormonal treatment, 100% of the donor 
does showed sign of oestrus which was similar with the findings of earlier researchers 
who reported 100% of oestrus by using different dosages of eCG with CIDR 
(Motlomelo et al., 2002); FGA intravaginal sponge (Espinosa-Marquez et al., 2004); 
MAP intravaginal sponges (Pampukidou et al., 2011) and PGF2α (Goel and Agrawal, 
2005). On the other hand, other researchers reported lower values which were 87%  and 
85% of does showed oestrus using different amount of eCG with intravaginal sponges 
(Kelidari et al., 2010) and CIDR (Xiao et al., 2013), respectively. As shown in 
Appendix 4; 80, 100, 100, 80, 60 and 40% of does showed signs of standing oestrus in 
24, 30, 36, 48, 54 and 60 hours after CIDR withdrawal. None of the does showed 
oestrus at 72 hours after CIDR withdrawal. Our present research data also confirmed 
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that CIDR could be an effective means of oestrus synchronisation of Boer crossbred 
does.  
The eCG superovulatory responses on number of ovulation and ovulation 
percentage in this experiment were significantly higher in hCG-supplemented group 
compared to GnRH-supplemented and control groups. This might be due to the 
similarity of the time of LH surge of hCG-supplemented doe with the non-
superovulated normal cyclic doe. The time interval between onset of oestrus and LH 
surge was 11 to 13 hour for normal cyclic goats (Greyling and Van Niekerk, 1990). 
Saleh (2011) reported that the time interval between GnRH- or hCG-supplementation 
and LH surge were 1 and 12 hour, respectively.  
In other words, the former caused earlier secretion of LH that might compromise 
ovulation than the latter after the respective supplementation. From pharmacokinetics 
point of view, the faster absorption (12 hr) and slower elimination (70 hr) of hCG 
resulted prolonged bioavailability in the circulation, maintaining the function of CL 
(Saleh et al., 2012). In addition, hCG had been reported to have long half-life (40 hr) 
compared with the endogenous LH in doe (Saleh et al., 2012). In cow, administration of 
hCG at different times i.e. during or after mating caused ovulation of large follicles and 
subsequently induced CL formation and was similar with non-stimulated CL 
(Rajamahendran and Sianangama, 1992). 
In spite of the above hypothesis, administration of GnRH at the time of mating 
improved luteal function as a result of the release of FSH and LH from the anterior 
pituitary (Hafez and Hafez, 2000). Additionally, improved ovulation synchronisation in 
does by reducing the variation of timing between sponge removal and LH surge from 40 
to 26 hour (Pierson et al., 2003), increased the fertility in ewe (McMillan et al., 1986) 
and cow (Sheldon and Dobson, 1993). On the contrary, supplementation of GnRH at the 
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time of mating did not improve the pregnancy rate in doe (Riaz et al., 2012), in dairy 
cow (Ryan et al., 1994) and in ewe (Lashari and Tasawar, 2010) which might be due to 
an endogenous LH peak before administration of GnRH (Riaz et al., 2012). The result 
of present research was similar with the findings of above mentioned research.  
In this experiment, the average numbers of recovered and transferable embryos 
were higher in hCG-supplemented group than GnRH-supplemented and control groups, 
which was in agreement with the findings of Saleh (2011). The reason of this result 
might be due to premature luteal regression after superovulation. According to Saharrea 
et al. (1998), 100% of hCG-supplemented does had functional CL, while 57% of the 
control does and 38% of the GnRH-supplemented does had undergone premature luteal 
regression. This luteal malfunction might be due to untimely PGF2α secretion (Saharrea 
et al., 1998; Taponen et al., 2003). The peak concentration of PGF2α (0.9 ng/ml) in 
eCG-superovulated does was observed during Days 4 and 5 after sponge removal, 
whereas slightly lower peak concentration (~ 0.6 ng/ml) was observed at Day 14 in 
naturally cycling doe (Battye et al., 1988). At Day 6 after oestrus, low progesterone 
concentration (<1 ng/ml) was observed in GnRH-supplemented doe than hCG-
supplemented does (Saharrea et al., 1998). Saharrea et al. (1998) reported average 
progesterone concentration in the hCG-supplemented does (11ng/ml) at Day 6 was 
higher than GnRH-supplemented does (4 ng/ml). In addition, Kaya et al. (2013) did not 
observe any increase in plasma progesterone level due to supplementing GnRH in ewe. 
Aslan et al. (2011) reported that hCG-supplemented cow resulted in an increase in the 
CL blood flow significantly than GnRH supplementation. In research involving other 
ruminants, hCG supplementation increased the weight of the CL in ewe and cow by 
increasing blood flow to the CL and maintaining the healthiness of CL (Kittok et al., 
1983; Farin et al., 1988; Nephew et al., 1994; Schmitt et al., 1996). Cam and Kuran 
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(2004) reported that supplementation of hCG gave better embryo vitality than that of 
GnRH supplementation. 
The numbers of anovulated follicles per doe in this experiment were varied from 
10 to 14, which was similar among the supplemented does. The result was contradicted 
with the finding of Saleh (2011) who reported higher number of anovulated follicle in 
hCG-supplemented does than GnRH-supplemented does. The reason for having 
anovulated follicle has not been identified. It might be a combination of several factors, 
like source and purity of the gonadotrophin (Wollen et al., 1985; Lindsell et al., 1986), 
alterations in endocrine patterns, such as lowered endogenous LH secretion (Kendall et 
al., 2004) or defective or mistimed LH surges (Noel et al., 1994; D’Occhio et al., 1999), 
dominant follicles present in the ovaries at the onset of the superovulatory treatment 
(Veiga-Lopez et al., 2006), atretic follicles rescued by superovulatory treatments 
(Monniaux et al.,1983), defective maturation of follicles (Veiga-Lopez et al., 2006), 
desensitisation of the LH receptors of the follicles (Garcia-Garcia, 2003), improper 
nutrition or negative energy balance (Scaramuzzi et al., 2006). In this experiment, 
abnormal ovarian hyperstimulation (more than 15 anovulated follicles per doe) was 
observed in 40, 30 and 40% does in hCG-, GnRH-supplemented and control groups, 
respectively. As a result, ovarian size increased and ovarian surfaces had multiple 
anovulated follicles, giving a blister-like appearance. 
 Superovulatory responses using eCG under present experiment were not up to 
expectation, which might be due to the influence of different factors or their 
combinations such as breed, age, nutrition and reproductive status. All the breeds did 
not respond same way to the superovulation treatment. Breed effect had been associated 
with the prolificacy of breed, where a high prolific breed had been reported to respond 
better to exogenous gonadotrophin (Bindon et al., 1986). Moreover, different breeds 
produced variable results by using eCG for superovulation such as 3 in Jamnapari (Goel 
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and Agrawal, 1990); 3 in Boer goats (Nowshari et al., 1995); 6 in Jakhrana goats (Goel 
and Agrawal, 2005); 2 in indigenous dairy goats (Pampukidou et al., 2011) and 1 for 
crossbred (Xiao et al., 2013). 
Nutrition was known to play a fundamental role in controlling several 
reproductive events including, endogenous hormone production, gametogenesis, 
fertilisation and early embryonic development in farm animals (Ashworth, 1995; Cox, 
1997; Butler, 2000; Boland et al., 2001; Lucy, 2003; Peura et al., 2003; Paula et al., 
2005). In goat, a low level of nutrition reduced oocyte development and ovulation rate 
(Smith, 1991; Mani et al., 1992; Downing et al., 1995). Dietary energy had been 
indicated to alter the follicular dynamics in superovulated ruminant (Gong, 2002). 
Negative energy balance inhibited GnRH secretion by the hypothalamus, and in absence 
of LH pulses, low FSH concentrations inhibited folliculogenesis in ewe (Scaramuzzi et 
al., 2006). On the other hand, high energy level above maintenance increased blood 
glucose, insulin and leptin, leading to increased folliculogenesis and ovulation rates in 
ewe (Scaramuzzi et al., 2006). In other studies involving ewes, Mani et al. (1992) 
reported that low level of nutrition reduced ovulation rate. Abecia et al. (2006) and 
Scaramuzzi et al. (2006) reported that animal feeding with flushing diets increased 
folliculogenesis and ovulation rates.  
Several researchers reported that presence of dominant follicle during 
superovulation treatment decreased the superovulatory response of does (Menchaca et 
al., 2002; Gonzalez-Bulnes et al., 2003).  
LH had a significant effect on the embryo production performance of eCG-
superovulated does, as eCG has long biological half-life. Although, both hCG and 
GnRH were supplemented for ovulation synchronisation, hCG supplementation 
produced better results. hCG supplementation produced a significantly higher number 
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of structures but due to higher number of unfertilised oocyte total recovered and 
transferrable embryos was not increased significantly. In contrast to GnRH, present 
results indicated that hCG-supplementation was suitable for ovulation induction in the 
eCG-superovulated Boer crossbred goat. 
 
5.2 EFFECT OF SUPPLEMENTATION OF hCG OR GnRH ON 
OVULATION AND SUBSEQUENT EMBRYO PRODUCTION OF pFSH-
SUPEROVULATED GOATS (EXPERIMENT 2) 
Ovarian responses were largely varied upon the characteristics of gonadotrophin such as 
source of production (Senthil Kumar et al., 2003), biological half-life (approximately 5 
hr for FSH and approximately 20 hr for eCG) (Demoustier et al., 1988), ratio of FSH 
and LH in preparation (Nowshari et al., 1995; Martemucci and D’Alessandro, 2013). 
Nowadays, mostly used gonadotrophin for ruminant superovulation treatment is FSH 
whether prepared from ovine (oFSH) or porcine (pFSH) sources compared to eCG. In 
doe, due to short biological half-life, FSH was usually administered two times daily, 
over a period of 3 to 4 days (Pendleton et al., 1992; Gordon, 1997; Holtz, 2005; 
Menchaca et al., 2007; Abdullah et al., 2012; Lehloenya, 2013; Xiao et al., 2013). 
Although FSH produced better ovarian responses compared to eCG, the results of 
ovarian responses in FSH superovulated does varied from 2 to 16 embryos per doe 
(Gonzalez-Bulnes et al., 2003; Senthil Kumar et al., 2003; Menchaca et al., 2007; 
Abdullah et al., 2012; Lehloenya, 2013; Xiao et al., 2013) which mainly due to some 
associated intrinsic and extrinsic factors. 
In present experiment, the numbers of donor does showed signs of standing 
oestrus were 100, 83 and 67% for control, hCG- and GnRH-supplemented groups, 
respectively. The result of standing oestrus in control group was similar with the 
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findings of earlier researchers who reported 100% of oestrus by using different dosages 
of FSH with CIDR (Lehloenya and Greyling, 2009; Vilarino et al., 2011; Lehloenya, 
2013). Similarly, result on standing oestrus of control group of this experiment was 
almost similar with some other researchers who reported 98% of oestrus for dairy does 
using pFSH with fluorogestoneacetate (FGA) (Cervantes  et al., 2007), 94% (Malaysia) 
and 88% (China) oestrus for crossbred does using pFSH with CIDR (Xiao et al., 2013). 
On the other hand, this experiment produced superior results than some other 
researchers who reported 50% oestrus for Boer doe using intravaginal sponge (Greyling 
et al., 2002).  
The result of standing oestrus (83%) in hCG-supplemented group was 
comparable with the findings of earlier researchers who reported 75% of oestrus by 
supplementing hCG at the time of superovulatory oestrus (Majumdar et al., 1997). 
Present result of standing oestrus (67%) in GnRH-supplemented group was higher than 
the finding of earlier researchers who reported 50% oestrus by supplementing GnRH 
during breeding season (Menchaca et al., 2007). On the other hand, current finding on 
standing oestrus was lower than the finding of earlier researchers who reported 93% of 
oestrus by supplementing GnRH during non-breeding season (Menchaca et al., 2007). 
In addition, present results of standing oestrus in conventional superovulation protocol 
(Days 0-14 of CIDR insertion and Days 12 -14 of FSH administration) in control, hCG- 
and GnRH-supplemented groups were higher, comparable and lower than the findings 
of Day 0 protocol (immediately after ovulation of FSH administration), respectively 
(Menchaca et al., 2007). 
The pFSH superovulatory response in control and hCG-supplemented groups on 
percentage of donor does producing CL was similar (67%) and both were higher than 
GnRH-supplemented group (17%). Ovulation percentage was higher in control group 
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than hCG- and GnRH-supplemented groups which might be due to the LH secretion.  
To support this hypothesis, Breen and Knox (2012) reported that 80 mg of Folltropin 
alone could induce ovulation in gilt. FSH (Folltropin)-superovulated cow produced 
similar number of LH surge frequency with non-stimulated cow (Price et al., 1999). 
Theoretically, LH pulses in ewe were induced by hypothalamic GnRH pulses, and all 
LH pulses were preceded by a GnRH pulse and its frequency was determined by GnRH 
pulse frequency (Martin, 1984). It was controversial that GnRH-supplemented cow 
could not respond to the induced-LH surge and maximum LH concentration was 2 
ng/ml in GnRH-supplemented cow, compared to 28 ng/ml in non-supplemented cow 
(Price et al., 1999). Nowshari et al. (1995) stated that purified pFSH supplemented with 
about 40% pLH could provide the optimum superovulatory response and transferable 
embryos in does. 
In this experiment, all the embryo-related parameters did not differ significantly. 
Although control group produced numerically higher number of structures, due to a 
large number of unfertilised oocytes, the average numbers of recovered and transferable 
embryos were numerically lower than hCG-supplemented group. Superovulatory 
responses of present experiment were not up to expectations, which might be due to the 
influence of breed, age, nutrition and reproductive status. Breed or genotype had been 
identified as a major factor that affects superovulation and ET programme (Holness et 
al., 1980; Donaldson, 1984; Bindon et al., 1986; Nuti et al., 1987; Baril et al., 1989; 
Dufour et al., 2000; Lee et al., 2000). In FSH superovulated goat, a higher number of 
embryos (10) were recovered in Alpine does compared to Angora does (8) (Baril et al., 
1989). Breed effect has been associated with the prolificacy of breed where a high 
prolific breed has been reported to respond better to exogenous gonadotrophin (Bindon 
et al., 1986). Moreover, different breeds produced different results using FSH for 
superovulation such as 2 embryos in crossbred (Abdullah et al., 2012); 2 in Jamnapari 
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(Goel et al., 1993); 3 in Alpine (Menchaca et al., 2007); 5 in Pashmina (Mahmood et 
al., 1991); 5 in Alpine (Menchaca et al., 2007); 5 in Jamnapari (Goel and Agrawal, 
1990); 9 in Alpine and Nubian (Nuti et al., 1987); 6 in Korean Native goats (Lee et al., 
2000) and 11 in Boer (Lehloenya, 2013).  
Nutrition had been known to play a fundamental role in controlling several 
reproductive events including, hormone production, gametogenesis, fertilisation and 
early embryonic development in farm animals (Ashworth, 1995; Cox, 1997; Butler, 
2000; Boland et al., 2001; Lucy, 2003; Peura et al., 2003; Paula et al., 2005). In goat, a 
low level of nutrition reduced oocyte development and ovulation rate (Smith, 1991; 
Mani et al., 1992; Downing et al., 1995). Dietary energy had been indicated to alter the 
follicular dynamics in superovulated ruminant (Gong, 2002). Negative energy balance 
inhibited GnRH secretion by the hypothalamus, absence of LH pulses, low FSH 
concentrations which inhibited folliculogenesis in ewe (Scaramuzzi et al., 2006). On the 
other hand, high energy level above maintenance increased blood glucose, insulin and 
leptin, leading to increased folliculogenesis and ovulation rates in ewe (Scaramuzzi et 
al., 2006).  
Anovulatory follicles were obvious in the findings of any superovulatory 
protocols (Veiga-Lopez et al., 2006). In this experiment, the incidence of anovulatory 
follicle was 59, 76 and 92% for control, hCG- and GnRH-supplemented groups. These 
results might be due to the presence of LH in the FSH-commercial preparation. A 
minimum amount of LH was necessary for ovulation but high concentrations of LH for 
prolonged periods before the LH surge in both heifer (Taft et al., 1996) and ewe 
(Dobson et al., 1997) disturbed the ability of follicles to ovulate without changes in 
previous processes of follicular recruitment and selection for Graafian follicle (Roberts 
et al., 1994). Moreover, it might alter the endocrine and ovarian functions and resulted 
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in a smaller size and defective maturation of follicles (Murphy et al., 1984; Noel et al., 
1994; D’Occhio, 1999; Kendall et al., 2004; Veiga-Lopez et al., 2006).   
Supplementation of hCG or GnRH had no significant effect on the embryo 
production performance of pFSH-superovulated does. Price et al. (1999) reported that 
serum oestradiol concentration of FSH-superovulated cows was increased in within the 
first 20 hour but progesterone concentration did not increase. Presence of increased 
concentration of oestradiol was associated with the decrease in LH pulse frequency. 
Due to the absence of luteal-phase concentration of progesterone, oestradiol could not 
inhibit LH pulse frequency (Stumpf et al., 1989).  
Although the result of ovarian responses in eCG-superovulated goat 
supplemented with hCG (Experiment 1) was comparable with the results of control 
group of pFSH-superovulated doe (Experiment 2), the number of transferrable embryos 
was higher in later experiment. For that reason all the subsequent experiments were 
conducted using pFSH for superovulation without supplementation with hCG or GnRH. 
 
5.3 EFFECT OF pFSH DOSAGE BASED ON BW ON SUPEROVULATION 
PERFORMANCE (EXPERIMENT 3) 
Superovulatory treatment of pFSH in goat mostly consisted of 200 mg pFSH without 
consideration of BW, which could vary from 20 to 70 kg, consequently could produce 
variable results (Menchaca et al., 2007; Lehloenya and Greyling, 2010a; Yuan et al., 
2011; Xiao et al., 2013). Some researchers used different dosages of pFSH for 
superovulation without considering the BW of doe (Chang et al., 2006; Yuan et al., 
2011; Abdullah et al., 2012). Obese women required higher dosage of gonadotrophin 
and produce fewer follicles (Souter et al., 2011). Thus, the dosage of pFSH without 
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basing on BW might be a cause of variation in superovulation response in does which 
was the basis of this research.  
In this experiment, all the donor does of Group 2 (5mg pFSH per kg BW; total 
110-180 mg per doe) and Group 3 (8 mg pFSH per kg BW; total 136-276 mg per doe) 
showed the signs of standing oestrus by using 14-day CIDR insertion which was in 
agreement with the findings of earlier researchers who reported 100% oestrus by using 
around 200 mg pFSH (without basing the BW) with CIDR (Lehloenya et al., 2008; 
Lehloenya and Greyling, 2009; Lehloenya, 2013) and 100% of oestrus in goat actively 
immunised against inhibin by using around 16 AU pFSH (without basing the BW) with 
Norgestomet ear implants (Holtz et al., 2012). Similarly, result on standing oestrus of 
Group 2 and Group 3 was almost similar with some other researchers who reported 98% 
oestrus for dairy does using pFSH with FGA intravaginal sponge (Cervantes et al., 
2007). Additionally, oestrus was observed in 94% (Malaysia) and 88% (China) for Boer 
crossbred does using pFSH with CIDR (Xiao et al., 2013). On the other hand, this 
experiment produced superior results than some other researchers who reported 50 and 
48% oestrus for Boer purebred does using pFSH with Norgestomet ear implant and 
intravaginal sponge, respectively (Greyling et al., 2002; Holtz et al., 2012). On the 
contrary, only 62% of donor does of Group 1 administered with 3 mg pFSH per kg BW 
(total 60-123 mg per doe) showed oestrus in this experiment, and this result might be 
due to low dosage of pFSH, which may not be sufficient to stimulate the ovary of all the 
goats in this experiment. In a nutshell, this new approach of superovulation protocol 
may give an indication that oestrus synchronisation with CIDR using a sufficient and 
correct amount of pFSH based on BW could increase the efficiency of superovulation in 
goats.  
 The pFSH superovulatory response on percentage of donor does producing CL 
was similar among the treatment groups and the rate was 62, 69 and 69% for Groups 1, 
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2 and 3, respectively. Numbers of ovulation and ovulation percentages were similar 
among the treatment groups. Present results might be indicated that the treatment had no 
endocrine effect on preovulatory LH surge. Although ovulation rate was similar for all 
the treated groups, Group 2 produced significantly higher number of embryos than other 
treatment groups. However, ovulation rates for all the respective treated groups studied 
were not correspondingly represented by embryos, whereby it was observed that many 
ovulated oocytes had failed to be fertilised. It implied that the negative superovulation 
effect was detected in the high- and low- dosages of exogenous pFSH. The exact reason 
was unknown. However, it was believed that low dosage produced less ovarian 
response lower total stimulation and higher number of unfertilised oocytes compared to 
the suitable dosage (5 mg pFSH per kg BW for this experiment). On the contrary, high 
dosage produced higher ovarian response at the same time produced higher number of 
anovulatory follicles and unfertilised oocytes compared to the suitable dosage as 
mentioned earlier. In relation to this, it might be due to endocrine imbalance whereby 
reduced fertility occurred as a result of prolonged elevation in oestrogen concentration 
secreted by the thecainterna of large number of anovulatory follicles as well as the 
abnormal maturation of oocytes as shown by Cameron (1988), Kumar et al. (1991) and 
Ryan et al. (1991). Moreover, high oestradiol concentration around and/or beyond 
ovulation induced disorders on the later reproductive process of fertilisation and embryo 
development (Veiga-Lopez et al., 2006). Results of the present experiment were also in 
line with the findings of Ryan et al. (1991), who reported that embryo recovery and 
fertilisation rate generally declined with a pharmacological increase in the dosage of 
exogenous gonadotrophin administration. 
In this experiment, the numbers of recovered and transferrable embryos from 
Groups 1 and 3 were lower than Group 2. These results indicated that various range of 
exogenous pFSH could promote ovarian response but optimum superovulation results 
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could be obtained only with a certain pFSH dosage range based on BW. In other words, 
the superovulation effect was not promoted by too high (>5 mg per kg BW) and too low 
(<5 mg per kg BW) dosages of exogenous pFSH as suggested in this experiment. It 
could be explained that too high dosage of exogenous pFSH reduced the number for 
embryo production by producing a higher number of anovulatory follicles, which might 
be due to increase oestrogen level in the blood serum. Elevated oestrogen level in blood 
serum impaired sperm transportation in the female reproductive system and the 
breakage of sperm cells, which resulted in a higher number of unfertilised oocytes 
(Conley and Hawk, 1970; Armstrong et al., 1983b; Greve et al., 1995). On the contrary, 
a too low dosage of exogenous pFSH might not be sufficient for optimum stimulation, 
and at the same time the exogenous pFSH treatment coincided with the internal FSH 
secretion thus mimicking the natural ovulation process. However, to establish this fact it 
needs further research. 
 The number of CL could be associated with the number of ovarian stimulation 
for all the three dosages of pFSH but the number of recovered embryos was associated 
with the number of CL for Group 2. The lack of possible association with the number of 
recovered embryos with the number of CL for Groups 1 and 3 seemed to indicate that 
the follicles had ovulated but were not able to develop into viable embryos as discuss 
earlier. The highest numbers of total embryos, transferrable embryos and structures 
recovered were obtained by using 5 mg pFSH per kg BW. These results were higher 
than the findings of previous studies (Menchaca et al., 2007; Abdullah et al., 2012; 
Xiao et al., 2013) but lower than the findings of a recent study ( Lehloenya, 2013). 
These results might be explained due to the influence of breed, BW, nutrition and 
reproductive status (Gonzalez-Bulnes et al., 2000, 2002, 2004a; Bindon et al, 1986; 
Mani et al., 1992; Abecia et al., 2006; Scaramuzzi et al., 2006; Menchaca et al., 2007). 
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Anovulatory follicles were very common in any superovulatory protocols 
(Veiga-Lopez et al., 2006). In this experiment, the incidence of anovulatory follicle was 
30-53%, which was similar to the findings of previous studies (Gonzalez-Bulnes et al., 
2000; Abdullah et al., 2012). The anovulatory follicle number was increased with the 
increasing dosage of FSH and the highest number obtained in this study was similar 
with the findings of a previous study (Abdullah et al., 2012). The causal factor for 
anovulation might be the presence of LH in the FSH preparation, which altered the 
endocrine and ovarian functions after administration of a high dosage of exogenous 
gonadotrophin resulting in a smaller size and defective maturation of follicles (Murphy 
et al., 1984; Noel et al., 1994; D’Occhio, 1999; Kendall et al., 2004; Veiga-Lopez et al., 
2006). It was very challenging to reduce anovulatory follicles number in superovulated 
ovary. Several attempts could be taken to reduce the incidence of anovulatory follicles 
such as by increasing the number of small follicles or decreasing the number of 
dominant follicles in the ovary during the superovulation treatment or by reducing the 
LH level on FSH preparation (Gonzalez-Bulnes et al., 2004b). 
The results of correlation analysis of the current experiment indicated that total 
stimulation (number of CL plus number of anovulatory follicle) and embryo production 
performances were significant and related to the dosages of pFSH based on BW. The 
total stimulation was positively correlated with the number of CL and the number of 
anovulated follicles; and number of transferrable embryos was positively correlated 
with number of recovered embryos for all the treatment groups. For Group 1, number of 
unfertilised oocytes was positively correlated with total stimulation and number of 
anovulatory follicles. For Group 2, number of embryo and transferable embryos were 
positively correlated with the number of CL. Donor does in Group 3 showed positive 
correlation between number of CL and number of unfertilised oocyte; and total 
stimulation and the number of unfertilised oocytes, which was not desired in any 
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superovulation and ET programme. The findings on association of various ovarian and 
embryo structure parameters showed positive indication that 5 mg pFSH per kg BW 
dosage which may coincide with the natural endocrine system. 
In summary, the dosage of pFSH had a significant effect on the embryo 
production performance. Five mg of pFSH per kg BW produced a significantly higher 
number of total and transferrable embryos with the highest recovery rate. At the same 
time, this dosage produced the lowest number of degenerated embryos and unfertilised 
oocytes but no differences were observed among the treatment groups. Results indicated 
that 5 mg pFSH per kg BW was suitable for producing embryos in the Boer crossbred 
does. 
 
5.4  EFFECT OF DONOR AGE AND BW ON SUPEROVULATION 
PERFORMANCE (EXPERIMENT 4) 
Age and BW along with other factors determined the reproductive events of goat such 
as onset of puberty, kidding, litter size and birth weight. In farm animals, age and BW 
of donor does had positive correlation with the reproductive traits (Constantinou, 1989; 
Safari and Fogarty, 2003; Flores et al., 2008; Snyman, 2010). In this experiment, CIDR 
synchronised oestrus and pFSH superovulated donor does (5 mg pFSH per kg BW) 
from Group 2 (2-4 yr of age and more than 25 kg BW group; total pFSH 130-220 mg) 
showed 100% signs of standing oestrus using 14-day CIDR insertion. However, donor 
does of Group 1 (2-4 yr of age and 15-25 kg BW; total pFSH 75-120 mg), Group 3 
(more than 4 yr of age and 15-25 kg BW; total pFSH 90-125 mg) and Group 4 (more 
than 4 yr old and more than 25 kg BW; total pFSH 130-195 mg) showed 70, 70 and 
80% signs of standing oestrus, respectively. The results of standing oestrus in Group 2 
were in agreement with the findings of earlier researchers who reported 100% oestrus 
using goats with various ages (1-4 yr) and BW (29-69 kg) and superovulated with 200 
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mg of pFSH and CIDR (Lehloenya et al., 2008; Lehloenya and Greyling, 2009; 
Lehloenya and Greyling, 2010b; Lehloenya, 2013).  In addition, goats having 2 to 6 
years of age and 53 to 83 kg BW with immunised actively against inhibin showed 100% 
of oestrus by superovulating with pFSH and Norgestomet ear implants (Holtz et al., 
2012). 
Similarly, result on standing oestrus of Group 2 of this experiment was almost 
similar with some other researchers who reported 98% of standing oestrus for dairy 
does of 2 to 6 years of age using 180 mg pFSH with FGA intravaginal sponge 
(Cervantes et al., 2007). Moreover, oestrus was observed 94% in Boer crossbred does 
of 1.5 to 5 years age and 18 to 35 kg BW in Malaysia and 88% in Yunnan Black 
mountain does of 1.5 to 5 years age and 35 to 50 kg BW in China by using 160 mg 
pFSH with CIDR (Xiao et al., 2013). The lowest result of standing oestrus was 70% in 
this experiment which was higher than some other earlier researchers who reported 
around 50% of oestrus for Boer purebred does with 2 to 6 years age and 50 to 80 kg 
BW using 20 mg pFSH with CIDR and Norgestomet ear implant, respectively 
(Greyling et al., 2002; Holtz et al., 2012). The oestrus synchronisation and 
superovulation data prove that donor does with correct age and BW could be enhanced 
by administering with sufficient and correct amount of pFSH with CIDR. 
 The pFSH superovulatory response on percentage of donor does producing CL 
was higher in Group 2 (2-4 yr old and more than 25 kg BW group) than other treatment 
groups, and they were 50, 90, 40 and 30% for Groups 1, 2, 3 and 4, respectively. 
Numbers of ovulation and ovulation percentages were higher in Group 2 than all the 
other treatment groups which might be related to optimal specific dosages (5mg pFSH 
per kg BW) for specific age (2-4 yr) and BW (more than 25 kg BW). Several studies 
have been conducted to evaluate the effect of age on the ovarian response to 
superovulation. Fertility in the doe increased up to about 6 years of age, and after this 
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age the conception rates decreased gradually (Mohd Noor Hisham, 2007). It was well 
known that juveniles could be superovulated, and the follicles were sensitively recruited 
to gonadotrophin administration (Donaldson, 1984; Driancourt et al., 1990; Rangel-
Santos et al., 1991; Hasler, 1992; Kuhholzer and Brem, 1999) but ovarian response to 
superovulation (in terms of ovulation and fertilisation rates), embryo recovery and 
survival rates were not as good as compared to multiparous or adult does (Quirke and 
Hanrahan, 1977; Mahmood et al., 1991; Rangel-Santos et al., 1991; Driancourt and 
Avdi, 1993). Torres et al. (1987) reported that the highest embryo production in ewe 
can be obtained at around 6 years of age. On the contrary, Koemann et al. (2003) 
reported a significant greater number of oocyte recovery from superstimulated 3 to 7 
months old prepubertal does than in adult (2-4 yr of age) does. However, the use of 
older multiparous does as embryo donors in a multiple ovulation and ET programme 
was favourable (Lehloenya and Greyling, 2010b). 
Some researchers reported that reproductive performance of a doe was affected 
by the changes of her BW (Zarazaga et al., 2005), and severe BW loss might cause 
anoestrus in a cow (Richards et al., 1989). Several researchers reported that BW 
affected the fertility and prolificacy in ewe (Molina et al., 1994; Mellado et al., 2004; 
Madani et al., 2009). Serin et al. (2010) reported that low BW affected the pregnancy 
rate in synchronised and superovulated doe. The kidding performance of does less than 
25 kg BW (mature BW 18 kg) was very poor during the first year and reduced life-time 
production by 10 to 40% (McGregor, 2007). Smith (1985) reported that mature BW of a 
ewe was positively correlated with breeding specially ovulation. In ewe, increasing BW 
during mating was positively correlated with the prolificacy (Gaskins et al., 2005). In 
cow, low body condition score (low BW) reduced reproductive performance (Short et 
al., 1990; Diskin et al., 2003; Wettemann et al., 2003). Endocrinologicaly, average 
plasma LH level of growing mithuns were positively correlated with BW (Bos frontalis) 
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(Mondal et al., 2005). On the contrary, De la Isla-Herrera et al. (2011) did not observe 
any effect of body condition change (positive or negative) on the follicular development 
or the ovulation rate in ewes under a medium body condition. 
In this experiment, the numbers of recovered and transferrable embryos were 
higher in Group 2 than Groups 1, 3 and 4. This result indicated that exogenous pFSH (5 
mg per kg BW) could promote ovarian responses in the desired age and BW groups. 
However, the superovulation effect did not promote by old (>4 years) and low BW (<25 
kg) as suggested in this present experiment. It was hypothesised that old does had less 
response to the exogenous pFSH which might be due to the reduced ovarian sensitivity. 
Jainudeen et al. (2000) reported that age could contribute greatly to the variation in 
ovarian response to superovulation because animals of different ages had different 
physiological needs and responded differently. Theriez et al. (1971) reported that age 
had direct influence on embryo production in ewe due to the consequence on natural 
and spontaneous ovulation. At the same time, does with less BW also had less response 
which might be due to lack of LH production. Serin et al. (2010) reported that low BW 
affected the pregnancy rate in doe. On the contrary, Anna et al. (2013) reported that age 
and BW of doe had no effect on oocyte recovery of superstimulated does. 
Anovulatory follicles were very common in any superovulatory protocols 
(Veiga-Lopez et al., 2006). In this experiment, the incidence of anovulatory follicles 
was 30-78%, which was higher in Group 4 (78%) followed by Group 1 (50%), Group 3 
(47%) and Group 2 (30%). The results indicated that the incidence of anovulatory 
follicles generally was increased with the older age and higher BW or younger age and 
lower BW. However, younger age and higher BW gave the lower anovulatory follicles. 
The result of this study was similar with the findings of some other researcher who 
reported 28 to 60% for superovulated doe (Abdullah et al., 2012) and 42 to 60% for 
superovulated ewe (Gonzalez-Bulnes et al., 2000). However, age and BW were not 
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considered for their experiments. The real explanation for this phenomenon was 
unknown. However, the causal factor for anovulation might be due the presence of LH 
in the commercial FSH preparation, which may alter the endocrine and ovarian 
functions after administration of a high dosage of exogenous pFSH which resulted in 
smaller size and defective follicular recruitment and selection (Murphy et al., 1984; 
Noel et al., 1994; D’Occhio, 1999; Kendall et al., 2004; Veiga-Lopez et al., 2006). 
In summary, the age and BW had a significant effect on the embryo production 
performance. Two to 4 years of age and more than 25 kg BW produced a significantly 
higher number of ovarian stimulation and ovulation percentage, subsequently produced 
significantly higher number of the total and transferrable embryos with the highest 
recovery rate. Results indicated that 2 to 4 years old and more than 25 kg BW donor 
does superovulated with 5 mg pFSH per kg BW was suitable for producing embryos in 
the Boer crossbred does. 
 
5.5 EFFECT OF RECIPIENT PHYSICAL CONDITION ON PREGNANCY 
RATE AND SUBSEQUENT KIDDING (EXPERIMENT 5) 
Pregnancy and kidding are the last stages which influence the success of any goat 
superovulation and ET programme. In this experiment, pregnancy rate following fresh 
embryo transfer was 27% for intact recipient group while no pregnancy was detected 
for repeated used recipient group. Present result on pregnancy was lower than those of 
other researchers who reported 79% pregnancy rate in dairy goat (Kiessling et al., 
1986), 58% (Hong et al., 2007) and 86% (Lehloenya and Greyling, 2010c) pregnancy 
rate in Boer pure bred goat by transferring fresh embryos.  On the contrary, present 
result on pregnancy was in agreement with some other researchers who reported a range 
of 27 to 60% pregnancy rate following laparoscopic, surgical and non-surgical ET in 
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goat (Bessoudo et al., 1988; Li et al., 1990; Flores-Foxworth et al., 1992).The reasons 
of inferior performance of present result were unknown, but it might be due to the 
quality of embryos (developmental stage and grade), number of embryos transferred, 
ovulation rate and progesterone level, ovulation and transfer site and the nutrition of the 
recipient does (Armstrong et al., 1983a; Mani et al., 1994; Ishwar and Memon, 1996; 
Bari et al., 2003; Guignot et al., 2006).  
In present experiment, number of CL in recipient does was varied from 1 to 4, 
and the pregnant recipients had only 1 CL on either ovary. However, there were some 
intact recipients having 1 CL in this experiment did not conceive. Armstrong et al. 
(1983a) reported that there were significant relationships between the number of CL and 
embryo survivability in recipients does which might be due to increased blood serum 
progesterone levels. On the contrary, White et al. (1981) and Bari et al. (2003) 
concluded that recipient CL number in ewe had no effect on embryo survival rate. In 
normal circumstances, 1 CL is sufficient to secrete progesterone in order to maintain 
pregnancy in a doe. Therefore, the issue of number of CL affecting pregnancy still 
cannot be resolved. 
In this experiment, morula and blastocyst stage embryos were transferred to the 
both recipient groups on Day 7 after CIDR removal (Day 6 after oestrus). Previous 
researchers suggested that morula and blastocysts stages embryos could be transfer in 
recipient goat on Day 6 after oestrus (Bessoudo et al., 1988; Guignot et al., 2006; 
Lehloenya and Greyling, 2010c) and produced higher embryo survival rate than early 
stage embryo in ruminants (Baril et al., 2001; Guignot et al., 2006). However, some 
earlier researchers found higher survival rates for blastocyst compared to morula in cow 
(Armstrong and Evans, 1983a; Donaldson, 1985; Hasler et al., 1987; Block et al., 2009) 
and in doe (Li et al., 1990). On the contrary, some other earlier researchers reported that 
there was no effect of embryo developmental stage on pregnancy rate and subsequent 
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kidding in doe (Gibbons et al., 2011), in ewe (Bari et al., 2003) and in cow (Breuel et 
al., 1991). 
Number of transferred embryos might be a source of variations on pregnancy 
rate. In this experiment, the average number of embryo transferred per recipient doe 
was 2.60 and 2.56 for intact and multiple used recipient groups, respectively. Some 
researchers reported that transferring more than 2 embryos per recipient caused the low 
survival rate of the transferred embryos (Armstrong et al., 1983b; Li et al., 1990; Ishwar 
and Memon, 1996; El-Gayar and Holtz, 2005). In addition, higher embryo survival rate 
in dairy goats was obtained after transfer of 2 embryos per recipient (Moore and 
Eppleston, 1979; Armstrong and Evans, 1983b; Tervit et al., 1983). Tervit et al. (1986) 
reported that maximum pregnancy rate and kidding could be achieved by transferring 2 
blastocysts in each recipient which might be due to the ability of doe to produce 
multiple kids per pregnancy. On the contrary, Melican and Gavin (2008) had transferred 
1, 2 or 3 embryos per recipient during traditional and non-traditional breeding season, 
and concluded that there was no effect of transferred embryo number on the pregnancy 
rate and kidding. They also mentioned that both pregnancy rate and kidding were 
increased by transferring single embryo to the recipient (Melican and Gavin, 2008). 
Embryo survival rate by transferring fresh embryos were 7.69% in this 
experiment which was much lower than the 36, 37, 47, 52 and 65% reported by earlier 
researchers by transferring fresh embryo in recipient (Udy, 1987; Bessoudo et al., 1988; 
Ishwar and Memon, 1996; Lehloenya and Greyling, 2010c). The reason of inferior 
embryo survival rate was not identified, but it might be due to the maternal effect or 
interaction between transferred embryo and recipient does. All the live born kids were 
male in this current experiment. Some earlier researchers reported that the observed sex 
was higher for male kids than female kids. El-Gayar and Holtz (2001) reported that the 
sex ratio of male and female was 3.5:1 and 2.3:1 for vitrification and conventional 
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freezing, respectively. Melican and Gavin (2008) also reported that the sex ratio of male 
and female was 2.3:1 and 1.8:1 for fresh embryo transfer during non-traditional and 
traditional breeding season, respectively. The reason for this result was unknown, and 
more refined research in different aspects of intrinsic and extrinsic factors affecting 
pregnancy particularly involving male and female embryos/foetuses need to be 
conducted in future.  
The result of average gestation length in current experiment was 148 days (Day 
1 was day of mating and/or AI) which was similar with Lehloenya and Greyling 
(2010a), who reported 148 days of gestation period for Boer goat after transferring fresh 
embryos. On the other hand, gestation length of doe in this experiment was relatively 
shorter than the previous finding of Yuswiati and Holtz (1990) who reported 151 days 
of gestation period in Saanen breed following embryo transfer. These observations 
indicated that small differences in the gestation lengths of different goat breeds due to 
external and internal factors such as breeds (gestation period was shorter in lighter 
breeds of goats) (Mellado et al., 2000), season of kidding (Misra et al., 1983; Ruvuna et 
al., 1988; Deshpande and Mehta, 1992), litter size (Ruvuna et al., 1988; Deshpande and 
Mehta, 1992), litter weight and parity (Mellado et al., 2000), but all within an 
acceptable range. In this experiment, recipient of the repeated used goat group was not 
found as pregnant which might be explained by resistance against gonadotrophin 
(Beckers et al., 1990; Remy et al., 1991; Baril et al., 1993), surgical trauma during 
surgery and formation of post-operative adhesions (Mckelvey et al., 1985; Ishwar and 
Memon, 1996; Pereira et al., 1998; Suyadi et al., 2000) or some other unknown factors. 
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5.6 GENERAL DISCUSSION 
Generally, the overall embryo production from the superovulated donor does and ET 
kids from the recipient does involved multiple steps including oestrus synchronisation 
of donor and recipient does, superovulation, mating, embryo flushing of donor does, 
ET, pregnancy diagnosis and kidding of recipient does (Figure 5.1). Both technical and 
biological factors involved in these steps were known to influence the result of ET 
programme. In this research, a comprehensive study to optimise all of the influencing 
factors related to superovulation and ET stated in Figure 5.1 could not be conducted due 
to the short time frame. Thus, the researcher only selected some factors related to 
exogenous gonadotrophin (eCG and pFSH) and physical condition of donor and 
recipient does for improving embryo production performance of donor does, and 
pregnancy rate and kidding of recipient does in this research. The findings of the 
present research regarding supplementation of hCG or GnRH on eCG or pFSH 
superovulation protocol, dosage of pFSH, age and BW of donor does, physical 
condition of recipient will enhance caprine superovulation research in the future. 
Normal length of oestrous cycle in doe was varied from 17 to 25 days with an 
average of 21 days (Fatet et al., 2011) but it could be varied extremely from 8 to 39 
days (Baril et al., 1993). The variation in oestrous cycle length could be due to some 
environmental and physiological factors such as photoperiod or day length, latitude and 
climate, food availability, breed and breeding system (Jainudeen et al., 2000; Fatet et 
al., 2011). For getting donor does in oestrus in a predetermined time range, it was 
inevitable to synchronise oestrus. It was a fundamental step for any superovulation 
programme. 
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Figure 5.1: Flow chart of steps involved in oestrus synchronisation, 
superovulation and ET. 
 
Several types of progestagens were available for oestrus synchronisation such as 
FGA or MAP intravaginal sponges or CIDR (Motlomelo et al., 2002; Espinosa-
Marquez et al., 2004; Lehloenya et al., 2005). Exogenous progestagen treatment was 
applied for a period of 5 to 20 days (Ritar et al., 1989, 1994; Waldron et al., 1999; 
Romano, 2004; Menchaca et al., 2007; Vilarino et al., 2011). In this research, oestrus of 
all the donor does were successfully synchronised by inserting an intravaginal CIDR 
dispenser for 14 days. The oestrus synchronisation performance was evaluated by 
observing the oestrus sign in doe after CIDR removal. In this research, overall 
percentage of does (superovulated with eCG or pFSH) showed sign of standing oestrus 
was 87% which was in agreement with Xiao et al. (2013), who also reported 88% of 
standing oestrus for superovulated donor does. All the eCG-superovulated does 
synchronised with an intravaginal CIDR showed sign of standing oestrus.  
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Oestrus synchronisation   Oestrus synchronisation 
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Oestrus checking and mating    Oestrus checking 
 
 
Embryo flushing            Checking for viable CL 
 
 
Embryo searching      Embryo transfer 
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The results of standing oestrus in pFSH-superovulated does was varied from 62 
to 100%. Does superovulated with high dosage of pFSH with or without hCG, 
moderated dosage of pFSH with higher BW showed higher result on standing oestrus. 
On the other hand, does superovulated with low dosage of pFSH alone or high dosage 
of pFSH with GnRH or does with lower BW showed lower percentage of standing 
oestrus. Present research data also confirmed that CIDR could be an effective means of 
oestrus synchronisation of Boer crossbred does. 
 After oestrus synchronisation in donor doe, superovulation was conducted by 
using different gonadotrophin such as eCG (Goel and Agrawal, 2005) or combination of 
hormones such as P.G. 600 (400 IU of eCG and 200 IU of hCG) (Rowe and East, 1996) 
or FSH from ovine (oFSH) (Abdullah et al., 2012) or porcine (pFSH) origin 
(Lehloenya, 2013). Ovulation failure, asynchronous ovulation and luteal insufficiency 
were frequent for superovulated does (Armstrong et al., 1983b; Pintado et al., 1998; 
Taponen et al., 2003). In the initial experiments (Experiments 1 and 2), eCG- and 
pFSH-superovulated does were supplemented with hCG or GnRH as luteinising agent 
to select the better gonadotrophin combination for subsequent  experiments in order to 
obtain optimum superovulatory performance. Although hCG increased the performance 
of eCG-superovulated does significantly than GnRH, it was insignificant in pFSH-
superovulated counterpart. Saharrea et al. (1998) reported that luteal insufficiency was 
much more frequent in eCG-superovulated does than FSH-superovulated does. 
Although hCG-supplemented with  eCG superovulated does and pFSH superovulated 
does produced almost similar superovulatory performance, due to higher (double) 
number of transferrable embryo production, pFSH was selected for the further trials. 
The findings of earlier researchers also favoured the use of pFSH than eCG due to some 
factors such as higher ovulation rate, lower incidence of luteal insufficiency and small 
number of unfertilised oocytes. (Tsunada and Sugie, 1989; Mahmood et al., 1991; 
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Pendelton et al., 1992; Nowshari et al., 1992; Goel and Agrawal, 1990, 2005; 
Pampukidou et al., 2011; Holtz et al., 2012; Xiao et al., 2013).  
 Even though pFSH produced better result than eCG, the result of Experiment 2 
was inferior and inconsistent. Dosage of total 200 mg of pFSH per doe was used which 
was selected from earlier published literature but the does physical condition and 
environment were not similar with the present research. Most of the superovulatory 
treatment of pFSH consists of 200 mg pFSH per doe without considering BW, which 
could vary from 20 to 70 kg, consequently could produce variable results (Menchaca et 
al., 2007; Lehloenya and Greyling, 2010a; Yuan et al., 2011; Xiao et al., 2013). Thus, 
the dosage of pFSH without basing on BW might be a cause of variation. In this 
experiment, pFSH dosage based on BW was evaluated (Experiment 3). Total amount of 
pFSH was calculated according to the dosages of 3, 5 and 8 mg pFSH per kg BW and 
was administered on 3 successive days. All the donor does administered with 5 and 8 
mg pFSH per kg BW showed the signs of standing oestrus but 62% of donor does 
administered with 3 mg pFSH per kg BW showed oestrus. Total ovarian stimulation 
was almost similar for all the three groups. In case of anovulatory follicle, the number 
was increased with increasing the amount of pFSH. For ovulation percentage and 
number of total and transferrable embryos were increased and then decreased again with 
the increase of pFSH dosages from 3 to 5 to 8 mg per kg BW. It meant that the ovarian 
stimulation could promote with the certain level of pFSH and extra dosage beyond the 
optimal physiological level could be detrimental to ovulatory response. This was in line 
with the findings of Ryan et al. (1991), who reported that embryo recovery and 
fertilisation rate generally declined with a pharmacological increase in the dosage of 
exogenous gonadotrophin administration. However, higher number of anovulatory 
follicles and unfertilised oocytes were interrelated.  
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 Reduced fertilisation rate occurred as a result of prolonged elevation in 
oestrogen concentration secreted by the thecainterna of large number of anovulatory 
follicles as well as the abnormal maturation of oocytes resulted from using high dosage 
of pFSH during superovulation (Cameron, 1988; Kumar et al., 1991; Ryan et al.,1991; 
Greve et al., 1995; Kendall et al., 2004; Veiga-Lopez et al., 2006). The findings on 
association of various ovarian (number of ovarian stimulation, number of CL, number 
of anovulatory follicle and ovulation percentage) and embryo structure (number of 
structures recovered, number of embryos, number of transferable embryos, number of 
degenerated embryos, recovery rate, number of unfertilised oocytes) parameters showed 
positive indication that 5 mg pFSH per kg BW dosage which might coincide with the 
natural endocrine system. 
 Extending from the dosage of pFSH per kg BW, effects of age and BW on 
ovarian response of donor does superovulated with selected dosage (5 mg pFSH per kg 
BW) of pFSH were evaluated (Experiment 4). Some earlier researchers reported that 
age and BW of donor does had positive correlation with the reproductive traits such as 
onset of puberty, kidding, litter size and BW (Theriez et al., 1971; Constantinou, 1989; 
Safari and Fogarty, 2003; Flores et al., 2008; Snyman, 2010). In this research, does of 2 
to 4 years old and more than 25 kg BW group produced best results for all the 
superovulation and embryo production performances which might be related to optimal 
specific dosage for specific age and BW. Juveniles could be superovulated, and the 
follicles were sensitively recruited to gonadotrophin administration (Donaldson, 1984; 
Driancourt et al., 1990; Rangel-Santos et al., 1991; Hasler, 1992; Kuhholzer and Brem, 
1999) but ovarian response to superovulation (in terms of ovulation and fertilisation 
rates), embryo recovery and survival rates were not as good as compared to multiparous 
or adult does (Quirke and Hanrahan, 1977; Mahmood et al., 1991; Rangel-Santos et al., 
1991; Driancourt and Avdi, 1993; Lehloenya and Greyling, 2010b). Jainudeen et al. 
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(2000) reported that age could contribute greatly to the variation in ovarian response to 
superovulation. Low BW affected the pregnancy rate in synchronised and superovulated 
does (McGregor, 2007; Serin et al., 2010). However, the superovulation effect did not 
promote by old (>4 years) and low BW (<25 kg) as suggested in this present 
experiment. At the same time, does with less BW also had less response which might be 
due to lack of LH production which was in agreement with Mondal et al. (2005) who 
reported BW was positively correlated with plasma LH level. Serin et al. (2010) 
reported that low BW affected the pregnancy rate in doe. Anovulatory follicle of this 
experiment was higher in the older age and higher BW or younger age and lower BW. 
Two to 4 years of age and more than 25 kg BW produced a significantly higher number 
of ovarian stimulation and ovulation percentage, subsequently produced significantly 
higher number of the total and transferrable embryos with the highest recovery rate. 
 Following embryo flushing, the recovered fresh embryos were directly 
transferred to the recipient doe (Experiment 5). In this experiment, 2 groups of recipient 
were used for comparing the pregnancy rate and subsequent kidding after ET. An 
average of 27% of pregnancy rate was obtained by transferring fresh embryos to the 
intact recipient group while no pregnancy was detected for repeated used recipient 
group. The possible reason for the surprising negative result for the latter was not 
known. Earlier researchers reported that several general factors influenced survivability 
of transferred embryos into the recipient does such as ovulation rate and progesterone 
level, the quality of embryos (developmental stage and grade), number of embryos 
transferred, ovulation and transfer site, the nutrition of the recipient does (Armstrong et 
al., 1983b; Mani et al., 1994; Ishwar and Memon, 1996; Bari et al., 2003; Guignot et 
al., 2006). Progesterone level was very important for maintaining pregnancy. In this 
experiment, recipient of the repeated used goat group was not found as pregnant which 
might be explained by resistance against gonadotrophin (Beckers et al., 1990; Remy et 
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al., 1991; Baril et al., 1993), surgical trauma during surgery and formation of post-
operative adhesions (Mckelvey et al., 1985; Ishwar and Memon, 1996; Pereira et al., 
1998; Suyadi et al., 2000) or some other unknown factors that yet to be further studied. 
 
5.6.1 Summary of Significant Findings and Strength of the Research 
The findings achieved in this research includes: (a) LH (hCG and GnRH) 
supplementation was needed to synchronise the ovulation and to overcome the luteal 
insufficiency for eCG-superovulated does whereby hCG performed better than GnRH in 
Boer crossbred does; (b) No additional LH supplementation was needed for ovulation 
synchronisation in pFSH-superovulated Boer crossbred does; (c) The optimal dosage of 
pFSH according to BW for superovulating Boer crossbred does was 5 mg pFSH per kg 
BW per doe; (d) Two to 4 years of age and more than 25 kg BW Boer crossbred does 
were favourable for superovulation using 5 mg pFSH per kg BW per doe; and (e) Intact 
does were favourable than repeated surgery does as recipients for ET programme but it 
was needed further detailed research on the latter to enhance their pregnancy efficiency. 
Superovulation and ET in goats is very complex and the outcomes are fluctuating even 
though research activities in this area have been carried out for the last half a century. 
This research attempted to understand the physiology of manipulated reproductive 
system of donor and recipient does in an effort to overcome their constraints of 
superovulation and ET techniques that could be recommended for the goat production 
particularly in Malaysia. It is hoped that the present findings of this research will 
enlighten a future research to make superovulation and ET in goats be a routine practice 
in goat production in country. 
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Table 5.1: Research objectives achievement 
Research objectives  Achievement  
To compare the effect of supplementation of 
hCG or GnRH on superovulation and embryo 
production performances of eCG superovulated 
does.  
hCG is more suitable for ovulation 
induction in eCG superovulated 
does.  
To compare the effect of supplementation of 
hCG or GnRH on superovulation and embryo 
production performances of pFSH superovulated 
does. 
No additional hormone is needed 
for ovulation induction in pFSH 
superovulated does .  
To evaluate the effect of pFSH dosage based on 
body weight on the superovulation and embryo 
production performances. 
5 mg pFSH per kg BW is 
significantly better for 
superovulation and embryo 
production.  
To evaluate the effect of donor age and body 
weight on the superovulation and embryo 
production efficiencies by using pFSH dosage 
based on BW.  
2 to 4 years old and more than 25 
(25-45) kg BW is significantly 
better for superovulation and 
embryo production.  
To compare the effect of recipient physical 
condition (surgery cycle) on pregnancy rate and 
subsequent kidding.  
Intact recipient does produced 
better pregnancy rate and 
subsequent kidding.  
 
 
5.6.2 Constraints of the Present Research 
The present research was carried out with a view to evaluate the performance of Boer 
crossbred does in the superovulation and ET programme. During this research, 
emphasis was given more to determine the effect of exogenous gonadotrophin and 
physical condition of donor does for the improvement of superovulation protocol. At 
the same time, effect of recipient physical condition (surgery cycle) on pregnancy was 
evaluated. Hence, it was not possible to do research on other factors affecting 
superovulation and ET of Boer crossbred does due to time, resources, facilities and 
logistic constraints. Since superovulation and ET on goat research was conducted 
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mainly in our laboratory in Malaysia, many fundamental issues at the local setting had 
to be faced and overcome. During this research project, the difficulties encountered 
included factors such as: 
a)  Heterogenous goat sample: In this experiment non-descriptive Boer crossbred 
(Boer × Katjang) does of various BW (16.5-44.5 kg) and age (2-4 yr) groups 
were used as donor and recipient which could not be standardised as need to use 
the available stock,  and very low population available for experimentation, does 
derived from non systematic breeding plan. Therefore, limited but adequate 
numbers of the donor and recipient does were collected from RASB Farm and 
ISB Mini Farm after consultation and subsequent approval by the farm 
authority. It was worth noting that careful planning was made before arriving at 
the decision. 
b) Inconsistent superovulation response: Inconsistent superovulation response 
was observed during the entire experiment which as a result of single or 
interaction of many intrinsic and extrinsic factors. Many of the factors were 
neutralised by changing gonadotrophin source, gonadotrophin dosages and 
interaction of hormones. However, there still unsolved issues such as factors 
related to the donor does like heterogeneity of does, age, BW, nutrition, health 
and physiological status could not be standardised and optimised throughout the 
research due to the scarcity of does available for selection as mentioned earlier. 
c) Gonadotrophin hormone collection: Gonadotrophin hormone especially pFSH 
was collected from overseas and it took long time (around 6 month) to process 
the payment, to take approval from the authority and finally to receive the 
consignment. As a consequence, the proposed specific experiments could not be 
carried out as scheduled, modifications were made accordingly.  
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d) Inconsistent embryo production: In the preliminary experiment of 
superovulation in this research project, eCG was used as superovulatory agent. 
This hormone was selected based on relatively easier availability than pFSH in 
the market. As expected by many researchers, it produced poor superovulatory 
performance. Subsequently, the author attempted to obtain pFSH from overseas 
as an alternative. Initially, 200 mg pFSH (20 ml) per doe was used which was 
selected based on earlier published literature. Most of the superovulation 
protocol was established in different region of the world by using different goat 
breeds. In the earlier experiments of this research, variable results were obtained 
due to inappropriate recommendation by the established protocol need to be 
applied in our local setting. Consequently, the focus of the present research was 
modified accordingly to evaluate the effect of gonadotrophin source, dosages 
related to BW and age on superovulation and ET performance. 
e)  Large number of anovulatory follicles: One of the common and major 
problems faced by all the researchers in goat superovulation and ET programme 
was the presence of anovulatory follicles in small or large number. Anovulatory 
follicles were more frequent in eCG-superovulated does than pFSH-
superovulated does. Several factors influenced the number of anovulary follicles 
such as gonadotrophin source, gonadotrophin dosages, BW, age and nutrition of 
donor does. 
f) Failure in preparation of both the donor and recipient does for successful ET: 
Sometimes, donor does produced embryos but due to the absence of CL in 
recipient does, ET could not be carried out. On the other hand, sometimes the 
recipients had CL but due to the absence of embryos, ET could not be 
performed. 
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5.6.3 Future Directions 
Although there were some weaknesses in this research, the overall findings of the 
present project opened up new scope for more detailed research areas to improve the 
production of embryos through superovulation and subsequently kids through ET. The 
suggested aspects for future research involve:  
a) Establishment of fixed time artificial insemination (TAI) schedule for 
superovulated doe for reducing unfertilised oocytes (ejaculated semen and 
ovulation synchrony). 
b) Optimisation of different gonadotrophin combination according to BW for 
reducing the administration frequency of hormone thus reducing the animal 
handling without compromising the outcome. 
c) Comparison of FSH and eCG in detailed relating to combination of 
gonadotrophins, dosage, age, BW, breed, nutrition and stage of oestrous cycle.  
d) Improvement of the superovulation performance by understanding the endocrine 
mechanism of superovulated does for reducing the anovulatory follicles.   
e) Detailed research on the different extrinsic and intrinsic factors influenced the 
embryo survivability after transfer to the recipient does.  
f) Effect of superovulation on ovarian status using ultrasound scanning and 
laparoscopy for the subsequent production of embryos.  
g) Extending the utilisation of in vivo produced embryos derived from 
superovulation for other ARTs such as for production of blastocycst for 
embryonic stem cell line establishment. 
h) ET can be a fundamental step of transforming animal farming to bio-pharming 
through cloning and stem cell technologies.  
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Chapter 6 
6.0 CONCLUSIONS 
 
This research presented the improvement of some aspect of superovulation and ET 
techniques for the production of in vivo embryos and subsequent viable kids. This 
enhancement was obtained by using different combinations of gonadotrophin with 
different physical condition of donor and recipient does specificallyfor Malaysian Boer 
crossbred goat. From the findings obtained in this research, it could be concluded that:  
a) Boer crossbred does could be synchronised and superovulated for the 
production of in vivo embryos with subsequent ET kids produced under the 
local condition of Malaysia.  
b) eCG- and pFSH-superovulated does were supplemented with or without LH 
(hCG or GnRH), aimed to select the better gonadotrophin combination for 
synchronising the ovulation and overcoming the luteal insufficiency. eCG-
superovulated does were needed to supplement with LH whereby hCG 
performed better than GnRH in Boer crossbred does for the production of 
better superovulation response.   
c) No additional LH supplementation was needed for ovulation 
synchronisation in pFSH-superovulated Boer crossbred does.   
d) eCG-superovulated does supplemented with hCG produced comparable 
results with pFSH-superovulated does but the latter produced higher 
number of transferable embryos.   
e) The optimal dosage of pFSH for superovulating Boer crossbred does was 5 
mg pFSH per kg BW.   
f) Donor does with 2 to 4 years of age showed better superovulation responses 
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and embryo production efficiency by using 5 mg pFSH per kg BW.   
g) Donor does with more than 25 kg BW produced better superovulation 
responses and embryo production efficiency by using 5 mg pFSH per kg 
BW.  
h) Intact does were favourable as recipient in ET programme than repeated 
surgery does but further detailed research on the latter to enhance their 
pregnancy efficiency was needed.  
i) In summary, in vivo embryos and ET kids were successfully produced by 
combining the following summerised protocols:  
Table 6.1: A summary of the proposed protocols for the superovulation and ET 
Aspect  Donor  Recipient  
Oestrus synchronisation  14 days CIDR 14 days CIDR 
Source of gonadotrophin for 
ovarian stimulation  
pFSH eCG  
Dosage of gonadotrophin 5 mg pFSH per kg BW per 
doe 
300 IU per doe 
Age of donor does 2 to 4 years Not studied 
BW of donor does More than 25 kg Not studied 
Method of mating Natural mating and AI Not relevant 
Embryo flushing or embryo 
transfer 
7 days after CIDR removal  7 days after CIDR 
removal 
Physical condition of recipient Not relevant Intact does 
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APPENDICES 
 
APPENDIX 1: LIST OF MATERIALS 
 
Appendix Table 1.1: List of equipment and instruments  
Equipment/instrument Model no.  Manufacturer  
Atraumatic grasping 
forceps  
PO951R  Aesculap ®, Germany  
Autoclave  HA-300MII  Hirayama Hiclave, Japan  
CIDR applicator  -  Pharmacia and Upjohn, New 
Zealand  
CO2 incubator  HeraCell 240  Heraeus,Germany  
CO2 insufflator system  PG001  Aesculap® , Germany  
Digital balance  AB104  Mettler Toledo, Switzerland  
Heating stage 
(Thermoplate)  
HATS-U55R30  Tokai Hit, Japan  
Impulse sealer  KF-300H  Khind, Taiwan  
Inverted microscope  IX71  Olympus, Japan  
Laminar flow cabinet  HLF-120  Gelman Sciences, Australia  
Laparoscopic system :                                                     Aesculap® , Germany 
(a) Endoscopic camera 
system  
PV431  
 
 
(b) CCD camera  PV430   
(c) Pediatric Storz  
laparoscope(7mm)  
PE688A  
 
 
(d) Light probe with fibre 
optic cable  
OP913  
 
 
(e) Light system (300W)  OP927  
Liquid nitrogen tank 
(small)  
SC2/IV  MVE, USA  
Micropipette dispenser - Eppendorf, Germany 
Oven 40050-IP20 Memmert GmbH, Germany 
PH meter HI-122 Hanna Instruments, Singapore 
Refrigerator and freezer SR-21NME Samsung Electronics, Korea 
Stage warmer 
(Thermoplate) 
HATS-U55R30 Tokai Hit, Japan 
Stereomicroscope SZH10  Olypus Optical, Japan 
Spirit burner - Shanghai Machinery, China 
Surgical set - Aesculap®, Germany 
Surgical table - Syarikat Copens Enterprise, 
Malaysia 
Trocar and canula 
(5.5 mm & 7.0 mm) 
EJ456, EJ457 
 
Aesculap® , Germany 
Ultrapure purification 
water system 
Milli-Q PF Plus Millipore, USA 
Ultrasound scanner ALOKA SSD500 Aloka, Inc., Tokyo, Japan  
Water bath  GMP-GC-19 Meert GmbH, Germany 
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Appendix Table 1.2: List of chemicals, reagents and media 
 
Cheicals, reagents and media Catalogue 
no. 
Manufacturer 
BME amino acids solution (50x) B6766 Sigama-Aldrich,USA 
Chorulon® (hCG)  Intervet International, Holland 
Calcium chloride (CaCl2.2H2O) C7902 Sigama-Aldrich,USA 
Cloprostenol (Estrumate®) - Schering-Plough, Australia 
Ethyl alcohol 99.8% (absolute 
ethanol) 
ET150-50 Systerm ChemAR®, Poland 
 
Folligon®  Intervet®, EU 
Folltropin®-V - Bioniche, Animal Health 
Canada Inc. 
Goat/sheep pellet feed - KMM Berhad, Malaysia 
Heparin H0777 Sigama-Aldrich,USA 
Hibiscrub (antiseptic) HK-06770 SSL International Plc, UK 
Intravaginal progesterone release 
device 
 Pharmacia and Upjohn, New 
Zealand 
Ketamil injection (ketamine 
hydrochloride) 
L10077 Troy Laboratories, Australia 
K-Y Lubricating Jelly - Pharmedica Lab, South Africa 
L-glutamine G3126 Sigama-Aldrich,USA 
KCl P5404 Sigama-Aldrich,USA 
KH2PO4 P5655  
NaCl S5886 Sigama-Aldrich,USA 
NaHCO3 S5761 Sigama-Aldrich,USA 
MgCl2. 6H2O M2393 Sigama-Aldrich,USA 
MEM (100x) M7145 Sigama-Aldrich,USA 
Ovidrel - Industria Farmaceutica Serono, 
S.P.A., Bari, Italy 
PBS Dulbecco A tablets BR0014G Oxoid,England 
Penicillin G sodium salt P7794 Sigma-Aldrich,USA 
Polyvinylpyrrolidone-360 PVP360 Sigma-Aldrich,USA 
Sodium DL-lactate (60% syrup) L4263 Sigama-Aldrich,USA 
Sodium pyruvate P3662 Sigama-Aldrich,USA 
Streptomycin sulfate salt S1277 Sigma-Aldrich,USA 
Weak iodine solution - ICN Bioedicals, USA 
Xylazine hydrochloride (Ilium 
Xylazil-20) 
L10600 Troy Laboratories, Australia 
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Appendix Table 1.3: List of labwares and disposables 
 
Lab-wares and disposables Manufacturer 
Aluminium foil Reynolds Consumer Products, 
USA 
Autoclave disposal bag Megalab supplies, Malaysia 
Blades (Super Nacet) Gillette, USA 
Chromic catgut and other suture aterials Aesculap®, Germany 
Culture dish Nunc, Denark 
Disposable glass Pasteur pipette Hirschmann®, Laborgerete, 
Germany 
Disposable hand tissues Megalab supplies, Malaysia 
FalconTM conical tube Becton Dickinson, USA 
Foley Catheters Bardia®, India 
Glassware (beaker, flask, easuring cylinder ect.) Pyrex® , Japan 
Micropipette tips without filter Axygen Scientific,USA 
Needle Terumo Corporation, Japan 
Parafilm Pechiney Plastic Packaging, USA 
Schott bottle Duran, Germany 
Sterile glove Ansell International, Malaysia 
Syringe Terumo Corporation, Japan 
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APPENDIX 2: STATISTICAL DATA 
Appendix Table 2.1: Effect of Supplementation of hCG or GnRH on Ovulation and 
Subsequent Embryo Production of eCG Superovulated Goats 
(Experiment 1) 
Descriptives 
  
N Mean 
Std. 
Deviation Std. Error 
95% Confidence 
Interval for Mean 
Minimum Maximum 
  Lower 
Bound 
Upper 
Bound 
Number of 
CL 
ecg + hcg 10 10.9000 5.48635 1.73494 6.9753 14.8247 3.00 18.00 
ecg+gnrh 10 1.9000 2.88483 .91226 -.1637 3.9637 .00 9.00 
ecg 10 .9000 1.59513 .50442 -.2411 2.0411 .00 5.00 
Total 30 4.5667 5.79943 1.05883 2.4011 6.7322 .00 18.00 
Number of 
anovulated 
follicle 
ecg + hcg 10 9.8000 12.96834 4.10095 .5230 19.0770 .00 39.00 
ecg+gnrh 10 14.2000 13.20606 4.17612 4.7530 23.6470 2.00 49.00 
ecg 10 13.8000 11.07349 3.50175 5.8785 21.7215 1.00 38.00 
Total 30 12.6000 12.18422 2.22452 8.0503 17.1497 .00 49.00 
Total 
stimulation 
ecg + hcg 10 20.7000 13.96862 4.41726 10.7075 30.6925 7.00 50.00 
ecg+gnrh 10 16.1000 13.23673 4.18582 6.6310 25.5690 2.00 50.00 
ecg 10 14.7000 10.77085 3.40604 6.9950 22.4050 1.00 39.00 
Total 30 17.1667 12.55906 2.29296 12.4770 21.8563 1.00 50.00 
Number of 
embryo 
ecg + hcg 10 .9000 1.10050 .34801 .1127 1.6873 .00 3.00 
ecg+gnrh 10 .5000 1.26930 .40139 -.4080 1.4080 .00 4.00 
ecg 10 .0000 .00000 .00000 .0000 .0000 .00 .00 
Total 30 .4667 1.00801 .18404 .0903 .8431 .00 4.00 
Number of 
unfertilised 
ecg + hcg 10 2.2000 2.57337 .81377 .3591 4.0409 .00 7.00 
ecg+gnrh 10 .2000 .42164 .13333 -.1016 .5016 .00 1.00 
ecg 10 .0000 .00000 .00000 .0000 .0000 .00 .00 
Total 30 .8000 1.76947 .32306 .1393 1.4607 .00 7.00 
Degenerat
-ed 
embryo 
ecg + hcg 10 .5000 .84984 .26874 -.1079 1.1079 .00 2.00 
ecg+gnrh 10 .2000 .63246 .20000 -.2524 .6524 .00 2.00 
ecg 10 .0000 .00000 .00000 .0000 .0000 .00 .00 
Total 30 .2333 .62606 .11430 -.0004 .4671 .00 2.00 
(continued) 
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N Mean 
Std. 
Deviation Std. Error 
95% Confidence 
Interval for Mean 
Minimum 
 
 
 
Maximum 
Lower 
Bound 
Upper 
Bound 
Transferra
ble embryo 
ecg + hcg 10 .4000 .69921 .22111 -.1002 .9002 .00 2.00 
ecg+gnrh 10 .3000 .67495 .21344 -.1828 .7828 .00 2.00 
ecg 10 .0000 .00000 .00000 .0000 .0000 .00 .00 
Total 30 .2333 .56832 .10376 .0211 .4455 .00 2.00 
Structures 
recovery 
ecg + hcg 10 3.1000 3.21282 1.01598 .8017 5.3983 .00 9.00 
ecg+gnrh 10 .7000 1.33749 .42295 -.2568 1.6568 .00 4.00 
ecg 10 .0000 .00000 .00000 .0000 .0000 .00 .00 
Total 30 1.2667 2.36254 .43134 .3845 2.1489 .00 9.00 
Recovery 
rate 
ecg + hcg 10 25.8845 23.94076 7.57073 8.7583 43.0107 .00 66.67 
ecg+gnrh 10 21.1111 36.45844 11.52917 -4.9697 47.1919 .00 100.00 
ecg 10 .0000 .00000 .00000 .0000 .0000 .00 .00 
Total 30 15.6652 26.85614 4.90324 5.6370 25.6935 .00 100.00 
 
ANOVA 
  Sum of Squares df Mean Square F Sig. 
Number of CL Between Groups 606.667 2 303.333 22.213 .000 
Within Groups 368.700 27 13.656   
Total 975.367 29    
Number of anovulated 
follicle 
Between Groups 118.400 2 59.200 .382 .686 
Within Groups 4186.800 27 155.067   
Total 4305.200 29    
Total stimulation Between Groups 197.067 2 98.533 .608 .552 
Within Groups 4377.100 27 162.115   
Total 4574.167 29    
Number of embryo Between Groups 4.067 2 2.033 2.161 .135 
Within Groups 25.400 27 .941   
Total 29.467 29    
(continued) 
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  Sum of Squares df Mean Square F Sig. 
Number of unfertilized 
follicle 
Between Groups 29.600 2 14.800 6.529 .005 
Within Groups 61.200 27 2.267   
Total 90.800 29    
Degenarated embryo Between Groups 1.267 2 .633 1.693 .203 
Within Groups 10.100 27 .374   
Total 11.367 29    
Transferrable embryo Between Groups .867 2 .433 1.376 .270 
Within Groups 8.500 27 .315   
Total 9.367 29    
Structures recovery Between Groups 52.867 2 26.433 6.548 .005 
Within Groups 109.000 27 4.037   
Total 161.867 29    
Recovery rate Between Groups 3794.910 2 1897.455 2.992 .067 
Within Groups 17121.405 27 634.126   
Total 20916.315 29    
Multiple Comparisons 
Dependent 
Variable 
(I) 
treatment 
(J) 
treatment 
Mean 
Difference (I-
J) Std. Error Sig. 
95% Confidence Interval 
Lower Bound Upper Bound 
Number of 
CL 
ecg + hcg ecg+gnrh 9.00000* 1.65261 .000 5.6091 12.3909 
ecg 10.00000* 1.65261 .000 6.6091 13.3909 
ecg+gnrh ecg + hcg -9.00000* 1.65261 .000 -12.3909 -5.6091 
ecg 1.00000 1.65261 .550 -2.3909 4.3909 
ecg ecg + hcg -10.00000* 1.65261 .000 -13.3909 -6.6091 
ecg+gnrh -1.00000 1.65261 .550 -4.3909 2.3909 
Number of 
anovulated 
follicle 
ecg + hcg ecg+gnrh -4.40000 5.56896 .436 -15.8266 7.0266 
ecg -4.00000 5.56896 .479 -15.4266 7.4266 
ecg+gnrh ecg + hcg 4.40000 5.56896 .436 -7.0266 15.8266 
ecg .40000 5.56896 .943 -11.0266 11.8266 
ecg ecg + hcg 4.00000 5.56896 .479 -7.4266 15.4266 
ecg+gnrh -.40000 5.56896 .943 -11.8266 11.0266 
(continued) 
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Dependent 
Variable 
(I) 
treatment 
(J) 
treatment 
Mean 
Difference (I-
J) Std. Error Sig. 
95% Confidence Interval 
Lower Bound Upper Bound 
Total 
stimulation 
ecg + hcg ecg+gnrh 4.60000 5.69412 .426 -7.0834 16.2834 
ecg 6.00000 5.69412 .301 -5.6834 17.6834 
ecg+gnrh ecg + hcg -4.60000 5.69412 .426 -16.2834 7.0834 
ecg 1.40000 5.69412 .808 -10.2834 13.0834 
ecg ecg + hcg -6.00000 5.69412 .301 -17.6834 5.6834 
ecg+gnrh -1.40000 5.69412 .808 -13.0834 10.2834 
Number of 
embryo 
ecg + hcg ecg+gnrh .40000 .43376 .365 -.4900 1.2900 
ecg .90000* .43376 .048 .0100 1.7900 
ecg+gnrh ecg + hcg -.40000 .43376 .365 -1.2900 .4900 
ecg .50000 .43376 .259 -.3900 1.3900 
ecg ecg + hcg -.90000* .43376 .048 -1.7900 -.0100 
ecg+gnrh -.50000 .43376 .259 -1.3900 .3900 
Number of 
153nfertiliz
ed follicle 
ecg + hcg ecg+gnrh 2.00000* .67330 .006 .6185 3.3815 
ecg 2.20000* .67330 .003 .8185 3.5815 
ecg+gnrh ecg + hcg -2.00000* .67330 .006 -3.3815 -.6185 
ecg .20000 .67330 .769 -1.1815 1.5815 
ecg ecg + hcg -2.20000* .67330 .003 -3.5815 -.8185 
ecg+gnrh -.20000 .67330 .769 -1.5815 1.1815 
Degenerat
ed embryo 
ecg + hcg ecg+gnrh .30000 .27352 .282 -.2612 .8612 
ecg .50000 .27352 .079 -.0612 1.0612 
ecg+gnrh ecg + hcg -.30000 .27352 .282 -.8612 .2612 
ecg .20000 .27352 .471 -.3612 .7612 
ecg ecg + hcg -.50000 .27352 .079 -1.0612 .0612 
ecg+gnrh -.20000 .27352 .471 -.7612 .3612 
Transferrab
le embryo 
ecg + hcg ecg+gnrh .10000 .25092 .693 -.4149 .6149 
ecg .40000 .25092 .123 -.1149 .9149 
ecg+gnrh ecg + hcg -.10000 .25092 .693 -.6149 .4149 
ecg .30000 .25092 .242 -.2149 .8149 
ecg ecg + hcg -.40000 .25092 .123 -.9149 .1149 
ecg+gnrh -.30000 .25092 .242 -.8149 .2149 
(continued) 
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Dependent 
Variable 
(I) 
treatment 
(J) 
treatment 
Mean 
Difference (I-
J) 
Std. Error 
 
Sig. 
 
95% Confidence Interval 
Lower Bound Upper Bound 
Structures 
recovery 
ecg + hcg ecg+gnrh 2.40000* .89856 .013 .5563 4.2437 
ecg 3.10000* .89856 .002 1.2563 4.9437 
ecg+gnrh ecg + hcg -2.40000* .89856 .013 -4.2437 -.5563 
ecg .70000 .89856 .443 -1.1437 2.5437 
ecg ecg + hcg -3.10000* .89856 .002 -4.9437 -1.2563 
ecg+gnrh -.70000 .89856 .443 -2.5437 1.1437 
Recovery 
rate 
ecg + hcg ecg+gnrh 4.77341 11.26167 .675 -18.3336 27.8805 
ecg 25.88452* 11.26167 .030 2.7775 48.9916 
ecg+gnrh ecg + hcg -4.77341 11.26167 .675 -27.8805 18.3336 
ecg 21.11111 11.26167 .072 -1.9959 44.2182 
ecg ecg + hcg -25.88452* 11.26167 .030 -48.9916 -2.7775 
ecg+gnrh -21.11111 11.26167 .072 -44.2182 1.9959 
*. The mean difference is significant at the 0.05 level. 
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Appendix Table 2.2: Effect of Supplementation of hCG or GnRH on Ovulation and 
Subsequent Embryo Production of pFSH Superovulated Goats 
(Experiment 2) 
Descriptives 
 N Mean Std. 
Deviation 
Std. 
Error 
95% Confidence 
Interval for Mean 
Minimum Maximum 
Lower 
Bound 
Upper 
Bound 
Number of 
CL 
fhs+hcg 6 4.3333 4.03320 1.64655 .1008 8.5659 .00 10.00 
fsh+gnrh 6 .8333 2.04124 .83333 -1.3088 2.9755 .00 5.00 
fsh 6 4.8333 6.27429 2.56147 -1.7511 11.4178 .00 16.00 
Total 18 3.3333 4.57615 1.07861 1.0577 5.6090 .00 16.00 
Number of 
anovulated 
follicle 
fhs+hcg 6 13.5000 7.34166 2.99722 5.7954 21.2046 .00 20.00 
fsh+gnrh 6 9.5000 9.28978 3.79254 -.2490 19.2490 .00 20.00 
fsh 6 6.8333 6.70572 2.73760 -.2039 13.8706 .00 17.00 
Total 18 9.9444 7.89990 1.86203 6.0159 13.8730 .00 20.00 
Total 
stimulation 
fhs+hcg 6 17.8333 9.66264 3.94476 7.6930 27.9737 .00 25.00 
fsh+gnrh 6 10.3333 8.91441 3.63929 .9782 19.6884 .00 20.00 
fsh 6 11.6667 4.67618 1.90904 6.7593 16.5740 4.00 17.00 
Total 18 13.2778 8.28042 1.95171 9.1600 17.3955 .00 25.00 
Number of 
embryo 
fsh+hcg 6 1.5000 2.73861 1.11803 -1.3740 4.3740 .00 7.00 
fsh+gnrh 6 .3333 .81650 .33333 -.5235 1.1902 .00 2.00 
fsh 6 1.0000 2.44949 1.00000 -1.5706 3.5706 .00 6.00 
Total 18 .9444 2.09964 .49489 -.0997 1.9886 .00 7.00 
Number of 
unfertilised 
oocyte 
fhs+hcg 6 .8333 1.60208 .65405 -.8479 2.5146 .00 4.00 
fsh+gnrh 6 .0000 .00000 .00000 .0000 .0000 .00 .00 
fsh 6 2.1667 5.30723 2.16667 -3.4029 7.7363 .00 13.00 
Total 18 1.0000 3.14362 .74096 -.5633 2.5633 .00 13.00 
Degenerate
d embryo 
fhs+hcg 6 .1667 .40825 .16667 -.2618 .5951 .00 1.00 
fsh+gnrh 6 .0000 .00000 .00000 .0000 .0000 .00 .00 
fsh 6 .1667 .40825 .16667 -.2618 .5951 .00 1.00 
Total 18 .1111 .32338 .07622 -.0497 .2719 .00 1.00 
Transferrabl
e embryo 
fsh+hcg 6 1.3333 2.80476 1.14504 -1.6101 4.2767 .00 7.00 
fsh+gnrh 6 .3333 .81650 .33333 -.5235 1.1902 .00 2.00 
fsh 6 .8333 2.04124 .83333 -1.3088 2.9755 .00 5.00 
Total 18 .8333 1.97782 .46618 -.1502 1.8169 .00 7.00 
Structures 
recovery 
fhs+hcg 6 2.3333 3.38625 1.38243 -1.2203 5.8870 .00 8.00 
fsh+gnrh 6 .3333 .81650 .33333 -.5235 1.1902 .00 2.00 
fsh 6 3.1667 5.38207 2.19722 -2.4815 8.8148 .00 13.00 
Total 18 1.9444 3.68578 .86875 .1115 3.7773 .00 13.00 
(continued) 
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N Mean Std. 
Deviation 
Std. Error 95% Confidence 
Interval for Mean 
Minimum Maximum 
Lower 
Bound 
Upper 
Bound 
Ovulation 
percentage 
fhs+hcg 6 19.3106 16.27313 6.64348 2.2330 36.3882 .00 40.00 
fsh+gnrh 6 9.2593 22.68046 9.25926 -14.5424 33.0609 .00 55.56 
fsh 6 45.9596 48.68959 19.87744 -5.1370 97.0562 .00 100.00 
Total 18 24.8431 34.35601 8.09779 7.7583 41.9280 .00 100.00 
Recovery 
rate 
fhs+hcg 6 32.7778 40.02314 16.33938 -9.2239 74.7795 .00 83.33 
fsh+gnrh 6 6.6667 16.32993 6.66667 -10.4705 23.8039 .00 40.00 
fsh 6 26.0417 40.39196 16.48995 -16.3471 68.4304 .00 81.25 
Total 18 21.8287 34.04604 8.02473 4.8980 38.7594 .00 83.33 
 
ANOVA 
 Sum of 
Squares 
df Mean 
Square 
F Sig. 
Number of CL 
Between Groups 57.000 2 28.500 1.430 .270 
Within Groups 299.000 15 19.933   
Total 356.000 17    
Number of 
anovulated 
follicle 
Between Groups 135.111 2 67.556 1.095 .360 
Within Groups 925.833 15 61.722   
Total 1060.944 17    
Total 
stimulation 
Between Groups 192.111 2 96.056 1.480 .259 
Within Groups 973.500 15 64.900   
Total 1165.611 17    
Number of 
embryo 
Between Groups 4.111 2 2.056 .435 .655 
Within Groups 70.833 15 4.722   
Total 74.944 17    
Number of 
unfertilised 
oocytes 
Between Groups 14.333 2 7.167 .700 .512 
Within Groups 153.667 15 10.244   
Total 168.000 17    
Degenerated 
embryo 
Between Groups .111 2 .056 .500 .616 
Within Groups 1.667 15 .111   
Total 1.778 17    
Transferrable 
embryo 
Between Groups 3.000 2 1.500 .354 .707 
Within Groups 63.500 15 4.233   
Total 66.500 17    
(continued) 
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Sum of 
Squares 
df Mean 
Square 
F Sig. 
Structure 
recovery 
Between Groups 25.444 2 12.722 .929 .417 
Within Groups 205.500 15 13.700   
Total 230.944 17    
Ovulation 
percentage 
Between Groups 4316.229 2 2158.115 2.055 .163 
Within Groups 15749.472 15 1049.965   
Total 20065.701 17    
Recovery rate 
Between Groups 2205.112 2 1102.556 .945 .411 
Within Groups 17500.145 15 1166.676   
Total 19705.257 17    
 
Multiple Comparisons 
Dependent 
Variable 
(I) 
treatment 
(J) 
treatment 
Mean 
Difference  
(I-J) 
Std. Error Sig. 95% Confidence Interval 
Lower 
Bound 
Upper 
Bound 
Number of CL 
fhs+hcg 
fsh+gnrh 3.50000 2.57768 .195 -1.9942 8.9942 
fsh -.50000 2.57768 .849 -5.9942 4.9942 
fsh+gnrh 
fhs+hcg -3.50000 2.57768 .195 -8.9942 1.9942 
fsh -4.00000 2.57768 .142 -9.4942 1.4942 
fsh 
fhs+hcg .50000 2.57768 .849 -4.9942 5.9942 
fsh+gnrh 4.00000 2.57768 .142 -1.4942 9.4942 
Number of 
anovulatory 
follicle 
fhs+hcg 
fsh+gnrh 4.00000 4.53587 .392 -5.6680 13.6680 
fsh 6.66667 4.53587 .162 -3.0013 16.3346 
fsh+gnrh 
fhs+hcg -4.00000 4.53587 .392 -13.6680 5.6680 
fsh 2.66667 4.53587 .565 -7.0013 12.3346 
fsh 
fhs+hcg -6.66667 4.53587 .162 -16.3346 3.0013 
fsh+gnrh -2.66667 4.53587 .565 -12.3346 7.0013 
Total stimulation 
fhs+hcg 
fsh+gnrh 7.50000 4.65116 .128 -2.4137 17.4137 
fsh 6.16667 4.65116 .205 -3.7471 16.0804 
fsh+gnrh 
fhs+hcg -7.50000 4.65116 .128 -17.4137 2.4137 
fsh -1.33333 4.65116 .778 -11.2471 8.5804 
fsh 
fhs+hcg -6.16667 4.65116 .205 -16.0804 3.7471 
fsh+gnrh 1.33333 4.65116 .778 -8.5804 11.2471 
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Dependent 
Variable 
(I) 
treatment 
(J) 
treatment 
Mean 
Difference  
(I-J) 
Std. Error Sig. 95% Confidence Interval 
Lower 
Bound 
Upper 
Bound 
Nummber of 
embryo 
fsh + hcg 
fsh .50000 1.25462 .696 -2.1742 3.1742 
fsh + gnrh 1.16667 1.25462 .367 -1.5075 3.8408 
fsh + gnrh 
fsh -.66667 1.25462 .603 -3.3408 2.0075 
fsh + hcg -1.16667 1.25462 .367 -3.8408 1.5075 
fsh 
fsh + hcg -.50000 1.25462 .696 -3.1742 2.1742 
fsh + gnrh .66667 1.25462 .603 -2.0075 3.3408 
Number of 
unfertilised 
fhs+hcg 
fsh+gnrh .83333 1.84792 .658 -3.1054 4.7721 
fsh -1.33333 1.84792 .482 -5.2721 2.6054 
fsh+gnrh 
fhs+hcg -.83333 1.84792 .658 -4.7721 3.1054 
fsh -2.16667 1.84792 .259 -6.1054 1.7721 
fsh 
fhs+hcg 1.33333 1.84792 .482 -2.6054 5.2721 
fsh+gnrh 2.16667 1.84792 .259 -1.7721 6.1054 
Degenerated 
embryo 
fhs+hcg 
fsh+gnrh .16667 .19245 .400 -.2435 .5769 
fsh .00000 .19245 1.000 -.4102 .4102 
fsh+gnrh 
fhs+hcg -.16667 .19245 .400 -.5769 .2435 
fsh -.16667 .19245 .400 -.5769 .2435 
fsh 
fhs+hcg .00000 .19245 1.000 -.4102 .4102 
fsh+gnrh .16667 .19245 .400 -.2435 .5769 
Transferrable 
embryo 
fsh + hcg 
fsh .50000 1.18790 .680 -2.0320 3.0320 
fsh + gnrh 1.00000 1.18790 .413 -1.5320 3.5320 
fsh + gnrh 
fsh -.50000 1.18790 .680 -3.0320 2.0320 
fsh + hcg -1.00000 1.18790 .413 -3.5320 1.5320 
fsh 
fsh + hcg -.50000 1.18790 .680 -3.0320 2.0320 
fsh + gnrh .50000 1.18790 .680 -2.0320 3.0320 
Structures 
recovered 
fhs+hcg 
fsh+gnrh 2.00000 2.13698 .364 -2.5549 6.5549 
fsh -.83333 2.13698 .702 -5.3882 3.7215 
fsh+gnrh 
fhs+hcg -2.00000 2.13698 .364 -6.5549 2.5549 
fsh -2.83333 2.13698 .205 -7.3882 1.7215 
fsh 
fhs+hcg .83333 2.13698 .702 -3.7215 5.3882 
fsh+gnrh 2.83333 2.13698 .205 -1.7215 7.3882 
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Dependent 
Variable 
(I) 
treatment 
(J) 
treatment 
Mean 
Difference  
(I-J) 
Std. Error Sig. 95% Confidence Interval 
Lower 
Bound 
Lower 
Bound 
Ovulation 
percentage 
fhs+hcg 
fsh+gnrh 10.05130 18.70797 .599 -29.8238 49.9264 
fsh -26.64904 18.70797 .175 -66.5241 13.2261 
fsh+gnrh 
fhs+hcg -10.05130 18.70797 .599 -49.9264 29.8238 
fsh -36.70034 18.70797 .069 -76.5754 3.1748 
fsh 
fhs+hcg 26.64904 18.70797 .175 -13.2261 66.5241 
fsh+gnrh 36.70034 18.70797 .069 -3.1748 76.5754 
Recovery rate 
fhs+hcg 
fsh+gnrh 26.11111 19.72035 .205 -15.9218 68.1440 
fsh 6.73611 19.72035 .737 -35.2968 48.7690 
fsh+gnrh 
fhs+hcg -26.11111 19.72035 .205 -68.1440 15.9218 
fsh -19.37500 19.72035 .341 -61.4079 22.6579 
fsh 
fhs+hcg -6.73611 19.72035 .737 -48.7690 35.2968 
fsh+gnrh 19.37500 19.72035 .341 -22.6579 61.4079 
 
 
Appendix Table 2.3: Effect of pFSH Dosage Based on Body Weight on Superovulation Performance  
(Experiment 3) 
 
Descriptives 
 N Mean Std. 
Deviation 
Std. Error 95% Confidence 
Interval for Mean 
Minimum Maximum 
Lower 
Bound 
Upper 
Bound 
Number of CL 
3 mg 13 5.2308 6.04364 1.67621 1.5786 8.8829 .00 15.00 
5 mg 13 7.6923 8.47924 2.35172 2.5684 12.8163 .00 24.00 
8 mg 13 5.0769 5.36130 1.48696 1.8371 8.3167 .00 19.00 
Total 39 6.0000 6.69249 1.07166 3.8305 8.1695 .00 24.00 
Number of 
anovulated 
follicle 
3 mg 13 2.2308 5.24649 1.45511 -.9397 5.4012 .00 15.00 
5 mg 13 3.3077 5.26600 1.46053 .1255 6.4899 .00 15.00 
8 mg 13 5.6923 6.08803 1.68852 2.0133 9.3713 .00 17.00 
Total 39 3.7436 5.59472 .89587 1.9300 5.5572 .00 17.00 
Total 
stimulation  
3 mg 13 7.4615 8.26252 2.29161 2.4685 12.4545 .00 24.00 
5 mg 13 11.0000 6.95222 1.92820 6.7988 15.2012 3.00 24.00 
8 mg 13 10.7692 7.74762 2.14880 6.0874 15.4511 2.00 33.00 
Total 39 9.7436 7.64584 1.22431 7.2651 12.2221 .00 33.00 
(continued) 
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N Mean Std. 
Deviation 
Std. Error 95% Confidence 
Interval for Mean 
Minimum Maximum 
Lower 
Bound 
Lower 
Bound 
Number of 
embryo 
3 mg 13 1.3846 2.14237 .59419 .0900 2.6792 .00 6.00 
5 mg 13 4.0769 4.95751 1.37497 1.0811 7.0727 .00 14.00 
8 mg 13 1.2308 1.87767 .52077 .0961 2.3654 .00 6.00 
Total 39 2.2308 3.47519 .55648 1.1042 3.3573 .00 14.00 
Number of 
unfertilised 
oocytes 
3 mg 13 1.0769 2.36155 .65498 -.3501 2.5040 .00 8.00 
5 mg 13 .0769 .27735 .07692 -.0907 .2445 .00 1.00 
8 mg 13 1.3846 3.61798 1.00345 -.8017 3.5709 .00 13.00 
Total 39 .8462 2.49777 .39996 .0365 1.6558 .00 13.00 
Degenerated 
embryo 
3 mg 13 .1538 .37553 .10415 -.0731 .3808 .00 1.00 
5 mg 13 .0769 .27735 .07692 -.0907 .2445 .00 1.00 
8 mg 13 .3077 .48038 .13323 .0174 .5980 .00 1.00 
Total 39 .1795 .38878 .06225 .0535 .3055 .00 1.00 
Transferrable 
embryo 
3 mg 13 1.2308 1.92154 .53294 .0696 2.3919 .00 5.00 
5 mg 13 3.7692 5.11784 1.41943 .6765 6.8619 .00 14.00 
8 mg 13 .9231 1.70595 .47314 -.1078 1.9540 .00 6.00 
Total 39 1.9744 3.46780 .55529 .8502 3.0985 .00 14.00 
Structures 
recovery 
3 mg 13 2.4615 2.81707 .78132 .7592 4.1639 .00 8.00 
5 mg 13 4.1538 4.93028 1.36741 1.1745 7.1332 .00 14.00 
8 mg 13 2.6154 3.59487 .99704 .4430 4.7877 .00 13.00 
Total 39 3.0769 3.85517 .61732 1.8272 4.3266 .00 14.00 
Ovulation 
percentage 
3 mg 13 49.0460 47.75586 13.24509 20.1874 77.9046 .00 100.00 
5 mg 13 68.9103 47.82949 13.26551 40.0072 97.8133 .00 100.00 
8 mg 13 51.9564 43.95420 12.19070 25.3951 78.5176 .00 100.00 
Total 39 56.6375 46.16765 7.39274 41.6717 71.6034 .00 100.00 
Recovery rate 
3 mg 13 35.0000 34.79943 9.65162 13.9709 56.0291 .00 100.00 
5 mg 13 37.5385 35.23875 9.77347 16.2439 58.8330 .00 88.00 
8 mg 13 37.3846 37.50231 10.40127 14.7222 60.0470 .00 100.00 
Total 39 36.6410 34.92962 5.59322 25.3182 47.9639 .00 100.00 
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ANOVA 
 Sum of Squares df Mean Square F Sig. 
Number 
of CL 
Between Groups 56.000 2 28.000 .612 .548 
Within Groups 1646.000 36 45.722   
Total 1702.000 38    
nouv 
Between Groups 81.590 2 40.795 1.326 .278 
Within Groups 1107.846 36 30.774   
Total 1189.436 38    
ts 
Between Groups 101.897 2 50.949 .865 .429 
Within Groups 2119.538 36 58.876   
Total 2221.436 38    
noem 
Between Groups 66.615 2 33.308 3.056 .059 
Within Groups 392.308 36 10.897   
Total 458.923 38    
nounfer 
Between Groups 12.154 2 6.077 .973 .388 
Within Groups 224.923 36 6.248   
Total 237.077 38    
de 
Between Groups .359 2 .179 1.200 .313 
Within Groups 5.385 36 .150   
Total 5.744 38    
te 
Between Groups 63.436 2 31.718 2.901 .068 
Within Groups 393.538 36 10.932   
Total 456.974 38    
sr 
Between Groups 22.769 2 11.385 .756 .477 
Within Groups 542.000 36 15.056   
Total 564.769 38    
op 
Between Groups 2992.136 2 1496.068 .690 .508 
Within Groups 78003.047 36 2166.751   
Total 80995.182 38    
rr 
Between Groups 52.667 2 26.333 .020 .980 
Within Groups 46310.308 36 1286.397   
Total 46362.974 38    
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Multiple Comparisons 
Dependent 
Variable 
(I) 
treatment 
(J) 
treatment 
Mean Difference 
(I-J) 
Std. Error Sig. 95% Confidence 
Interval 
Lower 
Bound 
Upper 
Bound 
Number of 
CL 
3 mg 
5 mg -2.46154 2.65220 .360 -7.8405 2.9174 
8 mg .15385 2.65220 .954 -5.2251 5.5328 
5 mg 
3 mg 2.46154 2.65220 .360 -2.9174 7.8405 
8 mg 2.61538 2.65220 .331 -2.7635 7.9943 
8 mg 
3 mg -.15385 2.65220 .954 -5.5328 5.2251 
5 mg -2.61538 2.65220 .331 -7.9943 2.7635 
Number of 
anovulated 
follicle 
3 mg 
5 mg -1.07692 2.17586 .624 -5.4898 3.3359 
8 mg -3.46154 2.17586 .120 -7.8744 .9513 
5 mg 
3 mg 1.07692 2.17586 .624 -3.3359 5.4898 
8 mg -2.38462 2.17586 .280 -6.7975 2.0282 
8 mg 
3 mg 3.46154 2.17586 .120 -.9513 7.8744 
5 mg 2.38462 2.17586 .280 -2.0282 6.7975 
Total 
stimulation 
3 mg 
5 mg -3.53846 3.00963 .247 -9.6423 2.5653 
8 mg -3.30769 3.00963 .279 -9.4115 2.7961 
5 mg 
3 mg 3.53846 3.00963 .247 -2.5653 9.6423 
8 mg .23077 3.00963 .939 -5.8730 6.3346 
8 mg 
3 mg 3.30769 3.00963 .279 -2.7961 9.4115 
5 mg -.23077 3.00963 .939 -6.3346 5.8730 
Number of 
embryo 
3 mg 
5 mg -2.69231* 1.29481 .045 -5.3183 -.0663 
8 mg .15385 1.29481 .906 -2.4721 2.7798 
5 mg 
3 mg 2.69231* 1.29481 .045 .0663 5.3183 
8 mg 2.84615* 1.29481 .034 .2202 5.4721 
8 mg 
3 mg -.15385 1.29481 .906 -2.7798 2.4721 
5 mg -2.84615* 1.29481 .034 -5.4721 -.2202 
Number of 
unfertilised 
oocyte 
3 mg 
5 mg 1.00000 .98041 .315 -.9884 2.9884 
8 mg -.30769 .98041 .755 -2.2961 1.6807 
5 mg 
3 mg -1.00000 .98041 .315 -2.9884 .9884 
8 mg -1.30769 .98041 .191 -3.2961 .6807 
8 mg 
3 mg .30769 .98041 .755 -1.6807 2.2961 
5 mg 1.30769 .98041 .191 -.6807 3.2961 
(continued) 
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Dependent 
Variable 
(I) 
treatment 
(J) 
treatment 
Mean Difference 
(I-J) 
Std. Error Sig. 95% Confidence 
Interval 
Lower 
Bound 
Lower 
Bound 
Degenerate
d embryo 
3 mg 
5 mg .07692 .15169 .615 -.2307 .3846 
8 mg -.15385 .15169 .317 -.4615 .1538 
5 mg 
3 mg -.07692 .15169 .615 -.3846 .2307 
8 mg -.23077 .15169 .137 -.5384 .0769 
8 mg 
3 mg .15385 .15169 .317 -.1538 .4615 
5 mg .23077 .15169 .137 -.0769 .5384 
Transferrabl
e embryo 
3 mg 
5 mg -2.53846 1.29684 .058 -5.1686 .0916 
8 mg .30769 1.29684 .814 -2.3224 2.9378 
5 mg 
3 mg 2.53846 1.29684 .058 -.0916 5.1686 
8 mg 2.84615* 1.29684 .035 .2160 5.4763 
8 mg 
3 mg -.30769 1.29684 .814 -2.9378 2.3224 
5 mg -2.84615* 1.29684 .035 -5.4763 -.2160 
Structures 
recovery 
3 mg 
5 mg -1.69231 1.52192 .274 -4.7789 1.3943 
8 mg -.15385 1.52192 .920 -3.2404 2.9327 
5 mg 
3 mg 1.69231 1.52192 .274 -1.3943 4.7789 
8 mg 1.53846 1.52192 .319 -1.5481 4.6251 
8 mg 
3 mg .15385 1.52192 .920 -2.9327 3.2404 
5 mg -1.53846 1.52192 .319 -4.6251 1.5481 
Ovulation 
percentage 
3 mg 
5 mg -19.86425 18.25778 .284 -56.8927 17.1642 
8 mg -2.91037 18.25778 .874 -39.9389 34.1181 
5 mg 
3 mg 19.86425 18.25778 .284 -17.1642 56.8927 
8 mg 16.95388 18.25778 .359 -20.0746 53.9824 
8 mg 
3 mg 2.91037 18.25778 .874 -34.1181 39.9389 
5 mg -16.95388 18.25778 .359 -53.9824 20.0746 
Recovery 
rate 
3 mg 
5 mg -2.53846 14.06795 .858 -31.0696 25.9927 
8 mg -2.38462 14.06795 .866 -30.9157 26.1465 
5 mg 
3 mg 2.53846 14.06795 .858 -25.9927 31.0696 
8 mg .15385 14.06795 .991 -28.3773 28.6850 
8 mg 
3 mg 2.38462 14.06795 .866 -26.1465 30.9157 
5 mg -.15385 14.06795 .991 -28.6850 28.3773 
*. The mean difference is significant at the 0.05 level. 
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Appendix Table 2.4: Effect of Donor Age and Body Weight on Superovulation Performance 
(Experiment 4) 
Descriptives 
 N Mean Std. 
Deviation 
Std. 
Error 
95% Confidence 
Interval for Mean 
Minimum Maximum 
Lower 
Bound 
Upper 
Bound 
Number of 
CL 
2-4 y, 15-25 kg 10 3.3000 4.02906 1.27410 .4178 6.1822 .00 11.00 
2-4 y, >25 kg 10 11.7000 8.69291 2.74894 5.4815 17.9185 .00 24.00 
>4 y, 15-25 kg 10 3.3000 5.81282 1.83818 -.8582 7.4582 .00 16.00 
>4 y, > 25 kg 10 1.4000 2.87518 .90921 -.6568 3.4568 .00 9.00 
Total 40 4.9250 6.87018 1.08627 2.7278 7.1222 .00 24.00 
Number of 
anovulated 
follicle 
2-4 y, 15-25 kg 10 3.3000 5.33437 1.68688 -.5160 7.1160 .00 12.00 
2-4 y, >25 kg 10 5.2000 8.66410 2.73983 -.9979 11.3979 .00 22.00 
>4 y, 15-25 kg 10 2.9000 3.17805 1.00499 .6266 5.1734 .00 8.00 
>4 y, > 25 kg 10 5.1000 5.62633 1.77920 1.0752 9.1248 .00 15.00 
Total 40 4.1250 5.88430 .93039 2.2431 6.0069 .00 22.00 
Total 
stimulation 
2-4 y, 15-25 kg 10 6.6000 6.04060 1.91021 2.2788 10.9212 .00 18.00 
2-4 y, >25 kg 10 16.9000 13.19470 4.17253 7.4611 26.3389 4.00 38.00 
>4 y, 15-25 kg 10 6.2000 6.32104 1.99889 1.6782 10.7218 .00 17.00 
>4 y, > 25 kg 10 6.5000 5.10446 1.61417 2.8485 10.1515 .00 15.00 
Total 40 9.0500 9.21523 1.45706 6.1028 11.9972 .00 38.00 
Number of 
embryo 
2-4 y, 15-25 kg 10 1.1000 1.72884 .54671 -.1367 2.3367 .00 5.00 
2-4 y, >25 kg 10 5.1000 5.19508 1.64283 1.3837 8.8163 .00 14.00 
>4 y, 15-25 kg 10 .2000 .42164 .13333 -.1016 .5016 .00 1.00 
>4 y, > 25 kg 10 .8000 2.20101 .69602 -.7745 2.3745 .00 7.00 
Total 40 1.8000 3.45075 .54561 .6964 2.9036 .00 14.00 
Number of 
unfertilised 
oocyte 
2-4 y, 15-25 kg 10 .0000 .00000 .00000 .0000 .0000 .00 .00 
2-4 y, >25 kg 10 .1000 .31623 .10000 -.1262 .3262 .00 1.00 
>4 y, 15-25 kg 10 .3000 .94868 .30000 -.3786 .9786 .00 3.00 
>4 y, > 25 kg 10 .0000 .00000 .00000 .0000 .0000 .00 .00 
Total 40 .1000 .49614 .07845 -.0587 .2587 .00 3.00 
Degenerate
d embryo 
2-4 y, 15-25 kg 10 .2000 .42164 .13333 -.1016 .5016 .00 1.00 
2-4 y, >25 kg 10 .2000 .42164 .13333 -.1016 .5016 .00 1.00 
>4 y, 15-25 kg 10 .1000 .31623 .10000 -.1262 .3262 .00 1.00 
>4 y, > 25 kg 10 .1000 .31623 .10000 -.1262 .3262 .00 1.00 
Total 40 .1500 .36162 .05718 .0343 .2657 .00 1.00 
(continued) 
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N Mean Std. 
Deviation 
Std. Error 95% Confidence 
Interval for Mean 
Minimum Maximum 
Lower 
Bound 
Lower 
Bound 
Transferrable 
embryo 
2-4 y, 15-25 kg 10 .6000 1.57762 .49889 -.5286 1.7286 .00 5.00 
2-4 y, >25 kg 10 4.9000 5.36346 1.69607 1.0632 8.7368 .00 14.00 
>4 y, 15-25 kg 10 .0000 .00000 .00000 .0000 .0000 .00 .00 
>4 y, > 25 kg 10 .7000 2.21359 .70000 -.8835 2.2835 .00 7.00 
Total 40 1.5500 3.50055 .55349 .4305 2.6695 .00 14.00 
Structures 
recovery 
2-4 y, 15-25 kg 10 1.1000 1.72884 .54671 -.1367 2.3367 .00 5.00 
2-4 y, >25 kg 10 5.2000 5.13809 1.62481 1.5244 8.8756 .00 14.00 
>4 y, 15-25 kg 10 .5000 1.26930 .40139 -.4080 1.4080 .00 4.00 
>4 y, > 25 kg 10 .8000 2.20101 .69602 -.7745 2.3745 .00 7.00 
Total 40 1.9000 3.47002 .54866 .7902 3.0098 .00 14.00 
Ovulation 
percentage 
2-4 y, 15-25 kg 10 43.3333 49.81447 15.75272 7.6982 78.9685 .00 100.00 
2-4 y, >25 kg 10 78.6374 35.72919 11.29856 53.0783 104.1965 .00 100.00 
>4 y, 15-25 kg 10 29.1340 42.80325 13.53558 -1.4856 59.7536 .00 100.00 
>4 y, > 25 kg 10 29.0000 46.77369 14.79114 -4.4599 62.4599 .00 100.00 
Total 40 45.0262 47.07369 7.44300 29.9713 60.0811 .00 100.00 
Recovery rate 
2-4 y, 15-25 kg 10 16.3000 22.92524 7.24960 -.0997 32.6997 .00 63.00 
2-4 y, >25 kg 10 50.5000 38.10585 12.05013 23.2407 77.7593 .00 100.00 
>4 y, 15-25 kg 10 7.5000 16.87371 5.33594 -4.5707 19.5707 .00 50.00 
>4 y, > 25 kg 10 12.8000 27.78009 8.78484 -7.0727 32.6727 .00 78.00 
Total 40 21.7750 31.50131 4.98079 11.7004 31.8496 .00 100.00 
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ANOVA 
 Sum of 
Squares 
df Mean Square F Sig. 
Number of CL 
Between Groups 636.075 3 212.025 6.336 .001 
Within Groups 1204.700 36 33.464   
Total 1840.775 39    
Number of anovulated 
follicle 
Between Groups 42.875 3 14.292 .393 .758 
Within Groups 1307.500 36 36.319   
Total 1350.375 39    
Total stimulation 
Between Groups 822.500 3 274.167 3.965 .015 
Within Groups 2489.400 36 69.150   
Total 3311.900 39    
Number of embryo 
Between Groups 149.400 3 49.800 5.691 .003 
Within Groups 315.000 36 8.750   
Total 464.400 39    
Number of unfertilised 
Between Groups .600 3 .200 .800 .502 
Within Groups 9.000 36 .250   
Total 9.600 39    
Degenerated embryo 
Between Groups .100 3 .033 .240 .868 
Within Groups 5.000 36 .139   
Total 5.100 39    
Tranferable embryo 
Between Groups 152.500 3 50.833 5.624 .003 
Within Groups 325.400 36 9.039   
Total 477.900 39    
Structures recovery 
Between Groups 147.000 3 49.000 5.468 .003 
Within Groups 322.600 36 8.961   
Total 469.600 39    
Ovulation percentage 
Between Groups 16419.792 3 5473.264 2.815 .053 
Within Groups 70001.576 36 1944.488   
Total 86421.369 39    
Recovery rate 
Between Groups 11394.275 3 3798.092 5.007 .005 
Within Groups 27306.700 36 758.519   
Total 38700.975 39    
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Multiple Comparisons 
Dependent 
Variable 
(I) treatment (J) treatment Mean 
Difference  
(I-J) 
Std. Error Sig. 95% Confidence Interval 
Lower 
Bound 
Upper 
Bound 
Number of CL 
2-4y,15-25kg 
2-4 y, >25 kg -8.40000* 2.58704 .003 -13.6468 -3.1532 
>4 y, 15-25 kg .00000 2.58704 1.000 -5.2468 5.2468 
>4 y, > 25 kg 1.90000 2.58704 .467 -3.3468 7.1468 
2-4 y, >25 kg 
2-4 y, 15-25 kg 8.40000* 2.58704 .003 3.1532 13.6468 
>4 y, 15-25 kg 8.40000* 2.58704 .003 3.1532 13.6468 
>4 y, > 25 kg 10.30000* 2.58704 .000 5.0532 15.5468 
>4 y, 15-25 
kg 
2-4 y, 15-25 kg .00000 2.58704 1.000 -5.2468 5.2468 
2-4 y, >25 kg -8.40000* 2.58704 .003 -13.6468 -3.1532 
>4 y, > 25 kg 1.90000 2.58704 .467 -3.3468 7.1468 
>4 y, > 25 kg 
2-4 y, 15-25 kg -1.90000 2.58704 .467 -7.1468 3.3468 
2-4 y, >25 kg -10.30000* 2.58704 .000 -15.5468 -5.0532 
>4 y, 15-25 kg -1.90000 2.58704 .467 -7.1468 3.3468 
Number of 
unovulated follicle 
2-4 y, 15-25 
kg 
2-4 y, >25 kg -1.90000 2.69516 .485 -7.3660 3.5660 
>4 y, 15-25 kg .40000 2.69516 .883 -5.0660 5.8660 
>4 y, > 25 kg -1.80000 2.69516 .508 -7.2660 3.6660 
2-4 y, >25 kg 
2-4 y, 15-25 kg 1.90000 2.69516 .485 -3.5660 7.3660 
>4 y, 15-25 kg 2.30000 2.69516 .399 -3.1660 7.7660 
>4 y, > 25 kg .10000 2.69516 .971 -5.3660 5.5660 
>4 y, 15-25 
kg 
2-4 y, 15-25 kg -.40000 2.69516 .883 -5.8660 5.0660 
2-4 y, >25 kg -2.30000 2.69516 .399 -7.7660 3.1660 
>4 y, > 25 kg -2.20000 2.69516 .420 -7.6660 3.2660 
>4 y, > 25 kg 
2-4 y, 15-25 kg 1.80000 2.69516 .508 -3.6660 7.2660 
2-4 y, >25 kg -.10000 2.69516 .971 -5.5660 5.3660 
>4 y, 15-25 kg 2.20000 2.69516 .420 -3.2660 7.6660 
Total stimulation 
2-4 y, 15-25 
kg 
2-4 y, >25 kg -10.30000* 3.71887 .009 -17.8422 -2.7578 
>4 y, 15-25 kg .40000 3.71887 .915 -7.1422 7.9422 
>4 y, > 25 kg .10000 3.71887 .979 -7.4422 7.6422 
2-4 y, >25 kg 
2-4 y, 15-25 kg 10.30000* 3.71887 .009 2.7578 17.8422 
>4 y, 15-25 kg 10.70000* 3.71887 .007 3.1578 18.2422 
>4 y, > 25 kg 10.40000* 3.71887 .008 2.8578 17.9422 
>4 y, 15-25 
kg 
2-4 y, 15-25 kg -.40000 3.71887 .915 -7.9422 7.1422 
2-4 y, >25 kg -10.70000* 3.71887 .007 -18.2422 -3.1578 
>4 y, > 25 kg -.30000 3.71887 .936 -7.8422 7.2422 
>4 y, > 25 kg 
2-4 y, 15-25 kg -.10000 3.71887 .979 -7.6422 7.4422 
2-4 y, >25 kg -10.40000* 3.71887 .008 -17.9422 -2.8578 
>4 y, 15-25 kg .30000 3.71887 .936 -7.2422 7.8422 
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Dependent 
Variable 
(I) treatment (J) treatment Mean 
Difference  
(I-J) 
Std. Error Sig. 95% Confidence 
Interval 
Lower 
Bound 
Lower 
Bound 
Number of 
embryo 
2-4 y, 15-25 
kg 
2-4 y, >25 kg -4.00000* 1.32288 .005 -6.6829 -1.3171 
>4 y, 15-25 kg .90000 1.32288 .501 -1.7829 3.5829 
>4 y, > 25 kg .30000 1.32288 .822 -2.3829 2.9829 
2-4 y, >25 kg 
2-4 y, 15-25 kg 4.00000* 1.32288 .005 1.3171 6.6829 
>4 y, 15-25 kg 4.90000* 1.32288 .001 2.2171 7.5829 
>4 y, > 25 kg 4.30000* 1.32288 .003 1.6171 6.9829 
>4 y, 15-25 
kg 
2-4 y, 15-25 kg -.90000 1.32288 .501 -3.5829 1.7829 
2-4 y, >25 kg -4.90000* 1.32288 .001 -7.5829 -2.2171 
>4 y, > 25 kg -.60000 1.32288 .653 -3.2829 2.0829 
>4 y, > 25 kg 
2-4 y, 15-25 kg -.30000 1.32288 .822 -2.9829 2.3829 
2-4 y, >25 kg -4.30000* 1.32288 .003 -6.9829 -1.6171 
>4 y, 15-25 kg .60000 1.32288 .653 -2.0829 3.2829 
Number of 
unfertilised oocyte 
2-4 y, 15-25 
kg 
2-4 y, >25 kg -.10000 .22361 .657 -.5535 .3535 
>4 y, 15-25 kg -.30000 .22361 .188 -.7535 .1535 
>4 y, > 25 kg .00000 .22361 1.000 -.4535 .4535 
2-4 y, >25 kg 
2-4 y, 15-25 kg .10000 .22361 .657 -.3535 .5535 
>4 y, 15-25 kg -.20000 .22361 .377 -.6535 .2535 
>4 y, > 25 kg .10000 .22361 .657 -.3535 .5535 
>4 y, 15-25 
kg 
2-4 y, 15-25 kg .30000 .22361 .188 -.1535 .7535 
2-4 y, >25 kg .20000 .22361 .377 -.2535 .6535 
>4 y, > 25 kg .30000 .22361 .188 -.1535 .7535 
>4 y, > 25 kg 
2-4 y, 15-25 kg .00000 .22361 1.000 -.4535 .4535 
2-4 y, >25 kg -.10000 .22361 .657 -.5535 .3535 
>4 y, 15-25 kg -.30000 .22361 .188 -.7535 .1535 
Degenerated 
embryo 
2-4 y, 15-25 
kg 
2-4 y, >25 kg .00000 .16667 1.000 -.3380 .3380 
>4 y, 15-25 kg .10000 .16667 .552 -.2380 .4380 
>4 y, > 25 kg .10000 .16667 .552 -.2380 .4380 
2-4 y, >25 kg 
2-4 y, 15-25 kg .00000 .16667 1.000 -.3380 .3380 
>4 y, 15-25 kg .10000 .16667 .552 -.2380 .4380 
>4 y, > 25 kg .10000 .16667 .552 -.2380 .4380 
>4 y, 15-25 
kg 
2-4 y, 15-25 kg -.10000 .16667 .552 -.4380 .2380 
2-4 y, >25 kg -.10000 .16667 .552 -.4380 .2380 
>4 y, > 25 kg .00000 .16667 1.000 -.3380 .3380 
>4 y, > 25 kg 
2-4 y, 15-25 kg -.10000 .16667 .552 -.4380 .2380 
2-4 y, >25 kg -.10000 .16667 .552 -.4380 .2380 
>4 y, 15-25 kg .00000 .16667 1.000 -.3380 .3380 
(continued) 
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Dependent 
Variable 
(I) treatment (J) treatment Mean 
Difference  
(I-J) 
Std. Error Sig. 95% Confidence 
Interval 
Lower 
Bound 
Lower 
Bound 
Transferrable 
embryo 
2-4 y, 15-25 
kg 
2-4 y, >25 kg -4.30000* 1.34454 .003 -7.0268 -1.5732 
>4 y, 15-25 kg .60000 1.34454 .658 -2.1268 3.3268 
>4 y, > 25 kg -.10000 1.34454 .941 -2.8268 2.6268 
2-4 y, >25 kg 
2-4 y, 15-25 kg 4.30000* 1.34454 .003 1.5732 7.0268 
>4 y, 15-25 kg 4.90000* 1.34454 .001 2.1732 7.6268 
>4 y, > 25 kg 4.20000* 1.34454 .004 1.4732 6.9268 
>4 y, 15-25 
kg 
2-4 y, 15-25 kg -.60000 1.34454 .658 -3.3268 2.1268 
2-4 y, >25 kg -4.90000* 1.34454 .001 -7.6268 -2.1732 
>4 y, > 25 kg -.70000 1.34454 .606 -3.4268 2.0268 
>4 y, > 25 kg 
2-4 y, 15-25 kg .10000 1.34454 .941 -2.6268 2.8268 
2-4 y, >25 kg -4.20000* 1.34454 .004 -6.9268 -1.4732 
>4 y, 15-25 kg .70000 1.34454 .606 -2.0268 3.4268 
Structures 
recovery 
 
2-4 y, 15-25 
kg 
2-4 y, >25 kg -4.10000* 1.33874 .004 -6.8151 -1.3849 
>4 y, 15-25 kg .60000 1.33874 .657 -2.1151 3.3151 
>4 y, > 25 kg .30000 1.33874 .824 -2.4151 3.0151 
2-4 y, >25 kg 
2-4 y, 15-25 kg 4.10000* 1.33874 .004 1.3849 6.8151 
>4 y, 15-25 kg 4.70000* 1.33874 .001 1.9849 7.4151 
>4 y, > 25 kg 4.40000* 1.33874 .002 1.6849 7.1151 
>4 y, 15-25 
kg 
2-4 y, 15-25 kg -.60000 1.33874 .657 -3.3151 2.1151 
2-4 y, >25 kg -4.70000* 1.33874 .001 -7.4151 -1.9849 
>4 y, > 25 kg -.30000 1.33874 .824 -3.0151 2.4151 
>4 y, > 25 kg 
2-4 y, 15-25 kg -.30000 1.33874 .824 -3.0151 2.4151 
2-4 y, >25 kg -4.40000* 1.33874 .002 -7.1151 -1.6849 
>4 y, 15-25 kg .30000 1.33874 .824 -2.4151 3.0151 
Ovulation 
percentage 
2-4 y, 15-25 
kg 
2-4 y, >25 kg -35.30405 19.72049 .082 -75.2991 4.6909 
>4 y, 15-25 kg 14.19935 19.72049 .476 -25.7957 54.1943 
>4 y, > 25 kg 14.33333 19.72049 .472 -25.6617 54.3283 
2-4 y, >25 kg 
2-4 y, 15-25 kg 35.30405 19.72049 .082 -4.6909 75.2991 
>4 y, 15-25 kg 49.50340* 19.72049 .017 9.5084 89.4984 
>4 y, > 25 kg 49.63739* 19.72049 .016 9.6424 89.6324 
>4 y, 15-25 
kg 
2-4 y, 15-25 kg -14.19935 19.72049 .476 -54.1943 25.7957 
2-4 y, >25 kg -49.50340* 19.72049 .017 -89.4984 -9.5084 
>4 y, > 25 kg .13399 19.72049 .995 -39.8610 40.1290 
>4 y, > 25 kg 
2-4 y, 15-25 kg -14.33333 19.72049 .472 -54.3283 25.6617 
2-4 y, >25 kg -49.63739* 19.72049 .016 -89.6324 -9.6424 
>4 y, 15-25 kg -.13399 19.72049 .995 -40.1290 39.8610 
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Dependent 
Variable 
(I) treatment (J) treatment Mean 
Difference  
(I-J) 
Std. Error Sig. 95% Confidence 
Interval 
Lower 
Bound 
Lower 
Bound 
Recovery rate 
2-4 y, 15-25 
kg 
2-4 y, >25 kg -34.20000* 12.31681 .009 -59.1797 -9.2203 
>4 y, 15-25 kg 8.80000 12.31681 .480 -16.1797 33.7797 
>4 y, > 25 kg 3.50000 12.31681 .778 -21.4797 28.4797 
2-4 y, >25 kg 
2-4 y, 15-25 kg 34.20000* 12.31681 .009 9.2203 59.1797 
>4 y, 15-25 kg 43.00000* 12.31681 .001 18.0203 67.9797 
>4 y, > 25 kg 37.70000* 12.31681 .004 12.7203 62.6797 
>4 y, 15-25 
kg 
2-4 y, 15-25 kg -8.80000 12.31681 .480 -33.7797 16.1797 
2-4 y, >25 kg -43.00000* 12.31681 .001 -67.9797 -18.0203 
>4 y, > 25 kg -5.30000 12.31681 .670 -30.2797 19.6797 
>4 y, > 25 kg 
2-4 y, 15-25 kg -3.50000 12.31681 .778 -28.4797 21.4797 
2-4 y, >25 kg -37.70000* 12.31681 .004 -62.6797 -12.7203 
>4 y, 15-25 kg 5.30000 12.31681 .670 -19.6797 30.2797 
*. The mean difference is significant at the 0.05 level. 
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APPENDIX 4: OESTRUS DISTRIBUTION 
 
 
Figure Appendix 4.1: Distribution of oestrus after CIDR removal. 
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